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Chapter 1 
Introduction 
10 
1.1 The necessity for early detection of divergent arterial 
stiffness 
Globally, cardiovascular diseases (CVDs) are the number one cause of death. In 
2014, an estimated 20 million people died from CVDs, representing 30% of all 
global deaths [1]. Smoking, unhealthy diet, physical inactivity and excessive use of 
alcohol are the most important behavioral risk factors of CVDs. As an effect, 
individuals may develop hypertension, diabetes, heart failure or atherosclerosis, 
most of which are related to a change in arterial stiffness. Considering the wide 
spread of CVDs in the world, there is a strong need for an easy and quick 
prognostic indicator to determine divergent arterial stiffness to support in early 
diagnosis of CVDs. 
1.2 Pulse wave velocity as arterial stiffness measure 
Arterial stiffness is most commonly used to express the viscoelastic property of the 
arterial wall, which describes the relationship between change in pressure and 
change in arterial volume [2]. Therefore, arterial stiffness, or its inverse the arterial 
compliance, is a reliable prognostic indicator of cardiovascular morbidity and 
mortality in the adult population [3-5]. The compliance (C ) is a measure of the 
elasticity of the arteries and is defined as 
  (1.1) 
where ∆V is the change in arterial volume and ∆P the change in blood pressure 
[6]. At any given pressure change, the volume of stiffer vessels change less than 
that of more compliant vessels. The arterial stiffness of a blood vessel is of crucial 
importance because the elastic walls of the arteries attenuate the systolic pressure 
wave of each heartbeat. The potential energy stored in the vessel walls during 
systole is used to continue to continue propeling the blood during the diastole 
between successive heartbeats [2].  
The effect of increased arterial stiffness, and thus reduced arterial compliance, is a 
decreased propagation time of pressure pulse waves (PWs) through the vessels 
and thus an increase of the velocity (PWV) of the PWs [7, 8]. Therefore, the gold 
standard for determining arterial stiffness is measuring the PWV[9]. The PWV is 
inversely related to arterial distensiblility [10-12] and is directly related to the 
incremental elastic modulus Einc,vessel and vessel wall thickness hvessel, and inversely 
P
VC 

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related to the vessel radius rvessel by the Moens-Korteweg equation (with ρblood the 
density of blood) [13]:  
2
inc
blood
E hPWV
r 
    (1.2) 
As a consequence, PWV is widely used as an index of elasticity of the vessel wall 
and arterial stiffness [12]. The PWV is commonly measured as an average speed of 
a PW between two locations on the body or along an arterial trajectory. The 
assessment of the PWV involves measurement of two quantities:  
 the distance between both recording sites (d )  
 the transit time of the PW along that distance (t ) 
dPWV
t
   (1.3) 
Note that the PWV is not the speed of blood, but the speed of the pressure pulse 
traveling through the (usually also moving) blood. Therefore, a PW is comparable 
to a sound wave. For the evaluation of cardiovascular (CV) risk, the PWV can be 
measured both invasively and non-invasively and is highly reproducible [14]. 
In clinical practice, the PWV is generally determined over the carotid-femoral 
trajectory or the brachial-ankle trajectory. Depending on age, in healthy subjects 
the PWV is about 6-10 m/s over the carotid-femoral trajectory. In cardiovascular 
risk patients the PWV can be as high as 20 m/s over the same trajectory [8, 15, 
16], which is two to three times as high as in healthy subjects. 
1.3 State of the art  
Several non-invasive techniques for measuring PWV are currently clinically 
available, such as [17-19]: 
 the SphygmoCor system (AtCor Medical, West Ryde, Australia), which 
measures PWV via carotid tonometry and a thigh sphygmomanometer 
cuff, 
 the Arteriograph system (Tensiomed, Budapest, Hungary), which 
measures PWV by analysis of the oscillometric pressure curves registered 
on the upper arm, 
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 and the Complior system (Alam Medical, Saint Quentin Fallavier, France), 
which measures PWV by means of piezo-electronic pressure transducers 
placed at the neck and at the groin.  
The Arteriography system uses the pressure curves on the upper arm to analyze 
the time difference between the beginning of a PW and the beginning of the 
succeeding PW, related to the distance from the jugulum to the symphysis [18]. 
This provides a PWV value as a global measurement of the PWV over the whole 
body and not the PWV of a particular section of an arterial vascular trajectory. 
The drawback of the Sphygmocor and Complior systems is that they require two 
separate and rather large sensors to be placed on the patients. Limitations of these 
techniques include the difficulty of accurately positioning the sensors, and the 
discrepancy between the measured distance between the sensors and the actual 
path length travelled by the PWs. For this purpose magnetic resonance imaging 
could can be used. However, measuring the actual path length with the aid of such 
medical imaging techniques is too expensive and time-consuming in clinical 
practice.  
The systems described above are sub-optimal for use in clinical practice. The 
sensor clip used with the Complior is placed around the neck, which may be 
experienced as uncomfortable, and the system requires placement of two sensors 
on different locations of the body. With the SphygmoCor system it is not possible 
to fix the sensor on the patient’s carotic artery: it has to be kept steady by an 
operator. These aspects limit the suitability of these systems as monitoring 
devices. When using a sphygmomanometer cuff to measure the PWV, the blood 
flow will temporarily be disturbed, causing an unknown impact on the PWV 
measurements during monitoring. Other disadvantages of the existing systems are 
their prolonged learning periods for becoming an experienced operator and that 
the devices lack versatility [19]. 
1.4 Goal 
It would be beneficial if PWV measurements could be performed while integrated 
into currently available medical devices. One of the simplest potentially suitable 
devices broadly used in the clinic are the commonly available finger clip 
PPG-sensors used for SpO2 and pulse rate monitoring. Clinical practice could 
benefit from such a device that can measure the PWV over a short distance, using 
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a simple technique that is already familiar to clinicians, while being comfortable for 
patients and easy-to-use. 
Therefore, the goal of this Ph.D. study was to develop and validate a non-invasive, 
PPG-based device for peripheral measurement of the PWV on the finger. To that 
purpose, the following aims were formulated: 
 to confirm the value of peripheral PWV measurements, 
 to design and technically validate a PPG-based device for measuring PWV 
in the finger, 
 to validate the developed device in clinical studies. 
1.5 Approach & Outline  
This thesis consists of two main parts. Part I - Substantiation, shows the value of 
peripheral PWV measurements and provides a platform-independent and 
measurement technique independent algorithm for improvement of PWV 
measurements. Part II - Development & Validation, describes the design, technical 
validation, testing, further improvement and final validation of the Multi Photodiode 
Array, the PWV measurement device developed during this Ph.D. study. A more 
detailed outline is provided below. 
 Part I Substantiation 
Chapter 2: During pilot measurements and earlier studies using existing techniques 
for PWV and PTT (Pulse Transit Time, the time a PW takes to travel from one point 
to another: PWV=distance/PTT) measurements, it appeared that many PWs get 
distorted when patients move or have severe vascular disease. These distorted 
PWs affect PWV and PTT values, undermining the reliability of such metrics in 
clinical practice. Therefore, a ‘7-Step PW Filter’ was developed with the aim to 
eliminate pulse waves that are unsuitable for common PWV and PTT analysis 
methods from PPG signals. 
Chapter 3: Several PWV and PTT measuring methods are based on assessing the 
time between the ECG R-peak of a heartbeat and the successive arrival of the PWV 
at a peripheral point on a vascular trajectory. However, this time consists of two 
parts: the pre-ejection period (PEP), which is the time between the ECG R-peak 
and the moment the PW actually leaves the heart, and the Vascular Transit Time 
(VTT), the time needed by the PW to travel from the heart to the peripheral 
measurement point. If the PEP were of the same or larger order of magnitude than 
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the VTT, as these values may reflect more how fast the heart can built up pressure 
than the state of the vascular system. After all, in such cases these values may tell 
more about how fast the heart can build up pressure, than about the state of the 
vascular system. A study on healthy volunteers and patients was done in order to 
estimate the variability of PEP at rest and to establish the accuracy or PTT as an 
approximation for VTT. 
Chapter 4: Before upper limb surgery under locoregional anesthesia, an axillary 
brachial plexus block is used to desensitise and demobilize the arm, which also 
releases vascular tone. Currently, testing whether a patient can sense a cold-pack 
on the upper limb’s skin is used to verify the effect of the axillary brachial plexus 
block. In this chapter, peripheral measurements were used to explore whether PTT 
can be used to objectively, reliably, and quickly establish the state of the vascular 
system.  
Chapter 5: Pain is a sensation that is highly subjective, but also has objective 
aspects. Tests for determining whether a patient experiences pain are based on 
obtaining feedback from an individual and therefore require individuals to be 
conscious and able to communicate. Therefore, having an objective measure for 
nociception (which, simply put, is the objective part of pain caused by physical 
stimuli), would be of great value in many clinical settings, such as to determine 
whether patients under anesthesia experience nociception during surgery. A study 
on healthy volunteers was done to investigate whether an effect of heat-induced 
pain stimuli on PTT and pulse wave amplitude could be measured using a PPG-
based technique. 
Part II Development & Validation 
Chapter 6: This chapter describes the design and validation of the Multi Photodiode 
Array (MPA), a PPG-based system for PWV measurements on the finger that also 
measures heart rate, pulse wave amplitude and peripheral PTT, and could also 
measure SpO2. The accuracy of the MPA system was determined through an 
experiment with a focused light dot scanning over the MPA with known velocity. 
The tested velocities matched the broad range of PWVs known from literature to 
have been measured in volunteers and patients. The aim of this study was to 
verify the functionality of the MPA. 
Chapter 7: An experiment was conducted on healthy volunteers between 20 and 
30 years old. PWVs were measured with, two different systems (Biopac and 
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Complior) over two different trajectories. to investigate whether these provided 
comparable results. This was done because in clinical practice it is crucial to know 
whether using different devices for the same purpose provides the same outcome. 
Chapter 8: During one volunteers study and two patient studies (described in 
Appendices 8.A to 8.C) it was noticed that the technically validated MPA provided 
extremely varying and unlikely PWV values in practice. A systematic investigation 
was conducted to discover the cause of these outcomes and to determine a 
standardized, optimal use condition for the MPA sensor that would provide reliable 
and consistent PWV measurements. 
Chapter 9: A final clinical validation study was done by applying the optimal use 
condition of the MPA determined in Chapter 8 to measure PWV in healthy 
volunteers of two age groups (18-35 years old and 55+). The measurements were 
done both in baseline situations and during application of a ‘flow mediated 
dilation’-technique, a standard test for measuring endothelial dysfunction. This was 
done to investigate whether the MPA results correspond with gold-standard PWV 
and to validate the optimal use condition from Chapter 8. 
Chapter 10: The technical software and hardware developments and validations, 
the four studies on healthy volunteers and four patient studies that formed this 
Ph.D. study are discussed in this final chapter. Advice is given about the 
application of the MPA and suggestions for future research are given to guide the 
further development of the MPA into an elegant, economical, easy-to-use medical 
device for measuring all sorts of PPG-based physiological parameters at the finger.  
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 Photoplethysmography (PPG) is a widely available non invasive optical technique to
visualize    pressure  pulse  waves  (PWs).  Pulse  transit  time  (PTT)  is  a  physiological
parameter  that  is  often derived  from calculations on ECG‐  and PPG  signals  and  is
based on tightly defined characteristics of the PW shape. PPG‐signals are sensitive
to artefacts. Coughing or movement of the subject can affect PW shapes that much
that the PWs become unsuitable for further analysis. The aim of this study was to
develop an algorithm that automatically and objectively eliminates unsuitable PWs.
In order to develop a proper algorithm for eliminating unsuitable PWs, a literature
study  was  conducted.  Next,  a  ‘7Step  PW  Filter’  algorithm  was  developed  that
applies 7 criteria to determine whether a PW matches the characteristics required
to allow PTT calculation. To validate whether the ‘7Step PW‐Filter’ eliminates only
and  all  unsuitable  PWs,  its  elimination  results were  compared  to  the  outcome of
manual  elimination  of  unsuitable  PWs.  The  ‘7Step  PW‐Filter’  had  a  sensitivity  of
96.3% and a specificity of 99.3%. The overall accuracy of  the  ‘7Step PW‐Filter’  for
detection of unsuitable PWs was 99.3%. Compared to manual elimination, using the
‘7Step PW Filter’ reduces PW elimination times from hours to minutes and helps to
increase the validity, reliability and reproducibility of PTT data. 
Increasing accuracy of pulse transit time measurements 
by automated elimination of distorted 
photoplethysmography waves 
Chapter 2
Marit H.N. van Velzen, Arjo J. Loeve, Sjoerd P. Niehof, Egbert G. Mik 
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2.1  Introduction  
Photoplethysmography (PPG) is a widely available non-invasive optical technique 
that uses infrared light and photodiodes to visualize the pressure pulse waves 
(PWs) in blood vessels by measuring the volumetric changes of pulsating blood 
and thus the expansion and contraction of the vessels. These PWs result from the 
contraction of the heart when the blood is pumped through the body [1]. 
PPG enables continuous measurement of the PWs [2, 3] and is routinely used in 
everyday medicine for measuring physiological parameters such as heart rate, 
blood oxygen saturation (SpO2), Pulse Wave Velocity (PWV) and Pulse Transit Time 
(PTT) [1]. PTT is usually defined as the propagation time of a PW going from the 
heart to the peripheral arteries and is calculated as the time between the R-peak 
of the ECG and a reference point on the PW measured using PPG (see Figure 2.1). 
PTT is commonly used for assessing arterial stiffness, vessel compliance and 
sympathetic activity in sleep apnoea patients [4], for measuring endothelial 
function [5] and as indicator for arterial blood pressure [6]. Generally, PTT is 
inversely related to PWV [7]. PWV may be considered as the gold standard 
measure of arterial stiffness [8, 9], which is a very reliable prognostic parameter 
for cardiovascular diseases [10-12]. Therefore, PTT is considered to be very useful 
for studying cardiovascular diseases.  
The calculation of PTT is based on tightly defined characteristics of the PW-shape. 
 
 Figure 2.1: Graphical explanation of PTT calculation when using the PW foot as the landmark that 
indicates arrival of the PW. PTT = Pulse Transit Time, ECG = Electrocardiogram, 
PPG = Photoplethysmography 
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PWs measured using PPG are artefact sensitive to talking, moving, breathing and 
temperature-changes [1]. These artefacts can disturb the shapes of the PWs in 
such a way that the PWs become unsuitable for further analysis. However, when 
such unsuitable PWs are nevertheless used for further analysis, nonactual values of 
calculated parameters may result, which may lead to misinterpretation or even 
misdiagnosis in clinical practice. Such nonactual values may easily be left unnoticed 
as these may still fall within the range of commonly encountered values.  
Using an algorithm to eliminate unsuitable PWs based on their shape, instead of 
using, for example, the bandpass-filtering-method [13] probably gives more 
reliable results. The bandpass-filtering-method ignores the fact that a PW within 
that band is not always suitable, and a PW outside that band is not always 
unsuitable, which easily results in false positive and false negative filtering results. 
In addition, the bandpass-filtering-method does not exclude unsuitable PWs. This 
paper describes and evaluates an algorithm for assessing the suitability of a PW for 
PTT-analyses based on the reference points detected on the PW.  
During PTT-measurement in clinical experiments, thousands of PWs may be 
recorded and may have to be checked manually, as is often done in studies 
described in literature (see Table 2.1), which is obviously highly time consuming. 
Furthermore, manual assessment of PWs is prone to cause variations due to 
subjective interpretations. 
The goal of this study was to develop an automated filtering method to quickly and 
objectively eliminate unsuitable PWs. This algorithm should provide consistent and 
reproducible results and increase the reliability of PTT-values that are calculated 
based on PW characteristics. Although, ECG-signal artefacts may also cause 
nonactual PTT-values, this article focuses  on the PW-shape.  
2.2  Materials and methods 
2.2.1  Literature study 
In order to develop a proper algorithm for eliminating unsuitable PWs, it should 
first be clear how the suitability of a PW for PTT calculation should be defined. In 
literature, the foot, minimum value, point of steepest ascend, or peak or maximum 
value of a pulse wave are the locations on the PW that are commonly used to 
calculate the PTT. These locations are all used under the assumption that every 
PW has a certain characteristic shape and that the arrival of such a location on the 
PW indicates the arrival of the PW. In order to enable automated extraction of 
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such data, it should be well defined where a PW starts and how the characteristic 
shape of this wave should be described.  
For PTT calculations, there are several definitions of PTT, each of which using a 
different location on a PW as the reference point indicating the arrival of the PW. A 
literature study was done to get an overview of methods that are being used to 
calculate the PTT in clinical experiments and to see if and how unsuitable PWs are 
being eliminated. The literature study was conducted in PubMed for studies up to 
25 June 2015 and using the search query: "photoplethysmography" [MeSH Terms] 
OR "photoplethysmography" [All Fields]) AND "pulse transit time" [All Fields] AND 
("humans" [MeSH Terms] AND English[lang]) NOT Review[ptyp]. The query 
returned 53 studies, of which the relevant ones are listed in Table 2.1. Nine studies 
were eliminated because PTT was measured using a different technique than PPG 
or because the study focussed on monitoring devices. Four characteristics of the 
studies were extracted and listed in Table 2.1:  
 Population; 
 Period over which PTT was averaged; 
 Definition of PTT used; 
 Method of filtering applied to the data; 
Table 2.1: Results of the literature review showing how the  PTT was determined in the respective 
studies. The studies are sorted by year and grouped by filtering method. 
Reference Population 
study 
Average period Definition of PTT Filtering 
[14] patients 1, 2min foot :maximum of 2nd 
derivative; 50% is 
maximum of 1st 
derivative; peak: 
maximum of PW 
algorithm 
[15] healthy 
volunteers 
The first 
50consective PWs 
25% peak of PW algorithm 
[16] children >30 heartbeats onset of PW algorithm 
[17] healthy 
volunteers 
1min, 5min upstroke of PW algorithm 
[18] children 30 motion free 
heartbeats 
upstroke of PW algorithm 
[19] healthy 
volunteers 
50 heartbeats 25% peak point of PW algorithm 
[20] healthy 
volunteers 
8s upslope of PW algorithm 
[21] healthy 
volunteers 
5min slope of PW algorithm 
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[22] patients 1min peak of PW filtered, not 
specified 
[23] healthy blood 
donors 
3min, 6min foot, pulse onset of 1st 
derivative PW 
filtered, not 
specified 
[24] healthy 
volunteers 
30s, 2min peak of 1st derivative 
of PW 
manually 
[25] healthy 
volunteers 
1heartbeat 50% peak of PW manually 
[26] healthy 
volunteers 
60 heartbeats foot: minimum; peak: 
maximum 
manually 
[27] healthy 
volunteers 
and patients 
100sec, 400sec foot of PW median 
analysis 
[28] healthy 
volunteers 
1min PTTa: foot of PW; 
PTTb: peak of PW; 
PTTp: 25% of 
amplitude of PW; 
PTTq:max slope of PW 
not 
specified 
[29] children 1min 50% point upstroke of 
PW 
not 
specified 
[30] patients 1heartbeat not specified not 
specified 
[31] not specified n/a cross correlation of ECG 
and derivative PGG 
not 
specified 
[32] patients 5heartbeats, 1min maximal upslope of 
derivative PW 
not 
specified 
[33] patients 1min, 5min foot: signal voltage is 
10% of baseline value 
not 
specified 
[34] healthy 
volunteers 
10s maximum of 1st 
derivative 
not 
specified 
[35] healthy 
volunteers 
not specified foot/onset of the PW not 
specified 
[36] healthy 
volunteers 
and patients 
20-30s foot-foot delay not 
specified 
[37] healthy 
volunteers 
2min, 4min peak of the first 
derivative of PW 
not 
specified 
[38] healthy 
volunteers 
18s foot: onset of PW; 
PTTdp: max derivative 
point 
not 
specified 
[39] healthy 
volunteers 
1min onset of PW not 
specified 
[40] healthy 
volunteers 
1min foot of PW not 
specified 
[41] healthy 
volunteers 
not specified 50% point on the rising 
slope of the PPG signal 
not 
specified 
[42] children not specified 50% point on the rising 
slope of PW 
not 
specified 
[43] children >30 heartbeats upstroke of PW not 
specified 
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[44] healthy 
volunteers 
 25% peak of PW not 
specified 
[45] not specified not specified 5% peak systolic value not 
specified 
[46] healthy 
volunteers 
20s foot of PW not 
specified 
[47] children >30 heartbeats not specified not 
specified 
[48] healthy 
volunteers 
15s PTT1: peak of 2nd 
derivative of PW; PTT2: 
50% of PW; PTT3: 
90% of PW 
not 
specified 
[49] healthy 
volunteers 
2min, 5min Foot; maximal sloop; 
peak 
not 
specified 
[50] healthy 
volunteers 
2min upslope of PW not 
specified 
[2] healthy 
volunteers 
60 heartbeats minimum of PW not 
specified 
[51] patients 2min minimum of PW not 
specified 
[13] children 1heartbeat onset of  PW PTT 
outside 
range of 
150 to 
400ms 
considered 
invalid. 
[52] healthy 
volunteers 
1min foot, onset of the PW visually 
[53] healthy 
volunteers 
and patients 
1min foot/onset of PW visually 
[54] healthy 
volunteers 
5min upstroke of PW visually 
[55] healthy 
volunteers 
15s foot of PW visually 
Population 
The populations described in the studies listed in Table 2.1 consisted of healthy 
volunteers in 26 studies, of a combination of healthy volunteers and patients in 
three studies and of only patients in six studies. In seven studies the population 
consisted of children and in two studies the population was not specified. 
Period over which PTT was averaged 
In many studies the PTT-values used as the outcome measure were not single-PW 
PTT-values of all individual PWs, but were average PTT-values over a certain 
number of heartbeats or a certain period of time. These averaging periods ranged 
Chapter 2 – Increasing accuracy of PTT measurements 25
from 5 heartbeats to 6 minutes. An averaging period of 1 minute was most 
common (10x). The smaller the number of PTT-values included in the averaging 
period, the more sensitive the calculated value will be to unsuitable PWs. Yet, in 
patients having many unsuitable PWs, even PTT-values obtained from long 
averaging periods may be highly affected by unsuitable PWs. 
Definition of PTT used 
The PW foot is the reference point most commonly used (19 studies) in PTT-
analysis to pinpoint the arrival instance of a PW. However, the PW foot was not 
always defined identically. In three studies the foot was defined as the minimum of 
the PW and in three studies the foot was defined as the maximum of the second 
derivative of the PW. In seven studies the ‘onset’ of the PW was defined as its foot 
and six studies did not define what was used as the foot of a PW. In four studies 
the PW peak was taken as the PW arrival instance, while in eight studies the 
maximum upslope of the PW was used. 
Method of filtering applied to the data 
Only seven reports mentioned that unsuitable PWs were eliminated manually or 
visually, but the criteria were not defined clearly or were not mentioned at all. In 
the majority of the studies it was unclear whether or not any PWs were eliminated. 
Some reports mentioned the use of a PW elimination algorithm, but did not specify 
the applied algorithm. Gil et al. used a filter that eliminated any PTT-values below 
150ms or above 400ms before further analysis [13]. Although this filter may 
eliminate PWs that are so heavily distorted that the calculated PTT becomes 
unrealistically low or high, it does not remove any nonactual values that are within 
normal ranges and it may eliminate valid values that simply are unusually low or 
high. 
2.2.2  PW elimination algorithm  
In 1937 Hertzman and Spealman [56] were the first to describe the shape of a PW, 
dividing PWs in two phases: The anacrotic phase consisting of the rising slope of 
the PW, and the catacrotic phase consisting of the falling slope of the PW. In the 
catacrotic phase a dicrotic notch is usually seen in subjects with healthy compliant 
arteries [1]. Common physiological parameters, such as PW-amplitude, PTT and 
PWV, are generally calculated based on the assumption that a PW has the 
described shape. Based on these principles, a PW elimination algorithm was 
formulated that checks whether a PW matches the characteristics of the described 
predefined shape. The algorithm exists of a list of seven criteria that a PW has to 
meet to be deemed a suitable PW (see also Figure 2.2):  
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 S1: The detected PPG foot should precede the detected PPG peak  in time. 
‐ t foot < t peak  
 S2: The detected PPG peak should be in the same heartbeat as the ECG 
R-peak 
‐ t R-peak1  < t peak < t R-peak2 
 S3: The detected PPG foot should be in the same heartbeat as the ECG 
R-peak 
‐ t R-peak1  < t foot < t R-peak2 
 S4:The detected PPG foot should have a lower magnitude than the detected 
PPG peak 
‐ PPG peak – PPG foot  > 0 
 S5: The detected PPG foot must be in an upward slope of the valley of the 
PW 
‐ 1st derivative at PPG foot > 0 
 
Figure 2.2: Graphical representation of the seven PW elimination criteria of the ‘7Step PW-Filter’. ECG = 
Electrocardiogram; PPG = Photoplethysmography. S1: The detected PPG foot should precede the 
detected PPG peak  in time; S2: The detected PPG peak should be in the same heartbeat as the ECG 
R-peak; S3: The detected PPG foot should be in the same heartbeat as the ECG R-peak; S4:The 
detected PPG foot should have a lower magnitude than the detected PPG peak; S5: The detected PPG 
foot must be in an upward slope of the valley of the PW; S6: The PW should be complete; The detected 
PPG peak  should be at a convex maximum of the PW; S7: The steepest rising part of the PW 
(maximum of its 1st derivative) must be situated between the detected PPG foot and the detected PPG 
peak 
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 S6: The PW should be complete; The detected PPG peak  should be at a 
convex maximum of the PW 
‐ 2nd derivative at PPG peak  < 0 
 S7: The steepest rising part of the PW (maximum of its 1st derivative) must 
be situated between the detected PPG foot and the detected PPG peak 
‐ t foot  < t maximum of the 1st derivative < t peak 
If one or more of the criteria are not met by the PW, that PW is deemed unsuitable 
and will be eliminated. This PW elimination algorithm will further be referred to as 
the ‘7Step PW-Filter’. 
2.2.3  PW-analysis 
The ‘7Step PW-Filter’ was validated using a dataset consisting of PWs that were 
collected from the first ten healthy volunteers (7 male, 3 female, ages between 23 
and 25 years) from a previous study conducted by the authors (medical ethics 
committee approval report MEC-2012-489, Erasmus MC, Rotterdam, the 
Netherlands) [57]. In this study, the PTT was measured using two PPG-sensors, 
one on each index finger, (TSD200 with the PPG100C amplifier, Biopac Systems, 
Inc, USA) and three external ECG-leads (ECG100C amplifier, Biopac Systems, Inc, 
USA). 
The three ECG-leads were placed on the subject’s right ankle and both wrists. The 
subject sat in a comfortable position under tranquil conditions and was instructed 
 
Figure 2.3: Examples of PPG-signals and their corresponding ECG-signal for all ten subjects. Each 
example shows the first 10 seconds of the baseline measurements on volunteers under tranquil 
conditions. Subjects 6 and 12 have a PPG-signal without any noticeable artefacts. Subjects 5 and 9 
haves many artefacts, rendering it difficult to identify the suitable PWs. 
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not to talk or move during the measurement. The PWs were measured for 180 or 
300 seconds in each subject. The subjects received 3 painful, heat-induced stimuli 
during the measurements. To give a general impression of the data, Figure 3 
shows 10 seconds of the datasets of all subjects. The figures clearly illustrate that 
it is not always easy to recognise the PWs and their ends or beginnings. 
The system used for measuring PTT registered the subject’s ECG and PPG signals 
which were simultaneously converted to digital signals using AcqKnowledge v3.7.3 
software (Biopac Systems, Inc, USA) at a sampling frequency of 2 kHz. Matlab 
R2010a (The MathWorks, Inc) was used for the data analysis. The PPG-signals 
were filtered with a fourth-order low-pass Butterworth filter with a cut-off 
frequency of 9 Hz. The PTT was determined by calculating the time between the 
R-peak of the ECG (tECG R-peak(n)) and the foot of the PW (tPPG foot(n)): 
( ) ( ) ( )
foot R peakPPG ECG
PTT n t n t n   (2.1) 
where n is the sequence number of the heartbeats. The R-peaks in the ECG were 
found using an off-the-shelf Matlab function called ‘R-peakdetect’ [58]. In order to 
 
Figure 2.4: Examples of unsuitable PWs. Section 1 shows a detected PW foot that is not on the 
beginning of the PW but at the beginning of the clipped dataset. This is not correct because the foot 
has to be at the start of the PW itself and not at the start of the clipped dataset. Section 2 shows a 
detected PW peak being lower than the detected foot of the same PW. This is not correct because the 
peak should always be higher than the foot. Section 3 shows a PW that is non-recognisable at all, 
causing the foot and peak to be incorrectly placed at the extreme values the of the clipped dataset. 
Section 4 shows a detected PW foot occurring later than the detected peak of the same PW. This is not 
correct, because the foot of the PW has to precede the peak of the PW. 
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always use an R-peak and PW that belonged to the same heartbeat, the PWs were 
digitally clipped from 50ms after the occurrence of the R-peak to 80% of the 
average interval between two R-peaks (see Figure 2.1). The peak of a PW was 
determined as the maximum of the PW and was found using an off-the-shelf 
Matlab function called ‘Peakdet’ [59]. The foot of a PW was located at the 
maximum of the second derivative of that PW. 
Figure 2.4 shows four examples of unsuitable PWs in which the Matlab detection 
software placed the foot and/or peak on a wrong location. Figure 2.4A shows a 
detected PW foot that is not on the beginning of the PW but at the beginning of 
the clipped dataset. This is not correct because the foot has to be at the start of 
the PW itself and not at the start of the clipped dataset. Figure 2.4B shows a 
detected PW peak being lower than the detected foot of the same PW. This is not 
correct because the peak should always be higher than the foot. Figure 2.4C 
shows a PW that is not recognisable at all, causing the foot and peak to be 
incorrectly placed at the extreme values the of the clipped dataset. Figure 2.4D 
shows a detected PW foot occurring later than the detected peak of the same PW. 
This is not correct, because the foot of the PW has to precede the peak of the PW. 
2.2.4 Validation  
To verify whether the ‘7Step PW-Filter’ eliminates only and all of the unsuitable 
PWs, all PWs of the obtained dataset were put through the ‘7Step PW-Filter’ as 
well as visually checked by the First Author (M.H.N.V.) and manually marked for 
elimination if deemed unsuitable (referred to as ‘manual elimination’ from now on). 
The literature review (Table 2.1) showed that manual/visual filtering was the most 
common way of filtering. During manual selection of unsuitable PWs in the current 
study, it was visually judged whether the detection software in Matlab placed the 
points of interest on the correct locations on the PWs. If any of those points was 
judged to be placed wrongly, the PW was marked for elimination. 
To analyse the performance of the ‘7Step PW-Filter’ compared to the manual 
elimination, the outcome of the two methods were considered as a binary 
classification test. Their sensitivity and specificity were used as statistical measures 
of performance. For each PW eliminated by the ‘7Step PW-Filter’ the reason for 
elimination was recorded by registering which of the seven criteria were not met.  
To explore the effect of eliminating unsuitable PWs before averaging a calculated 
outcome variable over a certain period, the mean PTT was calculated after using 
several distinct averaging periods for subject number five and compared for three 
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filtering situations: no filtering, filtered by the ‘7Step PW-Filter’ and filtered by 
manual elimination. This comparison was done for means of the entire dataset in 
which the individual PTT values were calculated as averages per 60, 30 and 5 
heartbeats or taken for each individual heartbeat.  
To gain insight into the effect of applying a filter on the PTT-values instead of 
applying the elimination algorithm on the actual PWs, the filter of Gil et al. 
(eliminating any PTT-values below 150ms or above 400ms) was applied to the 
dataset of subject number five. Consecutively, it was checked to what extent the 
Gil method and the 7Step PW-Filter included and excluded the same data points. 
All PTT analyses were done using an Intel Core i7-2640M CPU 2,80GHz, 64-bit 
operating system with Windows 7 professional Service Pack 1, Microsoft 
Corporation, Redmond WA. 
2.2.5 Statistical Analysis 
Three performance measures of the ‘7Step PW-Filter’ were calculated using the 
manual elimination results as a reference: the sensitivity, the specificity and the 
overall accuracy. In the context of the current work, the sensitivity is a measure of 
the ‘7Step PW-Filter’ ability to eliminate unsuitable PWs in accordance with the 
manual elimination. The specificity is a measure of the ‘7Step PW-Filter’ ability to 
keep-in suitable PWs in accordance with the manual elimination. The overall 
accuracy was calculated as the total of the number of true positive PWs plus the 
number of true negative PWs, divided by the total number of PWs. These three 
performance measures should ideally be close to 100% under the assumption that 
the manual elimination results are valid and reliable. The analysis was performed 
using SPSS version 20.0 (SPSS, Inc., Chicago, IL, USA) and Matlab R2010a (The 
MathWorks, Inc). The limit for statistical significance was chosen as p<0.01.  
2.3 Results 
The complete dataset consisted of a total of 7746 PWs, obtained from 10 subjects. 
Manual elimination eliminated 164 PWs (2.1%), based on visual inspection of the 
PWs. The ‘7Step PW-Filter’ eliminated 209 PWs (2.7%), based on the list of seven 
criteria. Full processing of the 7746 PWs took about 5 hours for manual elimination 
and under 5 minutes for the ‘7Step PW-Filter’. The manual elimination and 
‘7Step PW-Filter’ agreed on the elimination of 158 out of all eliminated PWs (which 
is 2.0% of the total number of PWs, 96% of the manually eliminated PWs and 
76% of the PWs eliminated by the ‘7Step PW-Filter’). 
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Additionally, 6 PWs were manually eliminated while not having been eliminated by 
the ‘7Step PW-Filter’. These 6 PWs were manually eliminated because there was 
no visually recognizable beginning of the PW.  
Furthermore, 51 PWs were eliminated by the ‘7Step PW-Filter’ while not having 
been eliminated manually. Mostly (in 39 instances), these PWs did not meet 
Criterion S5, (the detected PPGfoot must be in an upward slope of the valley of the 
PW). In eight instances the PW did not meet Criterion S2 (the detected PPGpeak 
should be in the same heartbeat as the ECG R-peak). In one instance the 
‘7Step PW-Filter’ eliminated a PW on Criterion S7 (the steepest rising part of the 
PW should be between the detected PPG foot and the detected PPGpeak). One PW 
was eliminated on Criteria S3 and S5 and two PWs were eliminated on Criteria S5 
and S7.  
The ‘7Step PW-Filter’ had a sensitivity of 96.3% and a specificity of 99.3%. The 
overall accuracy of the ‘7Step PW-Filter’ was 99.3%  (Table 2.2).  
In the dataset of subject number five the ‘7Step PW-Filter’ eliminated 125 PWs, 
 
Figure 2.5: Mean PTT values  of the dataset of subject number five; no filtering (‘No filtering’), after 
manual elimination of unsuitable PWs by the first author (‘Manual Filter’) and after applying the‘7Step 
PW-Filter’ (‘7Step PW-Filter’). The given PTT values are means over the entire dataset in which  the 
individual PTT values were taken as averages per 60, 30 and 5 heartbeats or taken for each individual 
heartbeat. The whiskers indicate the standard errors of the means. 
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which was 16.4% of the total dataset. Manual elimination resulted in 101 
eliminated PWs, which was 13.3% of the total dataset.  
Figure 2.5 shows the effect of eliminating unsuitable PWs before averaging a 
calculated outcome variable over a certain period. The difference between using 
filtered and unfiltered PPG data can lead to a difference in the calculated average 
PTT of up to 5ms, which is 1.8% of the original outcome value. The difference 
between the two filtering methods was less than 0.9 ms. Eliminating unsuitable 
PWs was over 60 times faster when using the ‘7Step PW-Filter’ (under 5 minutes) 
than when doing manual elimination (about 5 hours).  
Figure 2.6 shows the difference between using unfiltered data, using the Gil 
method and using the ‘7Step PW-Filter’. The mean PTT over the entire dataset was 
comparable for all three methods (no filter: 282 ms, Gil method: 281 ms, 7Step 
filter: 279 ms). However, the results clearly show that although few suitable PWs 
fell outside the Gil range, a very large number (91) of unsuitable PWs were 
included in the analysis when using the Gil method.  
2.4 Discussion  
The literature study revealed that filtering techniques that are used to eliminate 
unsuitable PWs are often not described and differ between studies. In fact, most 
studies do not report whether any or what kind of filtering algorithm was used to 
eliminate unsuitable PWs. Some studies report using manual techniques to select 
unsuitable PWs but these techniques are labour intensive, subjective and often not 
fully described either.  
By using seven morphologic criteria to determine the suitability of PWs for PTT 
analyses, the ‘7Step PW-Filter’ eliminated 158 out of the 164 PWs that were also 
Table 2.2: Sensitivity and specificity of the manual elimination and the 7Step PW-filter elimination. 
‘Positive’ indicates that a PW was marked as unsuitable and eliminated. ‘Negative’ indicates that a 
PW was marked as suitable and kept in the dataset. 
 ‘7Step PW-Filter’ 
outcome positive 
‘7Step PW-Filter’ 
outcome negative 
Manual elimination 
outcome positive 
2.0% - 158 PWs 0.1% - 6 PWs 
Manual elimination 
outcome negative 
0.7% - 51 PWs 97.2% - 7531 PWs 
 Sensitivity Specificity 
 96.3% 99.3% 
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eliminated by the manual method. The 6 PWs not eliminated by the ‘7Step PW-
Filter’ were eliminated manually because  a clear onset of the uprising slope could 
not be found visually in these 6 PWs. The advantage of the ‘7Step PW-Filter’ is that 
it objectively determines this onset and determines whether its location fits the 
characteristics of a suitable PW. Of the 51 PWs that were eliminated by ‘7Step PW-
Filter’ while not being eliminated by the manual method 39 PWs were eliminated 
because the maximum of the second derivative of the PW was not situated on an 
upward slope. This suggests that visual inspection of the PWs is less reliable 
because the location of a maximum of a second derivative is very hard to pinpoint 
by eyeballing. 
In order to show the relevance of eliminating unsuitable PWs, a case study on PTT 
data from a volunteers study was conducted. In that study the mean PTT-values 
were to be calculated based on finding specific landmarks on PWs and ECG-data. 
The case study showed that when reporting a mean PTT of a dataset the effect of 
using or not using elimination of unsuitable PWs can be considerable. PTT-values 
dropped by 1.5-1.8% when applying either manual elimination or the ‘7Step PW-
Filter’ as compared to using unfiltered data. Whether the mean PTT was 
determined for a range of PTT-values derived from short (5 heartbeats) or long 
(60 heartbeats) averaging intervals had little effect on the mean PTT.  
 
Figure 2.6: Comparison of the ‘7Step PW-Filter’ with the Gil method. The figure shows PTT-values for 
the dataset without no filtering (‘no filtering’), the boundaries set by the Gil method (‘Gil filter range’) 
and the PTT-values remaining in the dataset after eliminating unsuitable PWs with the ‘7Step PW-Filter’ 
(‘7Step PW-Filter). 
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However, the smaller the number of PWs over which the PTT-values were 
averaged, the more sensitive the calculated mean PTT was to unsuitable PWs. As 
fast physiological responses or fluctuations can only be measured or monitored 
properly without averaging over too many PWs, effective and reliable PW 
elimination algorithms are quintessential for obtaining reliable measurement of fast 
physiological responses. When measuring changes in PTT, significant results 
reported in the literature that are deemed clinically relevant amount about 10-
20ms [51], which is a change of 3-7% with respect to a common baseline PTT of 
300ms, implying that unremoved unsuitable PWs could potentially account for 50% 
of such results. This clearly indicates that it is essential to dispose of unsuitable 
PWs, as these can have a considerable effect on clinically relevant outcome values. 
As PTT is defined as the time difference between the ECG R-peak heartbeat and a 
reference point on the PPG signal of the corresponding PW, having proper ECG 
waves is just as relevant as having suitable PWs. However, several studies have 
already shown the robustness of various methods for detecting ECG R-peaks [60]. 
Therefore, this study focused solely on the PPG signal. 
Visually selecting unsuitable PWs and removing these manually is highly time 
consuming. It took about five hours to process the data of only ten subjects. 
Additionally, the manual elimination may be quite subjective. Although the manual 
elimination was taken as gold standard, it should be noted that the manual filtering 
may give varying results, depending on who conducts the filtering. However, in the 
current study the manual filtering was done by an expert researcher to as much as 
possible avoid bias in favour of the algorithm, Consequently, for less experienced 
researchers, large datasets and PWs hard to judge visually, the algorithm 
potentially offers even larger benefits. The ‘7Step PW-Filter’ offers great time 
savings compared to manual elimination and can be implemented in many coding 
languages due to its simple  and straight-forward concept. 
Gil et al. [13] used a filter that eliminated any PTT-values that were below 150ms 
or above 400ms before further analysis of the PTT data. However, if the shape of a 
PW does not show the characteristics that allow calculating a PTT but the PTT 
value is calculated anyway, this may result in PTT-values that fall within the Gil 
criteria but are still nonactual data. The comparison between the ‘7Step PW-Filter’ 
and the Gil method confirmed that although the calculated outcome value (mean 
PTT in this case) may be only slightly affected by the filtering method used, the Gil 
method kept a very large number of nonactual PTT-values in the dataset. The 
‘7Step PW-Filter’ did remove all unsuitable PWs, thereby preventing nonactual PTT-
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values from polluting the filtered dataset. Therefore, the ‘7Step PW-Filter’ should 
be preferred.  
’The ‘7Step PW-Filter’ was validated on healthy volunteers only and with potential 
sources of motion artefacts in the PWs being avoided. This clearly is quite an ideal 
situation. In clinical practice, patients may have cardiovascular disease, which 
affects arterial stiffness and could affect the shape of the PWs. Furthermore, 
patients may be anxious, in pain, coughing or moving for other reasons, which 
may also affect and most likely deteriorate the shapes of the PWs. In such 
situations, experience has shown that the number of unsuitable PWs increases, 
which makes proper filtering even more important. An extensive quantification of 
the performance of the ‘7Step PW-Filter’ in such situations has yet to be 
conducted. 
Apart from the artefacts caused by talking and moving, the shapes of the PWs can 
also be affected by too high contact forces between the subject and the sensor, as 
was reported by Teng et al. [48, 55] when using reflective PPG-sensors. This effect 
was also noticed during the current study: when the PPG-sensors were strapped 
too tightly to the fingers, the  blood flow stagnated, causing  the PWs to 
deteriorate both in amplitude and in shape. Therefore, care should be taken to 
limit or avoid any contact forces when using PPG-sensors. Although this study 
focused on applying PW elimination for PTT calculations, the advantages of 
automated elimination of unsuitable PWs will also apply when aiming at other 
outcome parameters, such as PW-amplitude, heart rate, SpO2, blood pressure, 
cardiac output and PWV. For such cases the list of criteria in the ‘7Step PW-Filter’ 
may have to be adapted. 
In order to obtain valid PTT data from PPG measurements, it is quintessential to 
only use PWs that contain the morphological landmarks on which the definition of 
PTT is based. The comparison of data-analysis and filtering methods in this study 
showed that without filtering, the period over which PTT-values are averaged can 
strongly affect the calculated outcome values. Using unfiltered data may result in 
deviations in the calculated PTT-values that are close to the orders of magnitude of 
commonly measured effect sizes in patient and healthy volunteer studies. 
Compared to manual elimination, using the ‘7Step PW-Filter’ reduces PW 
elimination times from hours to minutes and helps to increase the validity, 
reliability and reproducibility of PTT data.  
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 Vascular  transit  time  (VTT)  is  the  propagation  time  of  a  pulse  wave  through  an
artery;  it  is  a  measure  for  arterial  stiffness.  Because  reliable  non‐invasive  VTT
measurements are difficult, as an alternative we measure pulse transit time (PTT).
PTT is defined as the time between the R‐wave on electrocardiogram and arrival of
the resulting pulse wave in a distal location measured with photoplethysmography
(PPG).  The  time  between  electrical  activation  of  the  ventricles  and  the  resulting
pulse wave after opening of the aortic valve is called the pre‐ejection period (PEP), a
component of PTT. The aim of  this  study was  to estimate  the variability of PEP at
rest, to establish how accurate PTT is as approximation of VTT. PTT was measured
and PEP was assessed with echocardiography (gold standard) in three groups of 20
volunteers: 1) a control group without cardiovascular disease aged <50 years and 2)
aged >50 years, and 3) a group with cardiovascular risk factors, defined as arterial
hypertension,  dyslipidemia,  kidney  failure  and  diabetes  mellitus.    Per  group,  the
mean  PEP  was:  1)  58.5  ±  13.0  ms,  2)  52.4  ±  11.9  ms,  and  3)  57.6  ±  11.6  ms.
However, per individual the standard deviation was much smaller, i.e. 1) 2.0‐5.9 ms,
2) 2.8‐5.1 ms, and 3) 1.6‐12.0 ms, respectively. There was no significant difference
in  the  mean  PEP  of  the  3  groups  (p=0.236).  In  conclusion,  the  intra‐individual
variability of PEP is small. A change in PTT in a person at rest is most probably the
result  of  a  change  in  VTT  rather  than  of  PEP.  Thus,  PTT  at  rest  is  an  easy,  non‐
invasive and accurate approximation of VTT for monitoring arterial stiffness. 
Small intra‐individual variability of the pre‐ejection 
period justifies the use of pulse transit time as 
approximation of the vascular transit time 
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3.1 Introduction 
Pulse transit time (PTT) is the sum of the pre-ejection period (PEP) and the 
vascular transit time (VTT). After opening of the aortic valve, a pulse pressure 
wave propagates with a certain speed through the blood vessels from the heart to 
a distal location; this is called the VTT. If an artery is stiff or has a small diameter 
(or both), the pulse wave will propagate faster and, subsequently, the VTT 
decreases. Vice versa, if the diameter of the artery increases, the pulse wave 
propagation is slower and the VTT increases. Therefore, the VTT is a measure for 
arterial stiffness. Increased stiffness can be either structural (age and 
atherosclerosis) or functional due to higher sympathetic activity or elevated blood 
pressure [1-3]. It is a promising application for e.g. non-invasive continuous and 
cuffless blood pressure monitoring, which can also be used  in children or in 
ambulatory setting [4-8].  
Because reliable non-invasive VTT measurements are difficult, as an alternative we 
measure the PTT. PTT can be used to assess a successful loco regional block of an 
extremity [9, 10], to monitor vasomotor tone, and for assessment of autonomic 
nervous system response [11]. Another non-invasive measurement to estimate the 
VTT is the pulse wave velocity (PWV). However, determination of the arterial path 
length is necessary to calculate the PWV and this may create errors in the 
measurement [12].  
 
Figure 3.1: A = electrocardiogram (ECG), B = Doppler mode echocardiography signal over the aortic 
valve, C = photoplethysmographic (PPG) pulse wave; PEP = pre-ejection period, VTT = vascular transit 
time, PTT = Pulse transit time. 
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PTT is defined as the time between the R-wave on the electrocardiogram (ECG) 
and the arrival of the resulting pulse wave measured with photoplethysmography 
(PPG). The PEP is a component of the PTT measurement (Figure 3.1). 
The PEP represents the isovolumetric contraction time of the ventricles of the 
heart. It is the time between electrical activation of the ventricles (Q-wave) and 
opening of the aortic valve [13]. The R-wave is commonly used instead of the Q-
wave [14]. Identification of R-waves is easier and more reliable than Q-waves. 
Moreover, Seery et al. showed that PEP can be calculated using the R-wave 
instead of the Q-wave [15]. PEP can be considered as a measure of left ventricular 
function, as it reflects changes in the contractility of myocardium, left ventricular 
end-diastolic volume, and aortic diastolic pressure [13, 16-18]. In patients with 
diabetic chronic kidney disease, fluid overload is a marker for left ventricular 
systolic dysfunction and is associated with the ratio of brachial PEP and brachial 
ejection time [19]. Physical activity, as well as respiration or a stress response, can 
rapidly change the PEP [20, 21]. Therefore, a change in either PEP and/or VTT can 
result in a change in the PTT value [22]. 
Cardiothoracic impedance is a measurement that is often used to acquire data for 
calculation of the PEP and measured PEP values around 75-134 ms [14, 23, 24]. 
However, echocardiography is the gold standard for measuring the PEP [13]. 
Muehlsteff et al. investigated the role of the PEP on PTT [4]; they measured the 
PEP in a small group of young healthy volunteers with thorax impedance after 
exercise and found that PEP dominates the PTT variability after exercise. The use 
of different measuring tools introduces a discrepancy in literature about the 
magnitude of PEP and its contribution to the PTT. 
The aim of this study was to estimate the variability of PEP at rest, to establish 
how accurate PTT is as an approximation of VTT. Age and cardiovascular risk 
factors (arterial hypertension, dyslipidemia, kidney failure, and diabetes mellitus) 
can increase arterial stiffness and, thereby, decrease VTT and possibly influence 
the PEP. Therefore, to take these factors into account, the PEP was measured in a 
control group with no medical history of cardiovascular disease aged ≤50 years 
and aged ≥50 years, and in a group of persons with at least one cardiovascular 
risk factor. 
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3.2 Methods 
This single-center prospective observational study examined the variability of PEP 
at rest in 60 volunteers divided into 3 groups (20 per group): 
 a control group (group 1) of individuals without a medical history of 
cardiovascular disease aged under 50 years 
 a control group (group 2) aged over 50 years 
 a group of individuals with at least one cardiovascular risk factor (group 3), 
which are defined in the exclusion criteria for the control groups 
The study was approved by the Medical Ethical Committee of the Erasmus 
University Medical Centre in Rotterdam (MEC-2011-213), and was conducted in 
accordance with the Declaration of Helsinki. The primary endpoints of the study 
were PEP, VTT and PTT. Volunteers were eligible for inclusion when aged ≥18 
years and ≤ 75 years. Exclusion criteria were arrhythmia, tremor, muscle or 
skeletal injuries in upper limb, hematopoietic disease, and incapacitated subjects. 
Further exclusion criteria for the control group (groups 1 and 2) were history of 
cardiovascular or peripheral vascular risk factors; these were defined as arterial 
hypertension, dyslipidemia, kidney failure, and diabetes mellitus. All participants 
were informed about the aim of the study and gave written informed consent 
before being enrolled. None of the eligible volunteers refused inclusion in the trial. 
3.2.1 Measurement protocol 
All measurements were performed under standardized stable conditions in a quiet 
temperature- controlled room with dimmed light. First, the participant had a short 
interview to acquire the data such as weight, height and medication and blood 
pressure was measured. After that the participant was asked to lie down in a left 
lateral decubitus position and was connected to the measurement equipment 
(MP100, Biopac® Systems, Inc. Goleta, USA). ECG electrodes were placed 
(ECG100C amplifier, Biopac®) to calculate the PTT and for ECG registration during 
echocardiography. Four PPG sensors (TSD200 and PPG100C amplifier, Biopac®) 
were placed on the index fingers and big toes for measuring respectively the 
PTTfinger and PTTtoe. Data were sampled with 2 kHz using the AcqKnowledge 3.7.3 
version software (Biopac®). Per volunteer, the data acquisition took place in 5 to 
10 minutes. 
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3.2.2  Echocardiography 
ECG-gated echocardiography was performed at rest in the left lateral decubitus 
position by an experienced investigator, using a Vivid-i portable ultrasound system 
(GE, Solingen, Germany). Measurements were performed during 10 consecutive 
heartbeats, simultaneous with PTT measurements. A continuous wave Doppler 
registration through the aortic valve was obtained from a standard apical 5-
chamber view. The horizontal sweep was set to 200 mm/s for maximum accuracy. 
PEP was defined as the time measured from the R-wave of the ECG to the start of 
the ejection phase. The data were synchronized using the matching R-waves of 
the simultaneously acquired second lead ECG signals from the echocardiography 
and PTT measurements. 
3.2.3  PTT calculations 
Data from the AcqKnowledge software were imported into Matlab R2010a® (The 
MathWorks, Inc., Natick, MA, USA) with the Loadacq syntax for Matlab [25]. In the 
ECG data, the R-waves were detected using the Rpeakdetect syntax available from 
the ECGtoolbox [26]. The PPG data were filtered using a fourth-order low-pass 
Butterworth filter with a cut-off frequency of 9 Hz. For filtering we used a zero-
phase digital filtering by processing the input data, PPG, in both the forward and 
reverse directions. This gives a zero phase delay and is based on a method 
described by Oppenheim et al. [27]. The signals from the PPG were digitally cut 
between the R-wave and the next R-wave. Thereafter the pulse waves were 
selected by a ‘7Step PW-filter’ to filter out the pulse waves that strongly deviated 
in shape for a suitable pulse wave analysis [28].  PTT was determined by 
calculating the time between the R-wave of the ECG and the foot of the PPG pulse 
wave. The foot was determined as the maximum value of the second derivative of 
the pulse wave [29]. 
3.2.4  Analyses 
We calculated the mean PEP and PTT of the 10 consecutive but not necessary 
neighboring heartbeats for each participant and of the total group. All data are 
presented as mean ± standard deviation (SD). Furthermore, to show the 
magnitude of the contribution of PEP and its variation in the PTT measurements in 
an individual, the PTTMean PTTSD, PEPMean and PEPSD were normalized to a 
percentage of the PTTMean by the following formula (see Formula 3.1): 
% 100%SDSD
Mean
PTTPTT
PTT
   (3.1) 
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A similar calculation was used to determine the PEPMean% and PEPSD%. The values 
of the left and right sensors were compared with the Wilcoxon signed rank test. 
The difference in PEP and study population characteristics between the 3 groups 
was tested with ANOVA. To correct for the influence of systolic pressure on PTT 
the ANCOVE was used. A p-value <0.05 was considered statistically significant. 
Statistical analyses were performed using SPSS version 24 (SPSS Inc., Chicago, 
USA). Figures were made using GraphPad Prism version 5.00 for Windows 
(GraphPad Software, San Diego California USA) and Adobe Illustrator (Creative 
Suits 5 CS5, Adobe Systems Incorporated, San Jose, California, USA). 
3.3 Results 
The present study included 60 volunteers, divided into 3 groups of 20 participants 
each. As shown in Table 3.1, the mean age in group 1 is significantly lower than in 
the other groups. This is mainly caused by the age limit of 50 years in group 1. 
Also, the BMI was lower in the control group compared to group 2 and 3 and the 
mean heart rate was higher. The mean systolic blood pressure of group 3 was 
significantly higher than that of groups 1 and 2 (p=0.048). Of all the participants in 
group 3, 19 had risk factor arterial hypertension, 13 dyslipidemia, 2 diabetes and 1 
kidney failure. The characteristics of the study population are presented in Table 
3.1. 
In the total group of 60 participants, the mean PEP was 56.2 ± 12.3 ms. In groups 
1, 2 and 3 the mean PEP was 58.5 ± 13.0 ms, 52.4 ± 11.9 ms and 57.6 ± 11.6 
ms, respectively. The intra-individual SD of the PEP was much smaller, i.e. 2.0-5.9 
ms (group 1), 2.8-5.1 ms (group 2) and 1.6-12.0 ms (group 3) (Figure 3.2). There 
Table 3.1: Characteristics of the study population. n=20 per group. Group 1=control group <50 years, 
group 2=control group >50 years, group 3=participants with a cardiovascular risk factor. Data are 
presented as mean ± SD or number (%) of participants. MAP=mean arterial pressure. * p<0.05 
Variables Group 1 Group 2 Group 3 
Age, years 27 ± 4 55 ± 4 63 ± 10 
Sex (male), no.(%) 9 (45) 10 (50) 10 (50) 
Weight [kg] 69 ± 12 78 ± 12 74 ± 12 
Height [m] 1.77 ±0 .11 1.75 ± 0.0.9 1.71 ± 0.09 
Body Mass Index [ kg m2] 21.8 ± 2.5* 25.5 ± 3.6 25.3 ± 3.2 
Blood pressure [mmHg]    
   Systolic 131 ± 13 131 ± 17 141 ± 15* 
   Diastolic 81 ± 10 79 ± 9 81 ± 8 
MAP [mmHg] 98 ± 10 97 ± 10 101 ± 9 
Heart rate [beats min-1] 79 ± 21* 67 ± 10 68 ± 14 
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were no missing data in the PEP measurements and no significant difference in the 
mean PEP of the 3 groups (p=0.235).  
For all the PPG measurements of the 3 groups together, 18 sensors showed too 
many artifacts, modulated waves, for reliable PTT calculation; these measurements 
were excluded from the analysis, which represents 7.5% of the data (for 
 
Figure 3.2: Box plots of the pre-ejection period (PEP) of 10 consecutive heartbeats of each group. The 
boxes represent the median with interquartile range. The whiskers represent the minimum and 
maximum value. 
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specification see Figure 3.3, 3.4 and 3.5).  Pulse waves were only excluded from 
analyses when they did not pass the ‘7Step PW-filter’. 
In the normalized data of group 1, the PEPMean% contribution to the PTTMean% of the 
left hand was significantly different compared to the right hand (p=0.004) (Table 
3.2 and 3.3) (Figure 3.3). This result is still significant after applying the Bonferroni 
correction for multiple testing, p<0.008. In groups 2 and 3 there was no significant 
difference between the left and right measurements (Figure 3.4 and 3.5). Between 
the groups was no significant difference in the contribution of PEPMean% to the 
PTTMean%, neither after correction for SBP. 
  
Table 3.2: Data on normalized PTT and PEP variability.  
Subjects Normalized PTT [%] 
(PTTMean [ms]) 
PTTSD [%] 
(PTTSD [ms]) 
PEPMean PEPSD 
1 100 (305) 1.6 (5) 22.4 1.1 
2 100 (272) 2.6 (7) 25.8 1.1 
3 100 (285) 2.5 (7) 28.3 0.9 
4 100 (299) 1.7 (5) 18.5 1.3 
5 100 (309) 1.9 (6) 16.1 1.3 
6 100 (268) 1.1 (3) 21.8 1.3 
7 100 (266) 1.9 (5) 20.7 1.5 
8 100 (286) 1.0 (3) 17.9 0.8 
9 100 (230) 1.7 (4) 23.8 1.3 
10 100 (270) 1.9 (5) 25.9 1.5 
11 100 (272) 1.1 (3) 14.9 1.3 
12 100 (274) 0.7 (2) 18.3 1.3 
13 100 (247) 4.5 (11) 29.9 1.7 
14 100 (271) 3.3 (9) 19.6 0.7 
15 100 (292) 1.0 (3) 22.5 1.2 
16 100 (240) 5.8 (14) 17.5 1.3 
17 100 (330) 2.7 (9) 24.2 1.7 
18 100 (294) 2.0 (6) 12.7 1.5 
19 100 (276) 5.4 (15) 16.7 2.1 
20 100 (315) 3.8 (23) 22 1.2 
Mean Group 100 2.4 21.0 1.3 
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Figure 3.3: Contribution of the PEP (mean and SD) to the PTT for each sensor of group 1 (control group 
aged <50 years). All values are normalized to a percentage (%) of the mean PTT (which is 100%) of 
the specific sensor. PTTMean% of left hand (n=19) 100%±3.1%, PTTMean% of right hand (n=20): 
100%±2.4% (p=0.004). Contribution of PEPMean% for PTT of left versus right hand 22.2%±1.3% 
versus 21.0%±1.3%. PTTMean% of left big toe (n=18) 100%±4.7%, PTTMean% right big toe (n=17) 
100%±4.8%. Contribution of PEPMean% for left big toe versus right big toe 16.5%±1.0% versus 
16.3%±1.0%. 
 
Figure 3.4: Contribution of the PEP (mean and SD) to the PTT for each sensor of group 2 (control group 
aged >50 years). All values are normalized to a percentage (%) of the mean PTT (which is 100%) of 
the specific sensor. PTTMean% of left hand (n=19) 100%±3.5%, PTT of right hand (n=20) 
100%±2.6%. Contribution of PEPMean% for PTT of left versus right hand PEP 18.7%±1.4% versus 
PEP 19.4%±1.4%. PTTMean% of left big toe (n=18) 100%±5.9%, PTTMean% right big toe (n=17) 
PTT 100%±6.3%. Contribution of PEPMean% for left big toe versus right big toe 4.8%±1.1% versus 
5.1%±1.1%. 
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3.4 Discussion 
This study aimed to determine the variability of PEP at rest and its contribution to 
PTT in order to assess the accuracy of measuring VTT with PTT. Since it is difficult 
to measure PEP with echocardiography during exercise, we measured the PEP at 
rest only. The absolute value of the variability and SD of the PEP between 
individuals at rest was large when compared with the variability in one participant, 
However, in the normalized data, the SD of the PEP is only approximately 1.0-
1.5% of the PTT. In an earlier study, we found an increase of the PTT of 17 ms 
after a successful axillary block from 259 ms to 276 ms [30]. This change is larger 
than can be expected to be caused by a variation of PEP alone.  
This study has some limitations. The participants of this study did not refrain of 
caffeine, neither for physical activity for 48 hours. This might have an effect on the 
measurements. Nonetheless, in the study of Kohler et al caffeine had no significant 
effect on the PEP compared to the baseline measurements [31]. However, after 
exercise, the hemodynamic stress response is reduced and causes an significant 
increase in PEP [32]. Moreover, we did not control for the estrogenic phase of the 
participants. In this study 50% of the participants is female and the female 
participants in group 2 and 3 are above 50 years old and most likely 
 
Figure 3.5: Columns represent the contribution of the PEP (mean and SD) to the PTT for each sensor of 
group 3 (participants with a cardiovascular risk factor). All values are normalized to a percentage (%) of 
the mean PTT (which is 100%) of the specific sensor. PTTMean% of left hand (n=19) 100%±5.5%, 
PTT of right hand (n=20) 100%±4.2%. Contribution of PEPMean% for PTT of left versus right hand 
20.7%±1.5% versus 20.3%±1.4%. PTTMean% of left big toe (n=15) 100%±7.3%, PTTMean% right 
big toe (n=14) 100%±9.1%. Contribution of PEPMean% for left big toe versus right big toe 
17.6%±1.3% versus 17.7%±1.4%. 
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postmenopausal.  Farinatti et al showed in their study that the PEP was similar 
across age groups in men and women [33]. 
Furthermore, the PTT was measured bilaterally and the difference between the 
blocked arm and the contralateral arm was calculated. Other studies have shown 
that PTT difference is a method to exclude the effect of PEP and can be used to 
monitor arterial distensibility or pulse wave velocity changes [34]. Therefore, the 
increase in PTT in the present study is most probably a result of the vascular 
component of the PTT, the VTT.  
Furthermore, in group 1, the contribution of the PEP to the PTTfinger was 22.3% 
and 21.0% for the left and right hand, respectively; this was a significant 
difference between the left and right hand. This can be explained by the difference 
in PTT of the left and right hand. In our earlier study, we found no difference 
between the PTT of the left and right hand in a person at rest in supine position 
[30]. For an optimal apical 5-chamber view with echocardiography, a left lateral 
decubitus position was required with the left hand positioned above their head. 
PTT is related to the position of the arms [35, 36]. Moreover, this position can 
introduce a different curvature of the artery to the arm. Therefore, the left lateral 
decubitus position is a possible explanation for this difference in PTT and, 
subsequently, the contribution to PTT. However, there was no significant 
Table 3.3: Normalized PTT and PEP variability per group. Mean values per group, n=20 per group. 
Group 1=control group participants aged <50 years, group 2=control group participants aged >50 
years, group 3=participants with a cardiovascular risk factor. Values are normalized as percentage (%) 
of the PTT sensor. * = p<0.05 
Subjects Normalized PTT [%] 
(PTTMean [ms]) 
PTTSD [%] 
(PTTSD [ms]) 
PEPMean PEPSD 
Group 1     
  Left hand 100 (267)* 3.1 (8) 22.2 1.3 
  Right hand 100 (280)* 2.4 (7) 21.0 1.3 
  Left foot 100 (369) 4.7 (17) 16.5 1.0 
  Right foot 100 (375) 4.8 (18) 16.3 1.0 
Group 2     
  Left hand 100 (276) 3.5 (12) 18.7 1.4 
  Right hand 100 (275) 2.6 (7) 19.4 1.4 
  Left foot 100 (359) 5.9 (21) 14.8 1.1 
  Right foot 100 (350) 6.3 (20) 15.1 1.1 
Group 3     
  Left hand 100 (280) 5.5 (16) 20.7 1.5 
  Right hand 100 (284) 4.2 (12) 20.3 1.4 
  Left foot 100 (339) 7.3 (22) 17.6 1.3 
  Right foot 100 (336) 9.1 (25) 17.7 1.4 
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difference between the left and right hand in groups 2 and 3.The contribution of 
the PEP to the PTTtoe was smaller compared to the PTTfinger. This difference can be 
explained by the length of the arterial pathway to the toes and a subsequently 
longer VTT (and PTT). In this study, the mean PEP of all 3 groups was 56.2 ± 12.3 
ms; this differs from the values found in other studies. The main reason for this is 
the diverse acquisition techniques used and/or an estimation of PEP made by 
measuring the left ventricular ejection time [17]. Johansson et al. investigated the 
use of PTT for respiration rate monitoring; PTT varies with respiration. The authors 
investigated whether measuring the individual components of the PTT (PEP and 
VTT) could improve their respiration detection [21]. The PEP was measured with 
phonocardiography, by using the sound of the closing valves. For technical 
reasons, they used the first heart sound (S1) which represents the closing of the 
mitral valve, instead of measuring the opening of the aortic valve. However, after 
the mitral valve closes (S1) and the isovolumetric contraction starts, the ventricular 
pressure will rise. When the ventricular pressure is high enough, the aortic valve 
opens and the ejection of blood to the aorta starts. Therefore, using phonography 
will introduce an inaccuracy in the measurement. They found a mean PEP at rest 
of 30.1 ms with a SD of 8.0 ms. Furthermore, the PEP and VTT varied 
synchronously during respiration; focusing on these components did not improve 
their respiration detection. 
In most of the studies, the PEP was measured with cardiothoracic impedance, 
which measures the change in blood volume in the thorax, which is primarily 
caused by the blood flow in the aorta. The advantage of cardiothoracic impedance 
is that it does not require specially trained personnel and can be measured in every 
body position and also during movements. It is an indirect measurement and is 
less accurate than a direct measurement and gold standard echocardiography 
[37], which was used in the present study. Furthermore, these measurements 
were performed in three different groups. Age and cardiovascular risk factors such 
as hypertension and atherosclerosis are important factors for PTT. They influence 
the stiffness of arteries and can change the contribution of PEP to the PTT. 
However, our measurements showed no significant difference in the PEP between 
the groups; moreover, the PEPSD% was very small (between 1.0 and 1.5). 
3.5 Conclusion 
In conclusion, the contribution of PEP to the PTT measured at the finger tips at 
rest is approximately 20%. Therefore, the VTT is represented by the remaining 
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80% of the PTT. Since the PEP variability within an individual at rest is small 
(PEPSD%1.0-1.5% of the PTT value), its contribution to a change in PTT is also 
small. Therefore, PTT is an attractive method to non-invasively monitor arterial 
stiffness at rest. Furthermore, unlike methods such as Doppler ultrasound, it does 
not need specially trained personnel. ECG and PPG (pulse oximeter) are already 
available in hospitals and software implementation in the monitors is needed to 
enable PTT calculation. Therefore, PTT at rest is an easy, non-invasive, low-priced 
measurement, and accurate approximation of VTT for monitoring arterial stiffness.  
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 It  can  take  up  to  30  min  to  determine  whether  or  not  axillary  block  has  been
successful.  Pulse  transit  time  (PTT)  is  the  time  between  the  R‐wave  on
electrocardiography  (ECG)  and  the  arrival  of  the  resulting  pressure  pulse wave  in
the ﬁngertip measured with photoplethysmography.  It provides  information about
arterial resistance. Axillary block affects vasomotor tone causing loss of sympathetic
vasoconstriction resulting in an increased PTT. Early objective assessment of a block
can improve efﬁcacy of operating room time and minimize patient’s fear of possible
conversion to general anesthesia. This study explores whether PTT can objectively,
reliably  and  quickly  predict  a  successful  axillary  block.  Forty  patients  undergoing
hand  surgery  under  axillary  block  were  included.  A  three‐lead  ECG  and
photoplethysmographic sensors were placed on both index ﬁngers. Measurements
were made from 2 min before until 30 min after induction of the block or less if the
patient was  transferred  for operation. Afterwards, PTT was calculated as  the  time
between the R‐wave on ECG and a reference point on the photoplethysmogram. To
assess  the  change  in  PTT  caused  by  the  block,  the  PTT  difference  between  the
control and blocked arm was calculated. Sensitivity and speciﬁcity of PTT difference
were  calculated  using  receiver  operating  characteristic  analysis.  In  a  successful
block,  the mean PTT difference signiﬁcantly  increased after 3 min by 12 (standard
error of the mean 3.9) ms, sensitivity 87% and speciﬁcity 71% (area under the curve
0.87,  P=0.004).  PTT  is  a  reliable,  quick  and  objective  method  to  assess  whether
axillary block is going to be successful or not. 
Pulse transit time as a quick predictor of a successful 
axillary brachial plexus block 
Chapter 4
Minke C. Kortekaas,  Sjoerd P. Niehof, Marit H.N. van Velzen, Eilish M. Galvin, 
Frank J.P.M. Huyghen, Robert Jan Stolker 
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4.1 Introduction 
Patients scheduled for upper-limb surgery have a number of options regarding 
anesthesia techniques. Two such options are general anesthesia and a brachial 
plexus block, both of which have their own advantages and disadvantages. For 
example, patients undergoing locoregional anesthesia have less opioid-related 
side-effects (e.g. nausea and drowsiness) after surgery, but the block placement 
can be time consuming. On the other hand, general anesthesia is fast and can be a 
solution for patients who fear locoregional techniques or being awake during 
surgery. 
The success rate of a locoregional block depends on several factors, including the 
anatomy of the patient, available technology (e.g. electrostimulation or ultrasound) 
and the skills of the anesthesiologist. Since the introduction of ultrasound guided 
regional anesthesia success rates have improved [1], however ultrasound is not 
always available.  After injection of the local anesthetic, it can take up to 30 min or 
more to determine if the block is successful.  
Multiple tools are available to assess a block, the most common being a pinprick or 
loss of cold sensation with an icepack [2], as well as skin temperature and 
peripheral flow index  [3, 4]. In case of a partial or failed block, a supplemental 
regional block can be performed, or the local anesthesia technique can be 
converted to general anesthesia. However, this can be at the expense of additional 
(costly) operating room time. 
Locoregional blocks affect the sensory function (pain impulses are blocked) and 
somatic motor function, as well as the sympathetic nerves resulting in relaxation of 
the arterial wall muscle, vasodilatation, and increased blood flow [5, 6]. The 
compliance (C) is a measure of the elasticity of the arteries and is defined as 
 (4.1) 
where ∆V is the change in arterial volume and ∆P  the change in blood 
pressure[7]. A change in compliance can be measured with pulse wave velocity [8] 
and with the pulse transit time (PTT). Babchenko et al. [6] measured an increase 
in PTT to the feet after epidural anesthesia.  
Quick objective assessment of an axillary block can improve the efficacy of total 
operating room time by reducing the time to surgical incision and by minimizing 
P
VC 

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patients’ uncertainty about a possible conversion to general anesthesia. Therefore, 
this study explores whether PTT can be used to objectively, reliably and quickly 
predict whether an axillary block is going to be successful.  
4.2 Method 
4.2.1 Study population 
The trial protocol was approved by the Medical Ethics Committee of Erasmus 
University Center Rotterdam (MEC-2008-249), and this single-center observational 
study was conducted in accordance with the Declaration of Helsinki. All participants 
gave informed and written consent. ASA I-II patients (age 18–80 years) scheduled 
for elective unilateral upper limb surgery under axillary block were included. 
Exclusion criteria were diseases which can influence the vascular system (e.g. 
diabetes, Raynaud’s), cardiac disease, use of anti-hypertensive therapy, essential 
tremor in the upper extremity, neuropathy, malformation at the measurement 
sites, allergy for local anesthetic agents, or skin infection at the site of needle 
insertion.  
4.2.2 Protocol 
After arrival of the patient at the holding, an intravenous catheter was inserted and 
standard monitoring electrocardiography (ECG) and non-invasive blood pressure 
was applied. To measure the PTT three external ECG leads were placed (ECG100C 
amplifier, Biopac®, Goleta, U.S.A.), and photoplethysmography (PPG) sensors 
(TSD200 and PPG100C amplifier, Biopac®) were attached to the index finger of 
both hands. Data were sampled with 2 kHz with AcqKnowledge version 3.7.3 
software (Biopac®). Afterwards the recorded data were analysed in Matlab 
R2008b® (The MathWorks, Inc., Natick, Massachusetts, U.S.A.). 
The PTT was measured to establish the baseline for approximately 2 min with the 
patient lying supine in bed. The patient was asked not to move during this 
measurement. The arm was abducted to a 90° angle to apply the block.  A needle 
connected to a nerve stimulator was inserted and set to deliver 1mA current 
(50 mm insulated needle, Stimuplex B Braun, Melsungen, Germany). The nerves of 
the brachial plexus were identified with nerve stimulation techniques. Once an 
appropriate single nerve response was obtained of at least the nerve supplying the 
planned surgical site (hand twitch at a current of 0.2-0.5 mA), the local anesthetic 
was administered. The majority of the patients had the median, radial and ulnar 
nerve stimulated and injected separately. The local anesthetics that were used (at 
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choice of the individual anesthesiologist) are ropivacaine, mepivacaine, lidocaine, 
and prilocaine.  If any sedatives, propofol or midazolam were given during the 
procedure, this was documented. 
After the first injected bolus of local anesthetic (t=0), the PTT was measured on 
both arms for intra-subject comparison between the arms. Measurements were 
continued for 30 min after induction of the axillary block, or less if the 
anesthesiologist assessed the block with an ice pack as a complete sensory block 
and the patient was transferred to the operating room. A successful block was 
defined as a complete sensory block of the median, ulnar, and radial nerve, tested 
with ice pack and surgical forceps, where neither extra analgesics, nor 
supplemental local regional techniques were required at the time of surgical 
incision.  
4.2.3 Pulse wave analysis 
Data from the AcqKnowledge software were directly imported into Matlab with the 
Loadacq syntax for Matlab. ECG data were analysed with the Rpeakdetect syntax 
available from the ECGtoolbox [9]. PPG-data were filtered with a fourth-order low-
pass Butterworth filter with a cut-off frequency of 20 Hz. The signals from the 
PPG-sensors were digitally cut between the R-wave and the next R-wave. 
To reduce artefacts of the PPG-signal we filtered the data with the following 
algorithm. Each pulse wave was compared to an average pulse wave of 10 
subsequent pulse waves ±1 standard deviation. When 25% or more of the current 
pulse wave was outside this window, then the pulse wave was filtered out. The 
PTT was calculated for the remaining pulse waves. For each minute after injection 
of the local anesthetic, we fitted a mean pulse wave and identified 3 previously 
agreed reference points on this mean pulse wave, i.e. the foot, point of maximum 
steepness of the upstroke pulse wave (first derivative), and the peak (Figure 4.1). 
PTT was determined by calculating the time between the R-wave of the ECG and 
two different reference points on the pressure pulse wave: the foot, and first 
derivative. The ‘foot’ was determined by the maximum value of the second 
derivative of the pulse wave. The ‘first derivative’ was determined by taking the 
maximum of the first derivative of the upstroke pulse wave. The ‘peak’ was the 
maximum value of the pulse wave and was only used to determine the amplitude 
of the pulse wave. The amplitude of a pulse wave is determined by calculating the 
voltage difference between the reference points foot and peak.  
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The aim was to investigate the effect of the axillary block on PTT. Therefore, the 
calculated PTTs with standard error of the mean (SEM) from the baseline 
measurements were subtracted from the PTT values after an axillary block for both 
arms  
tx tx BaselinePTT PTT PTT     (4.2) 
The PTTtx was determined for each minute after the first injected bolus of local 
anesthetic (t=0),  where x is in minutes. Subsequently, we calculated the 
difference (PTTdifftx) between the blocked arm (PTTblocktx) and the contralateral arm 
(PTTcontralateraltx)) 
difftx blocktx contralateraltxPTT PTT PTT      (4.3) 
Similarly, the difference between the amplitude of the pulse waves was calculated. 
We tested the PTT and amplitude of the pulse waves against the above described 
definition of a successful axillary block. 
4.2.4 Statistical analysis 
Patient characteristics were calculated as mean and standard deviation. To find the 
most optimal combination of sensitivity and specificity of PTT in a successful 
axillary block a receiver operating characteristic (ROC) analysis was used. After 
injection of the local anesthetic, the PTTdifftx  of the subsequent 10 min was tested. 
Figure 4.1 Graphical representation of calculation of the pulse transit time (PTT). ECG = 
electrocardiogram; PPG = photoplethysmogram. Data were measured with a sampling rate of 2 kHz. 
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A p-value <0.05 was considered statistically significant. The coordinates on the 
ROC curve were selected on a combination of the highest sensitivity with specificity 
higher than 70%. Statistical analyses were performed with SPSS version 18 (SPSS 
Inc. Chicago, Illinois). 
4.3 Results 
A total of 40 patients were included. Because data from 3 patients contained too 
many artefacts they were excluded from the analyses. The overall success rate of 
the axillary blocks was 73%. Table 4.1 presents the characteristics of the study 
group (n=37). 
The first significant increase in PTT difference for the reference point ‘foot’ was 
reached 3 min after injection of the local anesthetic (t=3) with a sensitivity of 
78%, a specificity of 71% and an area under the curve (AUC) of 0.77 (p=0.031) 
(Figure 4.2). In a successful axillary block the mean increase in PTT was 12 (SEM 
6.9) ms. At 10 min after injection (t=10) this had improved to a sensitivity of 91% 
and a specificity of 86% (AUC=0.88, p=0.003).  
Table 4.1: Characteristics of the study population. N = 37, data are presented as mean ± SD or number 
(%) of patients. ASA = American Society of Anesthesiologists 
Variable  
Age [years] 43 ± 15 
Sex (female), no. (%) 17 (46) 
Weight [kg] 76 ± 14 
Height [m] 1.76 ± 0.11 
Body mass index [kg/m²] 24.6 ± 3.8 
ASA status, no. (%)  
  I 23 (62) 
  II 14 (38) 
Blood pressure [mmHg] 
  Systolic 136 ± 20 
  Diastolic 80 ± 12 
Smoker, no. (%) 12 (32) 
Success rate, no. (%) 27 (73) 
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Also for the ’first derivative’ reference point on the pulse wave, at t=3 the PTT 
difference showed a significant increase of 12 (SEM 3.9) ms, with a sensitivity of 
87% and a specificity of 71% (AUC 0.87, p=0.004) (Figure 4.3). At t=10 this had 
remained stable with the same sensitivity and specificity (AUC 0.85, p=0.005). At 
t=3 the amplitude difference of the pulse waves had increased, with a sensitivity of 
74% and a specificity of 71% (AUC 0.81, p=0.013). At t=10 the sensitivity had 
increased to 96%, with a specificity of 71% (AUC=0.91, p=0.001).  
 
Figure 4.2 Receiver operating characteristic of pulse transit time (PTT) difference between both arms of 
reference point ‘foot’ at 3 min (t=3) and at 10 min (t=10) after axillary block. The arrows indicate the 
selected coordinates of the ROC curve. At t=3 sensitivity 78%, specificity 71% and AUC=0.77 
(p=0.031). At t=10 sensitivity 91%, specificity 86% and AUC=0.88 (p=0.003). 
 
Figure 4.3 Receiver operating characteristic of pulse transit time (PTT) difference between both arms of 
reference point ‘first derivative’ at 3 min (t=3) and at 10 min (t=10) after axillary block. The arrow 
indicates the selected coordinates of the ROC curve. At t=3 sensitivity 87%, specificity 71% and AUC 
0.87 (p=0.004).  At t=10 sensitivity 87%, specificity 71% and AUC 0.85 (p=0.005). 
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For all these results the ROC analyses of only the contralateral arm (with baseline 
correction) showed no significant change after axillary block. 
4.4 Discussion 
From these results we can conclude that PTT can objectively predict a successful 
axillary block with a high sensitivity and specificity after only 3 min. Clinically, it is 
impossible to do this at such an early stage with sensory test such as ice pack, 
pinprick, skin temperature and peripheral flow index [2-4]. Although peripheral 
flow index and PTT are both measurements that use photoplethysmography, the 
main difference is that peripheral flow index is a local measure unlike the PTT. 
Peripheral flow index measures the ratio of the pulsatile to nonpulsatile component 
of the plethysmogram of the local digital blood flow [4]. A possible limitation of this 
study is the measurement of PTT on the index finger only, which is innervated by 
the median nerve. However, we were able to predict a successful complete 
sensory axillary block, as defined in the methods, by only measuring the index 
finger. Placement of additional PPG-sensors on the thumb and little finger, 
innervated by respectively the radial and ulnar nerve, or additionally measuring 
peripheral flow index on these sites, could solve this limitation. Then it would be 
possible to determine if there is a difference in PTT between the different 
innervation areas in a partial block. However, it may be questioned whether this 
additional measurements are necessary as we were able to make a reliable 
prediction after measuring the index finger only. This may indicate once more that 
PTT is more an overall measurement. We defined a failing block as a partial 
sensory block in which only one or two of the nerves were blocked. However, this 
is clinically irrelevant if there is no pain sensation in the operated area. 
In this observational study design the PTT measurement was standardized, 
however the choice of local anesthetic and injected volume depended on the 
duration of the surgery and was made by the individual anesthesiologist. Therefore 
different local anesthetics were used with different onset times. In the majority of 
the patients, ropivacaine with mepivacaine 30-40 ml was used. A standardized 
technique allowing only a standardized dose of a specific fast onset local anesthetic 
could shorten the time until prediction further. However, in routine everyday 
anesthesia, it is usual to use a variety of different local anesthetics, as we have 
done in this study.  
By calculating the difference between the blocked arm and the contralateral arm, 
we ruled out factors which influence the vascular tone of the total body. For 
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example, temperature change and systemic medication that influence vasomotor 
tone (e.g. propofol or midazolam), as well as a change in the pre-ejection period, 
can affect the PTT [10]. Therefore, in our calculations a change in PTT will be 
caused by a change in arterial resistance due to the axillary block. 
In our measurements we take into account that a change in the position of the 
blocked arm might influence the PTT [11]. After insertion of the block, the arm 
was restored to a resting position lateral to the body. This movement can cause 
artefacts in the PPG-signals. Moreover, a different arm position can change the 
angle and thereby the resistance of the arterial pathway to the hand. Therefore 
the pulse wave form and resulting PTT can change. However, our t=1 
measurement started immediately after the first bolus of local anesthetic was 
injected. Since the anesthesiologist stimulated and injected local anesthetic to 
multiple nerves of the brachial plexus separately, this takes several minutes. 
Therefore, it is most likely that the arm was moved after the significant change in 
PTT found at t=3, and the PTT change can therefore be attributed to the axillary 
block. 
In the present study we used a fixed protocol to filter the artefact of the measured 
data. Therefore, the analyses are more standardized and objective compared with 
subjective selection of the pulse waves by a researcher; in turn, this effectively 
removes artefacts caused by e.g. movements or non-invasive blood pressure 
measurement. However, this filter also removes pulse waves that increase very 
rapidly and differ from the average pulse wave by ±1 standard deviation; this may 
erroneously identify pulse waves as artefacts and cause loss of relevant data. 
Consequently, extreme values in the data are filtered out and this can result in a 
‘regression toward the mean phenomenon’ with a decrease in statistical 
significance, sensitivity and specificity. 
In our results the coordinate on the ROC curve with the highest sensitivity and a 
specificity of at least 70% were selected. The sensitivity indicates the probability of 
correctly identifying a successful axillary block, while specificity indicates the 
probability of correctly identifying failed axillary blocks. When a successful axillary 
block can be predicted quickly, patients with a successful axillary block can be 
transported from the holding to the operating room and prepared for operation. 
This saves time waiting for the onset of loss of pain sensation, where after the 
patient will be transported to the operating room. Therefore this improves the 
efficacy of operating room time. This is especially of value in a university hospital 
with a residency training setting were the block procedures can be more time 
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consuming. Moreover, the 73% success rate may be low, but is realistic in this 
setting [12]. However the use of ultrasound may improve the results, the problem 
of early recognition of failed blocks the problem of early recognition of failed blocks 
remains [1].  Even in a setting with higher success rates, early identification of 
failed axillary blocks is important and could potentially save time.  
The ultimate goal is to implement software to calculate PTT in the commonly used 
anesthesia monitors, enabling PTT measurement with a standard ECG and a 
standard pulse oximeter. This would allow PTT to be a widely available 
measurement tool, which is easy to use, non-invasive, and a safe and quick 
method of objectively assessing axillary blocks. 
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 Pain  is  commonly  assessed  subjectively  by  interpretations  of  patient  behaviour
and/or  reports  from  patients.  When  this  is  impossible  the  availability  of  a
quantitative  objective  pain  assessment  tool  based  on  objective  physiological
parameters would greatly benefit clinical practice and research beside the standard
self‐report tests. Vasoconstriction is one of the physiological responses to pain. The
aim of this study was to investigate whether pulse transit time (PTT) and pulse wave
amplitude  (PWA)  decrease  in  response  to  this  vasoconstriction  when  caused  by
heat‐induced  pain.    The  PTT  and  PWA  were  measured  in  healthy  volunteers,  on
both  index  fingers  using  photoplethysmography  and  electrocardiogram.  Each
subject received 3 heat‐induced pain stimuli using a Temperature‐Sensory Analyzer
thermode block to apply a controlled, increasing temperature from 32.0°C to 50.0°C
to the skin. After reaching 50.0°C, the thermode was  immediately cooled down to
32.0°C.  The  study  population  was  divided  in  to  2 groups  with  a  different
time‐interval  between  the  stimuli,  20s  or  60s.    The  results  showed  a  significant
(p<0.05) decrease of both PTT  and PWA on the stimulated and contralateral side.
Moreover, there was no significant effect between the stimulated and contralateral
side.  No  significant  effect  of  applying  multiple  successive  stimuli  was  found.  The
time‐interval  of  20s  was  too  short  to  allow  PTT  and  PWA  to  return  to  baseline
values  and  should  exceed  40s  in  future  studies.  Heat‐induced  pain  causes  a
decrease of PTT and PWA. Consequently, it is expected that, in the future, PTT and
PWA  may  be  applied  as  objective  indicators  of  pain,  either  beside  the  standard
self‐report test, or when self‐report testing is impossible. 
Effect of heat‐induced pain stimuli on pulse transit time 
and pulse wave amplitude in healthy volunteers 
Chapter 5
Marit H.N. van Velzen, Arjo J. Loeve, Minke C. Kortekaas,  
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5.1 Introduction 
According to the definition of the International Association for the Study of Pain, 
pain is “an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage, or described in terms of such damage” [1]. The clinical 
tests used most commonly to rate pain are the Numeric Rating Score (NRS) and 
the Visual Analog Scale (VAS) [2, 3]. These tests are based on self-reporting. Since 
pain is a subjective phenomenon, these self-report tests are generally accepted 
gold standard for the assessment of presence of pain. However, self-report is 
difficult or even impossible by intubated or sedated patients, intellectually disabled 
patients, and neonates and infants. There is an ongoing search for more objective 
methods for detection of pain, for example based on heart rate variability [4], skin 
conductance [5] and photoplethysmography (PPG) [6]. The availability of a 
quantitative objective pain assessment tool based on objective physiological 
parameters would greatly benefit clinical practice and research beside the standard 
self-report tests. 
Vasoconstriction is one of the physiological responses of the body to pain, causing 
a decrease in compliance and vessel diameter [7, 8]. The compliance is a measure 
of the elasticity of the arteries [9] and can be determined using Doppler ultrasound 
[10]. However, limited availability and the requirement of an experienced operator 
are disadvantages of Doppler ultrasound. Alternatively, the compliance may easily 
be measured using PPG [11, 12]. PPG is a widely available non-invasive optical 
technique that uses infrared light and a photodiode to visualize the pressure pulse 
e waves (PWs) in the vessels by measuring the volumetric changes of pulsating 
blood and thus the expansion and contraction of the vessels. PPG enables 
continuous measurement of the PWs [13, 14] and is routinely used in everyday 
medicine for measuring among others, heart rate and oxygen saturation (SpO2). 
During vasoconstriction the arterial stiffness increases, which causes an increase in 
pulse wave velocity [15]. Consequently, the propagation time of a PW going from 
the heart to the peripheral arteries (generally called Pulse Transit Time, PTT) 
should decrease due to pain-induced vasoconstriction [16]. The PTT is commonly 
used for the assessment of arterial stiffness, for monitoring sympathetic activity in 
sleep apnoea patients [17], measuring endothelial function [18] and as an 
indicator for arterial blood pressure [19]. The Pulse Wave Amplitude (PWA) is a 
measure of the difference between the foot and peak of one single PW. 
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Previous reports described the effect of cold exposure on PTT or studied local 
warming/heating in the upper extremities [20-22]. To the best of our knowledge, 
there are no reports about the effect of heat-induced pain on PTT. Grönroos et al. 
found a centrally mediated autonomic (sympathetic) vasoconstriction response to 
painful peripheral stimulation on healthy human volunteers [7]. Therefore, it is 
hypothesised that PTT and PWA decrease by a central mechanism in response to 
heat-induced pain, allowing these effects to be measured at the contralateral side 
as well. 
The goal of this study was to test whether PTT and PWA decrease in response to 
heat-induced pain stimuli and whether these could provide an objective binary 
indicator of pain, either beside the gold standard self-report, or when self-report is 
impossible. It was not the purpose of this study to relate the level (expressed in 
VAS and/or NRS) of pain to the change of PTT and/or PWA. Obviously the goal to 
develop an objective pain indicator is highly ambitious because pain is a complex 
phenomenon involving both (patho-)physiological and psychological mechanisms. 
Therefore, the experience of pain is likely to remain subjective, at least partly. 
5.2 Method 
5.2.1  Study population 
This study was approved by the Medical Ethics Committee of Erasmus University 
Medical Center Rotterdam (MEC-2012-489). Twenty healthy volunteers, 18-35 
years old, without any known history of atherosclerosis associated diseases, (such 
as diabetes mellitus, hypertension, coronary artery disease, stroke, renal disorder) 
or injuries at the upper limbs were included in this study after obtaining written 
informed consent from the subject.  
5.2.2  Protocol 
The PTT consists of 2 components, the isometric contraction time (pre-ejection 
period, PEP), and the PW propagation-time through the vessel. The PEP is known 
to vary with cardiac preload and heart rate [23, 24]. Therefore, all measurements 
were conducted in a quiet room under tranquil conditions at a room temperature 
of 22.5°C (SD 0.5°C). The subject sat on a chair with both hands resting on a 
table. To minimize any influences of a varying PEP or cardiac output during the 
measurement, the subject was instructed not to talk or move during the 
measurement. 
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Defrin et al. found that at a threshold of 42.8°C (SD 3.4°C) humans experience 
thermal heat as pain [25]. In the current study each stimulus consisted of a 
temperature rise, starting at ‘start(i) ’ at 32.0°C rising with a speed of 1.0°C/s and 
stopping at ‘stop(i) ’ at 50.0°C (where i ={1..3}) indicates the sequence number of 
the stimulus). As such, the applied stimulus gets well above 46.2°C (mean plus SD 
of the sensory determinant), which should thus be sufficient to assure pain at the 
end of the stimulus. When the maximum temperature was reached, the 
temperature of the thermode was programmed to immediately drop back from 
50.0°C to the starting temperature of 32.0°C with 10.0°C/s. Consequently, a 
relatively short pain stimulus was experienced by the subjects. 
Before the start of the first stimulus the baseline of PTT and PWA at rest were 
measured for 60s, in order to determine the range of the normal fluctuations. The 
baseline variations were calculated as standard deviation expressed as a 
percentage of the mean PTT and PWA over these 60s. The PTT and PWA were 
determined beat-to-beat during the entire measurement (Figure 5.1-ABCD). The 
system used for measuring the PTT, PWA and heart rate consisted of a 
measurement device and analysis software. The measurement device contained 
two PPG-sensors (TSD200 with the PPG100C amplifier, Biopac Systems, Inc, USA), 
positioned on each index finger, and three external ECG-leads (ECG100C amplifier, 
Biopac Systems, Inc, USA). The three ECG-leads were placed on the subject’s 
wrists and right ankle. The PPG- and ECG-signals were simultaneously converted to 
digital signals using AcqKnowledge version 3.7.3 software (Biopac Systems, Inc, 
USA), at a sampling frequency of 2kHz.  
Kortekaas et al. found no significant difference in PTT on left and right side 
baselines, but did not investigate, whether pain responses in the PTT or PWA 
differed between the stimulated and contralateral sides [26]. Therefore, in the 
current study the PWs were measured on the left side, where the heat-induced 
pain stimulus was applied, as well as on the contralateral side (right side) to 
determine whether PTT and PWA changed due to centrally mediated 
vasoconstriction.  
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Figure 5.1: Explanation of method and parameters. A = Graphical presentation of the method and Pulse 
Transit Time (PTT) and Pulse Wave Amplitude (PWA) calculation, B = Electrocardiogram (ECG), 
C = Photoplethysmography (PPG) and D = Visual presentation of the calculation of the PTT and the PWA. 
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To check whether the heat stimulus was indeed experienced as painful, the subject 
was asked to indicate how painful the stimulus was at the maximum temperature 
by giving an NRS-pain score for the amount of pain experienced. Each subject was 
told in advance that he/she would receive a painful heat stimulus rising up to 
50.0°C. If the stimulus would become too painful, the subject could terminate the 
heat stimulus by pressing a button with the left foot, therefore causing the 
temperature to immediately drop to the base temperature of 32.0°C. In order to 
minimise any potential fear for the pain, the stimulus was applied 3 times.  
To determine the influence of the duration of the time-interval between successive 
heat-induced pain stimuli, the study population was randomized into 2 groups 
(equal gender distribution) with different time-intervals between the heat stimuli; a 
time-interval of 20s (‘20s’) and a time-interval of 60s (‘60s’). Because the 
conditions before and during the first stimulus were identical in both interval 
groups, an additional dataset was made by combining the ‘20s’ and ‘60s’ groups 
data for the first stimulus (‘All Subjects’-group) for statistical reasons. The 
randomization was performed by blindly taking a ticket prescribing the time-
interval to be used from a closed envelope for each subject.  
5.2.3 Pulse wave analysis 
The PPG-signals were filtered with a fourth-order low-pass Butterworth filter with a 
cut-off frequency of 9Hz using Matlab R2010a (The MathWorks, Inc., Matick, MA, 
USA). The PTT was calculated as the time period between the time instance tECG R-
peak(n) of the occurrence of the R-peak of the ECG and the time instance tPPG foot(n) 
of the arrival of the foot of the PW measured by PPG on the fingertip 
(Figure 5.1D): 
 (5.1) 
where n is the sequence number of the heartbeats. To find the foot of the PW, the 
maximum of the second derivative of each PW was taken as PPGfoot [26-28]. In 
some articles the foot of the PW is taken as the minimum value of PPG occurring 
before the peak [29]. However, in practice, the shape of PWs is often quite 
irregular, showing multiple local minima before the peak. Therefore, finding the 
foot of the PW at the maximum of the second derivative proved to be much more 
robust and less sensitive for noise. 
Besides the foot of the PW (PPGfoot) there are two other common used reference 
points: the peak of the PW and the maximum of the first derivative of the PW [20]. 
)()()( ntntnPTT
peakRfoot ECGPPG 
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The arrival time of the peak of the PW depends on the steepness of the slope of 
the PW, other than the arrival time of the foot of the PW. Using the peak of the 
PW, the PTT may change disproportionally if the steepness of the slope or the 
shape of the PW in general is affected by a change in vascular stiffness. The 
amplitude of the PW and steepness of the slope are related to age and arterial 
stiffness, i.e. in young adults the amplitude and steepness of the slope are steeper 
[30]. In our opinion, PPGfoot is the most natural and accurate point to use for 
measuring the arrival time of the PW as it is least affected by factors that influence 
the shape of the PW. Therefore, PPG-foot was used as reference for determining the 
change in PW arrival time during the experiment.  
The R-peaks in the ECG were found using an off-the-shelf Matlab function called 
‘R-peakdetect’ [31]. The PWA was determined by subtracting the signal strength 
difference of PPGfoot from the peak of the PW (PPGpeak). The PPGpeak was found 
using an off-the-shelf Matlab function called ‘Peakdet’([32].  
As sensitive PPG-sensors were used, artefact signals sometimes distorted the 
shapes of the PWs in a way that these PWs were rendered unsuitable for further 
analysis. Therefore, a ‘7Step PW-filter’ was implemented in the data analysis to 
filter out any PWs that strongly deviated in shape from an undistorted PW. The 
‘7Step PW-filter’ was described in Chapter 2. 
Thereafter the pulse waves were selected by a ‘to filter out the pulse waves that 
strongly deviated in shape for a suitable pulse wave analysis. 
To find any decrease in PTT due to a heat-induced pain stimulus, the relative 
difference (∆%PTT) between the instantaneous PTT at the last heartbeat before 
starting (PTTstart(i)) and the instantaneous PTT at the first heartbeat after ending 
(PTTstop(i)) the I th stimulus was determined: 
( ) ( )
%
( )
( )( ) 100* stop i start i
start i
PTT PTT
PTT i
PTT
   (5.2) 
A similar calculation was used to determine the relative changes of PWA (∆%PWA) 
and heart rate (∆%heart rate). Some subjects had a distorted PW at stop(i) of 
some stimuli because they moved or talked. In these cases, the first available, 
recognisable and undistorted PW before stop(i) was used in order not to 
overestimate any potential effects. Please note that these ∆% values do not 
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represent any variance or variation over time, but are simply the difference 
between a variable’s instantaneous values at start(i) and at stop(i). 
At first analysis the raw data showed a continuing decrease of PTT and PWA after 
the stop(i), suggesting a prolonged effect of the stimuli beyond stop(i). Therefore, 
the data were interpolated over time using Matlab function ‘Piecewise cubic 
Hermite interpolation’ to compare the data between subjects and analyse whether 
the PTT and PWA decreased similarly over time in the 20 subjects. The data were 
mapped on a 0.1s resolution time axis ranging from the start(i) of a stimulus to the 
end of the time-interval after stop(i).  For each dataset the minimum PTT and PWA 
after the stop(i) and the time of the occurrence of these minima were determined.  
5.2.4  Statistical analysis 
A linear model Generalized Estimating Equations (GEE) test (Pearson chi-square) 
was used to test for any effects of the heat-induced pain on PTT, PWA and heart 
rate. Four factors were considered in the GEE: the time-interval (20s and 60s), the 
measurement instance (start(i) versus stop(i)), the measurement side (stimulated 
and contralateral), and the stimulus number  (1 to 3). The analysis was performed 
using SPSS version 20.0 (SPSS, Inc., Chicago, IL, USA) and Matlab. The 
significance level adopted was p<0.05. 
5.3 Results 
Twenty subjects were included at random, divided in 2 groups of 10 subjects. 
 
Table 5.1: Characteristics of the study population. There were no statistically significant differences 
between the groups. 
 
Variable 
‘20s’ Group 
Mean ± SD 
‘60s’ Group 
Mean ± SD 
Gender [m/f] 5 / 5 5 / 5 
Age [years] 28 ± 4 25 ± 5 
Weight [kg] 69 ± 13 75 ± 13 
Height [m] 1.73 ± 0.09 1.79 ± 0.12 
Body mass index [kg/m²] 22.7 ± 3.1 23.3 ± 3.0 
Blood pressure [mmHg] 
  Systolic 125 ± 13 124 ± 15 
  Diastolic 78 ± 10 77 ± 12 
Heart rate [bpm] 77 ± 15 69 ± 13 
Smoker, yes [%] 0 (0) 1 (10) 
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Table 5.1 presents the characteristic of the groups. The fluctuation of the PTT, 
PWA, and heart rate during the baseline measurements are listed in table 5.2.  
The algorithm used to remove distorted, unusable PWs, filtered out 
0.34% (median with Q1 = 0% and Q3 = 2.51%)  of the PWs. A distorted PW at 
stop(i) was observed in 4 subjects and exclusively in the first stimulus. In the worst 
case, the PW at the 3rd heartbeat before the stop(i) had to be used.  
Table 5.3 lists the results of the GEE test. There was a significant effect of the 
Table 5.2: Baseline fluctuations. The fluctuation in PTT (Pulse Transit Time), PWA (Pulse Wave 
Amplitude) and heart rate during the baseline measurements. N=20 
Baseline fluctuation SD (%) Left [Mean ± SD] 
SD (%) Right 
[Mean ± SD] 
Pearson 
Correlation of 
left and right 
PTT  2.71 ± 1.04 2.44 ± 0.81 0.867 
PWA 32.76 ± 14.95 29.37 ± 13.78 0.654 
heart rate 7.34 ± 2.64 
 
Figure 5.2: The decrease of PTT (Pulse Transit Time) and PWA (Pulse Wave Amplitude) in response to 
the three heat-induced pain stimuli. The ‘20s’ and ‘60s’ group names correspond with the time-interval 
between the stimuli. The standard deviations are given in Table 5.4. 
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measurement instance for all of the measured physiological responses, indicating 
that the values at stop(i) differed significantly from those at start(i). There was no 
significant effect of the time-interval, of the stimulus number, or the measurement 
side for any of the measured physiological responses. 
The algorithm used to remove distorted, unusable PWs, filtered out 
0.34% (median with Q1 = 0% and Q3 = 2.51%)  of the PWs. A distorted PW at 
Table 5.3: The Generalized Estimating Equations Test of Model Effects. PTT=Pulse Transit Time, 
PWA=Pulse Wave Amplitude. The ∆% changes for PTT, PWA and heart rate were used for the GEE 
model. Bold type p-values indicate statistically significant effects. 
∆%PTT ∆%PWA ∆%heart rate 
p-value p-value p-value 
Time-interval 0.717 0.815 0.835 
Measurement side 0.717 0.105 
start(i) versus stop(i) 0.000 0.000 0.001 
Stimulus number 0.065 0.306 0.154 
 
Figure 5.3: Mean PTT (∆%PTT) and PWA (∆%PWA) during the heat-induced pain stimuli interpolated and 
mapped onto a time axis. The mean PTT (Pulse Transit Time) and PWA (Pulse Wave Amplitude) for 
each heat-induced pain stimulus, for the left and right side. Shown from the start(i) of each stimulus to 
the start(i) of the next stimulus or till the end of the measurement in case of stimulus 3 data. One may 
notice that the time delays presented in Table 5.5 do not seem to correspond with the minima shown in 
Figure 5.3. However, the time delays in Table 5.5 are means of the individuals time delays whereas the 
minimum in a line in Figure 5.3 is a minimum of the mean of all data. 
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stop(i) was observed in 4 subjects and exclusively in the first stimulus. In the worst 
case, the PW at the 3rd heartbeat before the stop(i) had to be used.  
Table 5.3 lists the results of the GEE test. There was a significant effect of the 
measurement instance for all of the measured physiological responses, indicating 
that the values at stop(i) differed significantly from those at start(i). There was no 
significant effect of the time-interval, of the stimulus number, or the measurement 
side for any of the measured physiological responses. 
Table 5.4 and Figure 5.2 show the ∆%PTT, ∆%PWA, ∆%heart rate and NRS-pain 
score for each stim ulus. The data of the third stimulus for one subject (in 
‘60s’ group) were lost due to technical reasons and could not be analysed. 
All three stimuli were scored as equally painful within each subject. The stimuli 
were stopped by the subjects four times prior to reaching 50.0°C: by two subjects 
during the first stimulus at 49.3°C (NRS-score 7) and 49.7°C (NRS-score 8), 
respectively, and by one subject during the first and second stimulus at 49.4°C 
(NRS-score 9) and 49.3°C (NRS-score 9), respectively. Whenever the stimulus was 
stopped before reaching 50.0°C, vasoconstriction was still observed during the 
heat-induced pain stimuli as a reduced PWA.  
 
Figure 5.4: The maximum decrease of PTT (Pulse Transit Time) and PWA (Pulse Wave Amplitude) in 
response to the three heat-induced pain stimuli. The ‘20s’ and ‘60s’ group names correspond with the 
time-interval between the stimuli. The standard deviations are given in Table 5.5. 
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The data consistently showed that PTT and PWA continued to decrease after the 
stop(i) (Figure 5.1 shows a typical example). Figure 5.3 shows the 
time-interpolated PTT-data and PWA-data. It was noticed that the PTT and PWA 
generally had not returned to the baseline or a new stable value within 20s after 
the stop(i). The values for the minimum PTT and PWA (∆%PTTmin and ∆%PWAmin) 
after the stop(i) and their corresponding instances of occurrence are listed in 
Table 5.5 and show in Figure 5.4. 
5.4 Discussion 
This study is the first to demonstrate a decrease of PTT and PWA in response to 
heat-induced pain stimuli in healthy volunteers, who experienced equal pain scores 
in all stimuli. The effect on PTT is small but significant immediately after a stimulus 
and increases largely within several seconds after the stimulus. The effect on PTT 
may be different when another kind of pain stimulus is induced, such as pinprick or 
compression and therefore should be studied and compared to heat-pain. The data 
showed no significant effect of the measurement side on the PTT or PWA change 
due to heat-induced pain stimuli, suggesting that the PTT and PWA responses are 
centrally mediated. This suggests that the PTT and PWA are reliable parameters of 
pain-induced alterations of vasotonus and can be measured on a contralateral 
extremity in situations in which it is impossible or undesirable to measure directly 
on the affected extremity. Such measurement side independency of PTT and PWA 
has been demonstrated for baseline measurements as well [26]. The data showed 
no significant effect of the stimulus number on PTT, PWA or heart rate. This 
agrees with the consistently equal NRS-pain scores, which further suggest that no 
habituation or adaptation occurred to the pain stimuli during the successive 
measurements. The decrease of the PTT and PWA suggests these parameters 
potentially can be used as objective indicators of pain beside the gold standard 
self-report, or when the self-report is impossible. 
For calculating the change in PTT, PWA and heart rate before and after the stimuli, 
it was decided to calculate these changes over the first single values before and 
after the stimuli instead of averaging several values before and after the stimuli. A 
drawback of this simple approach might be that the calculated changes may be 
easily affected by stochastic variations, requiring larger sample sizes. However, 
because the data consistently showed that PTT and PWA continued to decrease 
after the stop(i), the chance of inadvertently suggesting too large effects by 
averaging several values before and after the stimulus would have been 
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considerable. Nevertheless, even when using the chosen, simple calculation, a 
significant effect of heat-induced pain stimuli on PTT, PWA and heart rate was still 
detected. However, the chosen approach might also be a reason why the effect is 
rather small for PTT directly at the stop(i). When including measuring points till a 
few seconds after stop(i) the change in PTT can reach up to 10.4%. For the same 
reasons, i.e. to prevent inadvertently overestimating any effect of the stimuli due 
to a distorted PW at stop(i), it was decided to use the first available, recognisable 
and undistorted PW before the stop(i) as opposed to after the stop(i).  
Few studies show that PTT reflects blood pressure quite well [19, 33]. As PTT is 
related to blood pressure and other factor, such as cardiac output, it might have 
been beneficial to measure blood pressure and/or cardiac output simultaneously 
with PTT. However, blood pressure and cardiac output were assumed to be kept 
constant due to the quiet and stable conditions in which the subjects were during 
the measurements. Furthermore, simultaneous measurement of blood pressure 
and cardiac output was not pragmatic as the required sensors would have affected 
the PPG measurements. Additionally, in this study, the point of interest specifically 
was whether the change in vasoconstriction during heat induced pain stimuli can 
be detected. PTT and PWA were measured, as these parameters are 
straightforward measures of vasoconstriction and thus the arterial stiffness. 
Furthermore, PTT and PWA are widely used in clinical practice and  can be easily 
measured continuously during interventions. In this study, a continuous measure 
that may be related to pain was found. 
In the ‘60s’ group PTT, PWA and heart rate returned to the baseline, or a new 
stable value, within about 40s after the stop(i). This return to the (new) baseline 
was incomplete in the ‘20s’ group. Therefore, it was concluded that even through 
the GEE showed no effect of the stimulus number, the responses measured for 
stimuli 2 and 3 in the ‘20s’ group should not be considered to be representative  as 
these could also include a partial effect of preceding stimuli. If the time-interval is 
chosen too short, the effects on the measured physiological parameters may 
diminish, which may specifically occur when there already was a maximal response 
of the vessels. In order to exclude any effects of earlier stimuli, using a 
time-interval of at least about 40s is advised.  
As the heart rate significantly increased together with PTT, the results are 
inconclusive whether the ∆%PTT was caused only by a change of 
PW propagation-time through the vessel or (also) by a changed PEP. It would be 
worthwhile to measure PEP using cardiothoracic impedance or echocardiography 
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[34, 35]. An decreased PEP could indicate stress and if stress occurred during the 
measurements it would be difficult to distinguish whether the ∆%PTT and ∆%PWA 
were caused by the actual pain stimuli or by the stress caused by anticipation on 
the pain stimuli. However, the fear for pain was limited in this study by clearly and 
carefully explaining the experiment to the subjects. Furthermore, the subjects sat 
in a comfortable position under tranquil conditions. So the stimuli are unlikely to 
have caused anxiety due to sudden application beyond control of the subjects. The 
temperature of the thermode block rose very slowly. For each stimulus it took 18s  
for the temperature to rise from 32.0 to 50.0°C and the subjects could stop the 
heat-induced pain stimuli at any desired moment. Therefore, it is expected that the 
measured effects were not caused by any anticipation stress but by the subjects’ 
reactions on the actual pain stimuli. To distinguish the vasoconstriction-reactions 
due to pain from reactions due to stress, metrics like the bispectral index or blood 
pressure could be used [36, 37]. An approach to assess the effect of stress during 
a stimulus could be to apply a placebo stimulus, during which the same procedure 
as during the real stimulus will be performed, but without heating the thermode 
block. 
PPG signals are influenced by and are highly dependent on heart rate, 
arteriosclerosis, use of anaesthetics and neurological diseases [38]. Hence, the 
usability of the absolute values of PTT and PWA in patients are at best 
questionable. The main reason is that the vessel compliance plays a major role in 
the change of PTT and PWA development. For this reason the relative change in 
PTT and PWA was used. To exclude the influence of some of the abovementioned 
factors, for this study only young healthy volunteers were included. However, 
factors like gender, age and Quetelet index are important determinants of the 
compliance, and thus of PTT and PWA [39]. Additionally, physiological responses 
may depend on the type of pain stimulus applied.  As this study focussed on heat-
induced pain in young, healthy adults, it remains unclear whether the results may 
be generalised for all populations and all types of pain stimuli.  
The utilized PPG-sensors were quite sensitive for motion and positioning 
disturbances. This sensitivity to disturbances poses a potential limitation on the 
usability. Although the algorithm used to eliminate distorted PWs functioned well, 
the availability of a more robust PPG-sensor would greatly benefit measuring PWs 
in awake and moving patients. Obviously, this is less relevant when measuring 
PWs in patients under general anesthesia. 
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Having a heat-induced pain stimulus with a fixed NRS-pain score was preferred 
over a stimulus with a constant end temperature. However, our pilot study showed 
a high variation of end temperatures when the volunteers were asked to end the 
heat-induced pain stimulus when pain started to occur (range 37.2°C – 50.0°C). 
Therefore, a fixed end temperature of 50°C was chosen for this study. The results 
show that the median NRS-pain score of all the stimuli at the stop(i) of 
heat-induced pain stimuli was 8 with an interquartile range of 2. This indicates that 
pain was present and that it was experienced as similarly painful by all subjects at 
50°C. Never the less, the study outcome was not the level of pain, but the 
possibility to measure pain in an objective way.  
Surprisingly, the decrease of the PTT and PWA consistently continued for a about 
9.4s and 6.2s, respectively, after each stop(i). These delayed PTT and PWA 
responses could partly be caused by the method used to apply the pain stimuli. 
Therefore, we investigated the course of the skin temperature in time with a 
thermography camera (ThermaCAM SC2000; FLIR Systems, Berchem, Belgium) 
after applying a heat-induced pain stimulus and quickly removing the thermode 
block. The thermode block temperature was 50.0°C when the stimulation stopped, 
while the skin temperature under the thermode block was 47.7°C. Due to this few 
degrees temperature difference between the thermode block and the skin there 
will be some residual heating of the skin during up to the first 0.3s of the rapid 
cooling of the thermode block. Only as soon as the thermode block is colder than 
the skin, the skin will be actively cooled down. However, since the measured 
delays in PTT and PWA responses were much larger, it is unlikely that these delays 
were caused entirely by the residual temperature difference between the thermode 
block and the skin. Therefore, the delayed response may more likely be caused by 
residual  heat present in the skin. The discharge of residual heat after a stimulus is 
limited by the vasoconstriction still present due the same heat, which could 
contribute to the persistence of the physiological responses to the heat-induced 
pain stimuli after the stop(i).  
5.5 Conclusion 
The results of this study suggest that PTT and PWA decrease centrally in response 
to heat-induced pain stimuli. PTT and PWA can be measured non-invasively and 
objectively by using standard ECG and PPG equipment generally available in 
hospitals. To limit cross-dependencies, time-intervals between successive stimuli 
should exceed 40s. Further research is required to investigate whether and how 
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the relation between pain (levels) and PTT and PWA responses can be quantified. 
A preferred next step is to adapt commonly used ECG/PPG monitors to also show 
PTT and PWA. This could make PTT and PWA widely available, objective indicators 
of pain, either beside the gold standard self-report, or when the self-report is 
impossible. 
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 The Multi Photodiode Array  (MPA)  is a novel  transmission photoplethysmography
sensor to measure pulse wave velocity (PWV) in the finger. To validate the MPA a
setup was built to generate a red laser dot traveling over the MPA with known and
constant  scanning  velocities.  These  scanning  velocities  were  chosen  to  include
speeds at least twice as high as those found in the normal range of PWV in healthy
populations, and were set at 12.9, 25.8, 36.0 or 46.7 m/s. The aim of this study  was
to  verify  the  functionality  of  the  MPA:  performing  local  non‐invasive  PWV
measurements.  To  illustrate  the applicability of  the MPA  in  clinical  practice,  an  in
vivo pilot study was conducted using the flow mediated dilation technique. The  in
vitro accuracy of the MPA was  ± 0.2%, 0.3%, 0.5% and 0.6% at  the applied scanning
velocities. The MPA can measure PWVs with a maximum deviation of 3.0%. The in
vivo pilot study showed a PWV before the flow mediated dilation  of 1.1 ± 0.2 m/s.
These results suggest that this novel MPA can reliably and accurately measure PWV
within clinically relevant ranges and even well beyond. 
Design and functional testing of a novel blood pulse 
wave velocity sensor 
Chapter 6
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6.1 Introduction 
Globally, cardiovascular diseases (CVDs) are the number one cause of death. 
Smoking, unhealthy diet, physical inactivity and excessive use of alcohol are the 
most important behavioural risk factors for CVDs. As an effect, individuals may 
develop hypertension, diabetes, heart failure or atherosclerosis, most of which are 
related to a change in arterial stiffness. Arterial stiffness is most commonly used to 
express the viscoelastic property of the arterial wall, which is expressed the 
relationship between change in pressure and change in volume[1]. Therefore, 
arterial stiffness, or its inverse the arterial compliance, is a reliable prognostic 
indicator of cardiovascular morbidity and mortality in the adult population [2-4]. 
The effect of increased arterial stiffness is a decreased propagation time of 
pressure pulse waves (PWs) through the vessels and thus an increase of the pulse 
wave velocity (PWV) [5, 6]. The arterial stiffness of a blood vessel is important 
because the elastic wall of the arteries attenuate the systolic pressure wave of 
each heartbeat. The potential energy stored in the vessel walls is used to continue 
to propel the blood during the diastole between successive heartbeats [1]. 
To determine arterial stiffness, the gold standard is to measure the PWV, because 
the speed with which the PWs travel through the blood is directly related to the 
incremental elastic modulus Einc,, vessel wall thickness hvessel and vessel radius rvessel 
by the Moens-Korteweg equation (with Ƿblood the density of blood) [7]: 


r
hE
PWV inc2   (6.1) 
The PWV is measured as an average speed of a PW between two locations on the 
body. Note that the PWV is not the speed of blood, but the speed of the pressure 
pulse traveling through the moving blood (comparable to a sound wave). The PWV 
can be measured both invasively and non-invasively and is highly reproducible [8]. 
In clinical practice, the PWV is generally determined as an average velocity over 
the carotid-femoral trajectory or the brachial-ankle trajectory. Depending on age, 
in healthy subjects the PWV is about 6-10 m/s over the carotid-femoral trajectory. 
In cardiovascular risk patients the PWV can be as high as 20 m/s over the same 
trajectory [6, 9, 10], so two to three times as high as in healthy subjects.  
Several non-invasive techniques to measure PWV are clinically available, e.g. 
Doppler ultrasound [11], tonometric (SphygmoCor), oscillometric (Arteriograph) 
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and piezoelectronic (Complior) techniques [12]. To the best of our knowledge, only 
one group has reported on relatively peripheral PWV, providing the average PWV 
over the trajectory between the wrist and finger [13], using the Hall-effect and 
photoplethysmography (PPG)  The drawback of these methods is that they require 
two separate devices. Limitations of these techniques include the difficulty of 
accurately placing the sensors, and the discrepancy between the distance between 
the sensors and the actual path length traveled by the PW. Moreover, these 
methods are not always comfortable for the patient, e.g., the use of the blood-
pressure cuff arteriography technique is inconvenient. Furthermore, Doppler 
ultrasound requires an experienced operator to conduct the measurements. Clinical 
practice would benefit from a device that can reliably measure the PWV over a 
short, accurately known distance, using a simple technique that is already familiar 
to clinicians. The measurement preferably should not require an experienced 
operator, should allow continuous monitoring, should not cause the patient 
discomfort and should potentially be easily added to available clinical monitoring 
systems.  
We designed a device, further called the Multi Photodiode Array (MPA), for 
peripheral, non-invasive PWV measurements along a trajectory of 12.0 mm, 
without having the drawbacks of the currently available alternatives. The MPA will 
guide enable comfortable measurements with a single, simple device without 
requiring highly trained operators. 
The working principle of the MPA is based on photoplethysmography (PPG). A 
widely used non-invasive optical technique, to measure volumetric expansion and 
contraction of vessels (Figure 6.1) [14].  
 
  
Figure 6.1. Schematic overview of the multi photodiode array (MPA) and calculation of the pulse wave 
velocity. 
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The maximum volumetric expansion at any point along a vessel occurs when the 
peak of a PW passes that point. Thus, the peripheral PWV can be calculated using 
the time differences between the detection of the PW peaks at successive points 
along the vessel spaced a known distance apart. It is not yet known to what extent 
this peripheral PWV measured in, for example,  a finger correlates with PWVs 
elsewhere in the vascular system. However, to investigate this, it should first be 
validated whether the MPA can be used to properly measure peripheral PWV. If 
this proves to be feasible and if there is good correlation with conventional 
measuring techniques, using the MPA for determining the PWV would open the 
road to fast and simple PWV-based diagnostics that do not put any burden on 
patients. Furthermore, with some small alterations of the design, the MPA could 
also be used for reflective measurements, making it suitable for non-invasive 
measurement of PWVs for, e.g., the carotid arteries. The aim of this study was to 
verify the functionality of the MPA. More specifically, to determine whether the 
MPA accurately measures the velocity of light pulses traveling over it.  
6.2  Materials and methods 
6.2.1  Multi Photodiode Array  
The MPA is a transmission PPG-sensor for measuring the PWV, for example, in the 
finger by measuring light transmission at multiple points along a short trajectory. 
The PPG-sensor element is a Si PIN S8558 photodiode array (Hamamatsu 
Photonics, Hamamatsu, Japan) with 16 high-sensitivity photodiodes, with a peak 
sensitivity wavelength of 960 nm, positioned in a single row. Each photodiode has 
an active area of 0.7 x 2.0 mm. An array with more than 2 photodiodes was 
chosen because this enabled assessing which combination of the number of 
photodiodes and the distances between them would provide the most accurate 
PWV measurements. The array of 16 photodiodes was chosen rather arbitrarily 
because of its availability and  because it enabled achieving the study goals. The 
light source of the MPA consists of two red (620 nm) and two infrared LEDs (880 
nm). These two wavelengths are known to provide very good signal transmission 
through the finger and to the photodiode array [15]. All 16 analogue signals from 
the photodiode array are converted to digital signals through a NI-USB 6229 
Multifunction Data Acquisition system and LabVIEW 2010 software (both: National 
Instruments, Austin, TX, USA). The data acquisition-system has a 250 kHz 
sampling rate and 32 analog, 16-bit input channels.  
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6.2.2  Validation setup and protocol 
To functionally validate the MPA a setup (Figure 6.2) was built in which a laser dot 
periodically scanned over the MPA with a known and constant scanning velocity. A 
linearly polarized laboratory Helium Neon Laser with a power of 0.5 mW 
(25-LHP-213, Melles Griot, Carlsbad, CA, USA) provided a continuous 632.8 nm 
wavelength red laser light dot with a 0.46 mm beam diameter (1/e2). This laser 
was chosen for its wavelength, as it resembles the spectrum transmission through 
the finger when using commercial PPG sensors. The laser dot was made to scan 
over the MPA using a rotating mirror, which was actuated using a stepper motor to 
deliver various velocities of the light dot scanning over the MPA. 
Four different scanning velocities were used with 24 scans (24 full mirror rotations) 
for each scanning velocity. These scanning velocities were chosen to include 
speeds over twice as high as the normal range of PWVs found in healthy 
populations over  the carotid-femoral trajectory to ensure including values that can 
be expected when measuring locally on the carotid artery and to explore the full 
potential of the MPA, and were chosen to be 12.9, 25.8, 36.0 or 46.7 m/s. These 
scanning velocities were pre-set by setting the motor actuating the mirror to a 
matching rotational speed   using the relation: 
2
set
path
v
r    (6.2) 
where vset is the desired scanning velocity and rpath is the distance between the 
mirror center and the MPA (Figure 6.3). In order to achieve a constant  scanning 
velocity over the entire MPA, it was necessary to have a  large rpath  of 1390 mm 
(Figure 6.3).  
To avoid requiring a very large space for the setup for increasing rpath, the laser 
beam was made to zigzag five times between two mirror strips before reaching the 
MPA (Figure 6.2). As a result, the resulting laser dot speed variation across the 
MPA was only about 0.0001%. 
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The MPA was placed in a holder that 
allowed precise horizontal, vertical and 
rotational positioning and orienting. A 
mask with a (1.00 ± 0.05 mm) high slot 
was placed over the entire width of the 
MPA to limit the amount of light exciting 
the photodiodes. As a result of the laser 
dot scanning over the MPA, the 
photodiodes consecutively received a 
light pulse of sinusoidally-varying 
intensity with a clearly defined peak. 
The actually delivered scanning velocity 
(vscan [m/s]) at the MPA depends on the 
accuracy of the set   and rpath. 
Therefore, vscan was continuously 
verified for each mirror rotation by 
measuring the time period t between 
the successive peaks received in the 
signal measured at photodiode 1 in the 
MPA: 
2 * path
scan
r
v
t
  (6.3) 
The peaks of the photodiode 1 signals were detected using an off-the-shelf Matlab 
(The MathWorks, Inc., Matick, MA, USA)  function called ‘Peakdet’ [16]. 
In order not to overestimate the accuracy of the MPA, the four most relevant 
 
Figure 6.3. Schematic overview of the validation 
setup in which vinput is the input velocity, and Ω 
the angular velocity. The distance between the 
mirror and the photodiode array is expressed in 
meters. 
Table 6.1: Scanning velocities and measured pulse velocity [m/s]  
(averaged over 24 scans for each velocity). 
Scanning Velocity 
[Mean ± SD] 
Protocol 1 Measured 
Pulse Velocity 
[Mean ± SD] 
Protocol 1 Measured 
Pulse Velocity 
[Mean ± SD] 
12.9 ± 0.02 13.1 ± 0.16 13.2 ± 0.28 
25.8 ± 0.06 25.9 ± 0.14 26.0 ± 0.52 
36.0 ± 0.04 36.0 ± 0.11 36.8 ± 0.78 
46.7 ± 0.09 46.7 ± 0.19 48.1 ± 1.23 
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tolerances (T1-T4) in the validation setup and the MPA were determined and taken 
into account: Firstly, the scanning velocity tolerance of the validation setup as 
determined by: 
 T1; the accuracy of the distance between the rotating mirror and the MPA 
 T2; the accuracy of the speed of the rotating mirror 
Secondly, the accuracy of the measured pulse velocity by the MPA as determined 
by: 
 T3; the tolerance of the distances between the successive photodiodes 
 T4; the accuracy of the detection of the peaks of the light pulses received 
by the photodiodes which is mainly determined by the data acquisition 
sampling frequency (SF) 
These tolerances were determined using manufacturers’ specifications of the 
components and the of measurement equipment used.  
Because of the multiplexing in the data acquisition system, the actual sampling 
frequencies with which the MPA-data were gathered depended on the number of 
photodiodes that were read out. To verify the functioning of the MPA at different 
SFs and inter-diode distances, all scanning velocities were applied 24 times with 
each of the three protocols: 
 Protocol 1: using 2 photodiodes (no. 1 and 16) at a SF of 125 kHz  
 Protocol 2: using 4 photodiodes (no. 1, 6, 11 and 16) at SF of 62.5 kHz  
 Protocol 3: using all 16 photodiodes at a SF of 15.6 kHz. 
Figure 6.4 shows an example of the signals measured when the laser dot makes a 
single scan over the MPA and Protocol 2 is used.  
6.2.3 Data analysis 
After obtaining the MPA data, Matlab R2010a was used for the data analysis and to 
calculate the velocity of the laser dot (‘measured pulse velocity’) from the signals 
received by the MPA. The measured pulse velocity was calculated as the distance 
between a pair of photodiodes divided by the time difference between the peaks 
detected on the signals measured by these photodiodes. The peaks were detected 
using an off-the-shelf Matlab function called ‘Peakdet’ [16].  
For each protocol, this was done for each combination of any two of the 
photodiodes used. That way, any eventual misalignments of the MPA with respect 
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to the laser dot travel path potentially causing slight laser dot speed variations over 
the MPA, and any influences of the geometrical tolerance on the distance between 
the sensor’s photodiodes (2%) were averaged out. Finally, the average measured 
pulse velocity was calculated by averaging all the measured pulse velocities from 
all combinations of two photodiodes for all 24 scans. 
The data obtained with Protocol 2 showed that the SF of 62.5 kHz was too low to 
accurately measure the highest simulated PWV of 45.0 m/s. Therefore, these data 
were interpolated over time using the Matlab function ‘v5cubic interpolation’. The 
v5cubic interpolation function determines the interpolated value at a point based 
on a shape-preserving piecewise cubic interpolation of the values at neighbouring 
points. This results in a more accurate approximation of the wave peaks because it 
takes the shape of the wave into account. 
For Protocol 3 the SF of 15.6 kHz was too low to fit any proper curve through the 
data samples for any of the applied scanning velocities. Therefore, the datasets for 
Protocol 3 were excluded from further analysis. For Protocols 1 and 2 it was 
verified whether the measured pulse velocities matched the applied scanning 
velocities. 
 
Figure 6.4: Example of light pulse detection with the multi photodiode array using four photodiodes. 
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6.2.4 In vivo pilot study 
To illustrate the applicability of the MPA in practice, an in vivo pilot measurement 
was conducted on the right finger of the first author (M.H.N.V.) as a healthy 
volunteer, using the flow-mediated dilation (FMD) technique [17] which provokes 
the release of nitric oxide, resulting in vasodilation, causing the pulse wave 
amplitude (PWA) to increase after release of the blood-pressure cuff and causing 
the PWV to decrease The Medical Ethics Committee Erasmus MC of Rotterdam, the 
Netherlands confirmed that the rules laid down in the Medical Research Involving 
Human Subjects Act (also known by its Dutch abbreviation WMO), do not apply for 
this in vivo pilot study. Therefore, the study was allowed without further review by 
the MEC board. The MPA was placed on the right finger and set to use Protocol 1. 
The healthy volunteer was sitting on a chair with both hands resting on a table, in 
a quiet room under tranquil conditions and without talking or moving during the 
measurement. First, the PWV was measured for 1 minute to obtain a baseline. 
Next, the blood-pressure cuff, placed around the upper arm, was inflated to  150 
mmHg pressure to block the blood flow to the lower arm. After 5 minutes, the 
blood-pressure cuff was instantly released. During this entire process, the PWV 
was measured. After releasing the blood-pressure cuff, the PWV and PWA were 
measured for 5 minutes and averaged over each 30 s. 
6.3  Results 
6.3.1  Functional validation 
The validation setup has a scanning velocity tolerance which is determined by: 
 T1; the accuracy of the distance between the rotating mirror and the MPA 
 T2; the accuracy of the speed of the rotating mirror.  
The tolerance of the distance between the rotating mirror and the MPA was 
determined to be 1% (using a solid aluminium breadboard with a tolerance of 0.25 
mm between the mounting holes). For the peak detection, the accuracy was 
± 1 sample for the two lowest scanning velocities and ± 2 samples for the two 
highest scanning velocities. T1 and T2 together lead to uncertainties in the 
scanning velocities of ± 0.5 m/s for two lowest scanning velocities and ± 1.1 m/s 
for two highest scanning velocities. Table 6.1 shows the mean ± SD of the 
scanning velocities. 
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The measured pulse velocity tolerance by the MPA as determined by: 
 T3; the tolerance of the distances between the successive photodiodes 
 T4; the accuracy of the detection of the peaks of the light pulses received 
by the photodiodes.  
The tolerance specified by the manufacturer for the distance between photodiodes 
1 and 16 was ± 0.25 mm over the full distance of 12.0 mm. Therefore, the 
uncertainties in the measured pulse velocities caused by T3 and T4 are ± 0.2%, 
0.3 %, 0.5 % and 0.6 % for the successive measured pulse velocities. Table 6.1 
shows the mean ± SD of the measured pulse velocities using Protocols 1 and 2.  
Figure 6.5 shows the relative difference between the scanning velocity and the 
measured pulse velocity and their variation. The maximum differences was 3.0 % 
when using the four photodiodes by the highest scanning velocity. For using two 
photodiodes, Protocol 1, the maximum differences was 1.7 %. Both reported 
accuracies are including the additional potential deviations caused by the system 
Figure 6.5: Boxplot of the relative differences between the set-scanning velocities (taken as the zero 
reference) and the measured pulse velocities (for 2 and 4 photodiodes). The line in the middle of each 
box is the sample median. The tops and bottoms of each "box" are the 25th and 75th percentiles of the 
samples, respectively. The whiskers are drawn from the ends of the interquartile ranges to the furthest 
observations excluding outliers. 
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tolerances. 
6.3.2. In vivo pilot study 
Figure 6.6 shows the PWV and the PWA averaged over each 30 seconds as 
measured for each heartbeat before and after the FMD test. After release of the 
blood-pressure cuff the PWA increased, which agrees with the Guidelines for the 
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of 
the Brachial Artery [17]. The PWV measured between photodiodes 1 and 16 before 
inflating the blood-pressure cuff was 1.1 ± 0.2 m/s during this 1 min baseline. The 
PWV was higher after releasing the blood-pressure cuff and then decreased over 
time.  
 
Figure 6.6: (A) pulse wave amplitude and (B) pulse wave velocity (PWV) before and after flow-mediated 
dilation (FMD) in a healthy volunteer. First a baseline of 1 min was measured (leftmost dot). Each dot 
indicates the average over each 30 sec. The dot at 0 s indicates the value at the moment the cuff is 
released immediately after the 5 min of FMD. 
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6.4 Discussion 
To the best of our knowledge, this study is the first to demonstrate measuring the 
PWV based on photoplethysmography with a single photodiode array. The 
validation setup used enabled assessing the maximum technical accuracy for 
measuring pulse speeds in the range of naturally occurring pressure pulse wave 
velocities and beyond. 
6.4.1 Scanning velocity 
The scanning velocities used to validate the functionality of the MPA were relatively 
high compared to commonly reported average PWVs in healthy subjects or 
patients. However, these velocities were chosen in order to assure that proper 
PWV measurements can also be obtained even in patients— who often have with 
exceptionally high PWVs— and to explore the full potential of the designed sensor, 
both for application in the primarily intended transmission measurements on the 
extremities as well as in future reflective measurements on, e.g., the carotid 
artery. Furthermore, the measurement inaccuracies increase with increasing PWV, 
which is why the chosen velocities provide a very strong worst-case validation. 
Despite the tolerances causing uncertainties in the applied scanning velocities, the 
validation setup proved to be sufficiently accurate for our purposes. 
6.4.2 Measured pulse velocity 
At all scanning velocities, the MPA accuracy proved to be more than adequate to 
provide reliable results. In the MPA, any inaccuracies in the measured pulse 
velocity could in principle be caused by:  
a) the tolerance on the distances between the photodiodes, which is a 
systematic error because the inter-diode distances never change; 
b) the response time of the MPA photodiodes, which was unlikely to be a 
source of inaccuracy because the amplitudes were comparable for all 
measured velocities; 
c) and the sampling frequency, of which the relative effect size depends on 
the pulse velocity to be measured. 
One may notice in Figure 6.4 that the amplitude of the response of photodiode 16 
was higher than that of the other photodiodes. No explanation for this systematic 
deviation could be found, but it could have been induced by a small irregularity in 
the laser-cut mask in front of  the MPA, which might have caused reflections or 
slightly more light to pass the mask. However, irrespective of the cause of the 
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amplitude variation, such systematic response amplitude variations between the 
different diodes do not affect the speed calculations, as these do not change the 
location of the amplitude peaks on the time axis. 
The MPA showed to enable accurate measurement of PWVs up to 45 m/s when 
using two photodiodes (spaced 12.0 mm apart) at 125 kHz. When using four 
photodiodes (spaced 4 mm apart) at 62.5 kHz the MPA can accurately measure 
PWVs up to 25.0 m/s without the need for interpolation and up to 45.0 m/s with 
interpolation. In clinical practice, the PWV is unlikely to exceed 20.0 m/s [6, 9, 10]. 
Therefore, the MPA is sufficiently accurate for clinical use when using four 
photodiodes. Having four photodiodes instead of two can be of potential value 
when local artefacts disturb the PW shapes and inhibit proper detection of the PW 
peaks, something often observed in clinical practice. In such cases, the velocity 
measurements can be made more robust by ignoring any diodes that return 
disturbed PW signals and averaging the velocities measured over several sections 
of the array. Furthermore, using more than two photodiodes allows to investigate 
whether there is a change in PWV over a short trajectory; this could potentially be 
useful to determine the presence of arthrosclerosis in a specific area. 
When sampling all 16 photodiodes, the MPA could not accurately measure the PWV 
for any of the applied scanning velocities. The sampling frequency (which is 
multiplexed over all channels) was too low to accurately provide the true peak 
location, even after interpolation. The 16 photodiodes array was selected because 
of its availability, but having 2 photodiodes suffices for measuring the PWV and 
with 4 photodiodes the robustness of the PWV measurements can be increased. 
However, having a plurality of photodiodes could potentially maximize the 
robustness of the velocity measurements in patients demonstrating high rates of 
disturbed PWs.  Obviously, the MPA performance with 16 photodiodes could be 
improved by using higher sampling frequencies, but that would require costlier 
equipment. A way to improve the measurements while using low sampling 
frequencies could be to determine the time differences of the pulse waves arriving 
at the different diodes using cross-correlation instead of peak detection. However, 
the current study focused on the use of peak detection because this is a simple 
approach that can applied easily in many software packages and analysis tools. 
Additionally, peak detection requires little computational power compared to using 
cross-correlation methods, making it more suitable for fast, real-time 
measurements. 
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The pulse velocities measured using two or four photodiodes had deviations of at 
most 3.0 % compared to the corresponding scanning velocities. In an in vivo 
study, Boutouyrie et al. measured PWVs to differ between healthy volunteers 
(Optimal) and patients with CVD (Grade II/III HT) by more than 25% (for ages ≤ 
30 years a mean PWV of 6.0 m/s versus 7.6 m/s) [6]. Implying once more that, 
when using two or four diodes, the MPA can reliably measure clinically realistic 
PWV values with sufficiently high accuracy to detect clinically relevant PWV 
variations. The applicability of the MPA could be even further increased by 
adapting it to enable reflective PPG measurements. This would allow measuring 
PWVs on locations that can be approached from a single side only, such as the 
carotid artery. 
6.4.3 In vivo pilot 
To further test the clinical applicability of the MPA, an in vivo pilot study was 
conducted on author M.H.N.V. These results were similar to those reported by 
Nam et al. [13], i.e. around 0.8 m/s. Furthermore, the response of the PWA to the 
FMD agrees with that described in the guidelines for FMD measurement [17]. It is 
known that the PWA increases during FMD. Assuming other parameters (e.g. 
cardiac output, heart rate) to be constant throughout the experiment, the PWV 
should decrease after FMD; our pilot results were in line with this expectation.  
It is not yet known to what extent the peripheral PWV measured in a finger 
correlates with conventional techniques of measuring the PWV in the aortic. To 
investigate this, the functionality of the MPA first had to be verified, as was done in 
this research. The correlation between conventional PWV measurements and 
peripheral PWV is currently being investigated. If there is good correlation, this 
novel way of measuring the PWV will open the road to fast and simple PWV-based 
diagnostics with minimal burden on patients. 
6.5  Conclusion 
The results of this study indicate that the novel photoplethysmography-based MPA 
can accurately and reliably measure PWV within clinically relevant ranges, and 
even well beyond. Some important advantages of the MPA as compared to other 
PWV measuring systems are that the MPA is easy-to-use, non-invasive and 
objective. Using the MPA will not require trained staff or costly equipment, and 
allows continuous monitoring. In addition, the MPA eliminates the need for any 
other measurement systems, such as ECG, for measuring PWVs. 
106 
Further research is required to investigate whether the PWVs measured with the 
MPA on the fingers can be used as an index for evaluation of aortic stiffness as a 
factor of cardiovascular risk [9]. A subsequent step is to examine the 
reproducibility and variance of the PWV in healthy volunteers and cardiovascular 
risk patients when applying measurements over short trajectories, instead of the 
currently used measurements over larger distances. 
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Arterial stiffness is a reliable prognostic parameter for cardiovascular diseases. The
effect  of  change  in  arterial  stiffness  can be measured by  the  change of  the pulse
wave velocity (PWV). The Complior system is widely used to measure PWV between
the  carotid  and  radial  arteries  by means  of  piezoelectric  clips  placed  around  the
neck and the wrist. The Biopac system is an easier to use alternative that uses ECG
and  simple  optical  sensors  to  measure  the  PWV  between  the  heart  and  the
fingertips, and thus extends a bit more to the peripheral vasculature compared to
the Complior system. The goal of this study was to test under various conditions to
what extent these systems provide comparable and correlating values. 25 Healthy
volunteers, 20 30 years old, were measured in 4 sequential position:, sitting,  lying,
standing  and  sitting.  The  results  showed  that  the  Biopac  system  measured
consistently  and  significantly  lower  PWV  values  than  the  Complior  system,  for  all
positions.  Correlation  values  and  Bland‐Altman  plots  showed  that  despite  the
difference in PWV magnitudes obtained by the two systems the measurements did
agree  well. Which  implies  that  as  long  as  the  difference  in  PWV magnitudes  are
taken  into  account,  either  system  could  be  used  to  measure  PWV  changes  over
time. However, when basing diagnosis on absolute PWV values, one should be very
much aware of how the PWV was measured and with what system. 
Comparison between pulse wave velocities measured 
using Complior or measured using Biopac 
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7.1  Introduction  
Arterial stiffness is a reliable prognostic parameter for cardiovascular morbidity and 
mortality in adults. In particular, this is the case in patients with renal disease, 
diabetes mellitus or hypertension and in elderly patients [1-4]. Cardiovascular 
disease (CVD) is worldwide the number one cause of death. Smoking, unhealthy 
diet, physical inactivity and harmful use of alcohol are the most important 
behavioural risk factors of CVD. These behavioural risks may lead to hypertension, 
diabetes, obesity, heart failure, or atherosclerosis. Most of these phenomena are 
related to an increase in arterial stiffness. 
Arterial stiffness is a measure of the capability of an artery to expand and contract 
in response to local blood pressure changes and is the inverse of arterial 
compliance. The compliance, and therefore the volume change in response to a 
blood pressure change, in a stiff vessel is reduced compared to a healthy vessel. 
The effect of reduced compliance is a decreased propagation time of pressure 
pulse waves (PWs) through the vessels and thus an increase of the velocity of the 
PW. The relationship between this pulse wave velocity (PWV) and the compliance 
of the vessel wall is described in the Moens-Korteweg equation [5]: 
  (7.1) 
where Einc is the incremental elastic modulus, h is the wall thickness, and r the 
radius of the vessel. The symbol ρ represents the density of blood. 
PWV measurements are widely used as an index of arterial stiffness [6] and for the 
evaluation of cardiovascular risk. PWV measurements are generally simple, 
accurate and highly reproducible [7, 8]. In clinical practice, several invasive and 
non-invasive measurement systems are readily available to measure PWV. Two of 
such systems, equally often used in clinical practice by the Erasmus Medical Centre 
in Rotterdam, the Netherlands, are the Complior (Alam Medical, Vincennes, 
France), using piezoelectric sensors [9], and the Biopac (Biopac Systems, Inc, 
USA), using a photoplethysmography (PPG) sensor and ECG. These systems are 
used to non-invasively measure PWV in big arteries over long trajectories.  
The Complior system is used to measure PWV between the carotid and radial 
arteries by means of piezoelectric clips placed around the neck and the wrist. The 
Biopac system is an easier-to-use alternative to the Complior system, but it 

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measures the PWV between the heart and the fingertips, and thus extends a bit 
more to the peripheral vasculature. One may expect the two systems to show 
good agreement, because the majority of the trajectory (sternoclavicular joint to 
wrist) of the arterial trajectories over which the Biopac and Complior systems 
measure PWV are identical. However, the trajectory for the Biopac additionally 
includes the wrist-fingertip vasculature. Furthermore, the Biopac includes the 
heart-sternoclavicular trajectory, whereas with the Complior the sternoclavicular-
carotid trajectory is taken as an approximation for the heart-sternoclavicular 
trajectory. 
While both systems are supposed to measure or approximate a PWV value for the 
more or less the same trajectory from the heart to the hand, the potentially 
differing physiological responses of the carotid and the peripheral arteries may 
cause different PWV measurement outcomes. The baroreceptor reflex is one of the 
body's homeostatic mechanisms that helps to maintain blood pressure at nearly 
constant levels [10] by detecting blood pressure using the baroreceptors located in 
the walls of the carotid arteries. If one suddenly rises from a lying position, gravity 
pulls the blood in the direction of the legs, which could endanger the blood flow to 
the brain. As a response, the baroreceptor reflex causes the peripheral veins to be 
squeezed and the carotid arteries to be widened to aid the blood flow to the brain. 
Therefore one may expect that depending on the measurement situations the PWV 
change measured with the Complior system will oppose the PWV measured with 
the Biopac system if the baroreceptor reflex is invoked. 
So while both systems are aimed at providing a similar measure of vascular 
condition and while the trajectories over which they measure PWV largely overlap, 
there are various reasons why it is unclear whether they will provide similar 
measurement outcomes. To the best of our knowledge, there are no reports about 
the agreement between PWV values measured using the Complior system or the 
Biopac system. Yet, in clinical practice it is crucial to know whether using different 
devices for the same purpose provides the same outcome. One would never accept 
it if measuring a heart rate using ECG versus using a pulse oximeter on the finger 
would provide a 30 bpm difference. Therefore, the goal of this health technology 
assessment was to test under various conditions to what extent these systems 
provide comparable values and to what extent these values correlate.  
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7.2 Method 
7.2.1  Study population 
Twenty-five healthy volunteers, 20-30 years old, without any known history of 
atherosclerosis associated diseases (such as diabetes mellitus, hypertension, 
coronary artery disease, stroke, renal disorder), or injuries at the upper limbs were 
included in this study after obtaining written informed consent from the subject. 
This study was approved by the medical ethics committee of Erasmus University 
Medical Center Rotterdam, the Netherlands (MEC-2012-139). 
7.2.2 Protocol 
The transit time of a PW traveling from within the heart to easily accessible 
locations, such as the extremities or the neck, consists of 2 components: the PW 
propagation-time from the heart through the artery to the PW measurement 
location, and the isometric contraction time of the heart (pre-ejection period, PEP). 
The PEP is known to vary with cardiac preload and heart rate [11-13]. Therefore, 
all measurements were conducted in a quiet room under tranquil conditions at a 
room temperature of 22.4°C (SD 0.5°C). To further minimize any influences of a 
varying PEP or cardiac output during the measurement, the subjects were 
instructed not to talk or move during the measurement for each position. Because 
caffeine, tobacco and alcohol influence the heart rate and cardiac output, all 
subjects were asked to not take any caffeine, tobacco or alcohol for at least 3 
hours prior to the experiment. 
The measurements were conducted 4 times for each subject, each time in a 
different body position. In the first position, the subject sat on a chair with both 
hands resting on a table. In the second position, the subject lied on a bed with 
both arms and hands resting along his/her body. In the third position, the subject 
stood upright with both hands hanging down along his/her body. The fourth 
position was the same as the first position, to check if the PWV-value was 
reproducible. 
Before the start of each measurement in each position the subject was kept at rest 
for 60s in the requested position. The PWV values were recorded with both of the 
tested systems simultaneously during the entire measurement, which lasted up to 
60s.  
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7.2.3  Pulse wave velocity analysis 
The PWV was measured between the carotid and radial arteries using the Complior 
system (Alam Medical, Vincennes, France) and between the carotid artery and the 
left index finger tip using ECG and PPG (described below). The Complior system 
measures the PWV using piezoelectric sensors. For measuring the PWs on the 
carotid artery, a clip containing a piezoelectric sensor was placed on the left side of 
the neck. For measuring the PWs on the radial artery, a clip containing a 
piezoelectric sensor was placed on the left wrist (see Figure 7.1). Both sensor 
signals were recorded by the ”Complior SP’’ software. The distance between the 
sensors, measured in a straight line from the sternoclavicular joint to the styloid 
process of the radius, was used to approximate the arterial distance travelled by 
the PWs. Using the ‘’Complior SP’’ software, the foot of the PW measured at both 
locations was used to calculate the mean PWV once per 5 s. 
The system used for measuring the PWV between the carotid artery and the left 
index finger tip consisted of a measuring device and analysis software. The 
measurement device contained one PPG-sensor (TSD200 with the PPG100C 
amplifier, Biopac Systems, Inc, Goleta, USA), positioned on the left index finger, 
and three external ECG-leads (ECG100C amplifier, Biopac Systems, Inc, Goleta, 
USA) (see Figure 7.1). The three ECG-leads were placed on the subject’s both 
wrists and right ankle. The PPG- and ECG-signals were simultaneously converted to 
digital signals using AcqKnowledge version 3.7.3 software (Biopac Systems, Inc, 
Goleta, USA), at a sampling frequency of 2 kHz. The PPG-signal was filtered with a 
 
Figure 7.1: Schematic view of placement of the both measurement systems. 
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fourth-order low pass Butterworth filter with a cut-off frequency of 9 Hz using 
Matlab R2010a (The MathWorks, Inc., Matick, MA, USA). The PWV was determined 
by dividing the distance between the PPG-sensor on the left index finger and the 
sternoclavicular joint (d) by the calculated time-difference between the time 
instance of the R-peak of the ECG (tECG R-peak(n)) and the foot of the PW measured 
at the left index finger tip (tPPG foot(n)): 
( ) ( ) ( )
foot R peak
Biopac
PPG ECG
dPWV n
t n t n
   (7.2) 
where n is the sequence number of the heartbeats. The R-peaks in the ECG were 
found using the off-the-shelf Matlab function ‘R-peakdetect’ [14]. The maximum of 
the second derivative of each PW was taken as the foot of the PW (PPGfoot) and 
the corresponding time was indicated as tPPG foot (n) [15]. The utilized PPG-sensor 
was quite sensitive for motion and positioning artefacts, which sometimes distorted 
the shapes of the PWs in a way that they were rendered unsuitable for further 
analysis. Therefore, a custom-made Matlab algorithm, called ‘7Step PW-Filter’, was 
implemented in the data analysis to filter out any PWs that strongly deviated in 
shape from a suitable PW [16]. If more than 50% of the PWs were filtered out for 
being too distorted, the data-set was excluded from further analysis. 
7.2.4  Statistical analysis 
The mean PWVs +/- standard deviation (SD) over 60s were calculated for each 
measurement technique for each body position. The Shapiro-Wilk test was used to 
check if the data was normally distributed. PWV values obtained using the 
Complior and Biopac system were compared using a paired samples t-test and a 
Bland-Altman plot was used to analyse the agreement between the two different 
PWV measurement techniques. Correlation between both sitting positions (Position 
1 and Position 4) were analysed using a Pearson Correlation test. A significance 
level of p-value < 0.05 was used. A repeated measurement ANOVA with 
Greenhouse-Geisser correction and a post hoc test with Bonferroni correction was 
used to test for any effects of the repeated measurements. All 7statistical analyses 
were performed using SPSS version 22.0 (SPSS, Inc., Chicago, IL, USA). 
7.3 Results 
Twenty-five subjects, (11 male, 14 female) were included in this study. The data of 
one male and one female subject were excluded from the analysis because there 
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was too much noise in the signals to obtain any usable PWs. Table 7.1 presents 
the characteristic of the remaining study population. For positions 1, 2 and 4 
(sitting 1, lying, sitting 2)the ‘7Step PW-Filter’ filtered out none of the PWs. For 
Position 3 (standing) there were 8 datasets with over 50% unsuitable PWs, which 
were therefore excluded from further analysis. In the remaining 15 datasets, the 
median percentage of unsuitable PWs that were filtered out was 2.2% (Q1 = 0% 
and Q3 = 36.6%). 
The means and SDs for the PWVcomplior and PWVbiopac for the 4 different positions 
are listed in Table 7.2, as well as the results of the paired samples t-test. 
Significant differences were found for each position between PWVcomplior and 
PWVbiopac.  
Table 7.1: Characteristics of the study population. Values are means ± SD or number (%) of 
participants 
Variable  [n =23] 
Gender (male), no. (%) 10 (43.5) 
Age [years] 25 ± 3 
Weight [kg] 72 ± 9 
Height [m] 1.77 ± 0.08 
Body mass index [kg/m²] 23.03 ± 2.72 
Blood pressure [mmHg] 
   Systolic 127 ± 11 
   Diastolic 80 ± 9 
Heart rate [bpm] 77 ± 14 
Smoker (yes), no. (%) 2 (8.33) 
Distance from sternoclavicular to wrist [cm] 69 ± 3 
Distance from wrist to fingertip [cm] 17 ± 1 
 
Table 7.2: Mean and standard deviation of the PWV 
Position PWVcomplior [m/s] PWVbiopac [m/s] Paired sampled t-test 
Sitting 1 10.2 ± 1.4 3.0 ± 0.2 t(21) = -24.442, p < 0.001 
Lying 9.3 ± 1.6 3.1 ± 0.2 t(19) = -18.654, p < 0.001 
Standing 9.8 ± 2.2 3.2 ± 0.2 t(13)= -16.178, p < 0.001 
Sitting 2 10.2 ± 1.1 3.0 ± 0.2 t(21) = -31.704, p < 0.001 
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Figure 7.2 shows a boxplot of PWVcomplior and PWVbiopac for each position. The data 
consistently showed that PWVbiopac was much lower than PWVcomplior.  
Figure 7.3 and Table 7.3 present the Bland-Altman values and plot, showing good 
agreement between the two PWV measurement techniques.  
The Pearson correlation between sitting Position 1 and Position 4 proved to be high 
and significant for PWVbiopac (0.778, p < 0.001). For PWVcomplior there was no 
 
Figure 7.2: Boxplot of the PWVbiopac and PWVcomplior, with the median as red line and the minimum 
and maximum value 
Table 7.3: Bland-Altman 
Position BIAS ± CI [m/s] % of overall mean PWV [%] 
Sitting 1 7.2 ± 2.7 37.6 
Lying 6.2 ± 2.9 47.0 
Standing 6.6 ± 4.3 64.4 
Sitting 2 7.3 ± 2.1 29 
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significant correlation (0.141, p = 0.541). 
The repeated measures ANOVA indicated that the four body positions were rated 
equally (F(3,45)=2.47, p=0.074), for the Complior. For the Biopac, the four body 
positions were not rated equally (F(3,39)=13,1, p=0.000).The post hoc tests of the 
Biopac-data revealed that Position 2 (lying) and Position 3 (standing) resulted in 
significantly higher PWV compared to Position 1 (sitting 1) ( (p=0.000, p=0.025, 
respectively). There was no significantly difference between Position 2 (lying) and 
Position 3 (standing) (p=1.000). 
7.4 Discussion 
This study compared PWV values measured over the carotid-radial artery trajectory 
using the Complior system with PWV values measured between the R-peak of the 
ECG and the arrival of the PW in the left index finger tip using the Biopac system in 
healthy volunteers in three body positions: sitting, lying and standing. The 
PWVbiopac values were considerably lower than the PWVcomplior values, and this effect 
persisted in each position. This absolute difference might be explained for a minor 
part by the fact that PWVbiopac includes the PEP, whereas PWVcomplior does not. 
However, the PEP could account for no more than 1 m/s of the PWVbiopac. 
Therefore, the large absolute difference between PWVbiopac and PWVcomplior may 
more likely be explained by the difference in vessel compliance between the two 
trajectories. More peripheral vessels are narrower, thinner walled and more 
Figure7.3: Bland-Altman plots of PWVcomplior and PWVbiopac by the 4 positions. The dotted lines represent 
the 95% limits of agreement and the straight mean difference (bias) between PWVcomplior and PWVbiopac 
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compliant. Because the more peripherally measured PWVbiopac showed to be lower, 
it is hypothesized that the reduced vessel stiffness and wall thickness (both 
reducing PWV) outweigh the reduced vascular radii (which would increase the 
PWV). However, the PWVcomplior values agree with values reported in other studies. 
The mean PWVcomplior values (10.2 ± 1.4 m/s) were in the same range as those 
reported by Rajzer et al. [17] (10.1 ± 1.7 m/s). Although Raizer et al. measured 
PWV over the carotid-femoral trajectory, it is expected that PWVs over that 
trajectory will be similar to those in the carotid-radial trajectory, because of similar 
lengths and because the effects of differences in vessel radii and wall thicknesses 
are likely to cancel each other out, according to Equation 1. Furthermore, the 
current results also agree with those of McEleavy, who measured a PWV of 
9.0 ± 1.2 m/s in the carotid-radial trajectory [18]. For the PWVbiopac no other 
studies reporting PWV between the heart and a fingertip were found, however the 
time between the R-peak of the ECG and arrival of the foot of the PW at the 
fingertip (called pulse transit time) (283 ± 21 ms) was in the same range as 
reported previously by van Velzen et al. (273 ± 20 ms) [16] and by Kortekaas et 
al. (271 ± 28 ms) [13].  
Table 7.2 shows that the PWVbiopac was consistently and significantly lower than 
PWVcomplior for all positions (1 to 4). However, the Bland-Altman plots (Figure 7.3) 
show that the bias is small and the values are scattered around the mean, leading 
to the conclusion that there is a good agreement between the PWVcomplior and 
PWVbiopac values, but they simply differ in magnitude.  
The PWV was slightly, but significantly higher when lying or standing as compared 
to sitting (with no significant difference between lying and standing), when 
measured by the Biopac system over the heart-fingertip trajectory. PWV may 
increase when vessels become stiffer and narrower due to contraction, but 
although this effect could be induced when standing up, it is less likely to happen 
when lying down. There was no significant effect of the different positions for the 
PWVcomplior, which suggests that the PWVcomplior is less suitable to detect such small 
PWV changes or it is less sensitive to changing positions. The Pearson correlation 
results show much better agreement between repetitions of the sitting position at 
different moments for the Biopac system than for the Complior system. This 
suggests that when doing longitudinal PWV measurements, the Biopac system 
should be preferred, provided that the same position is consistently used during 
successive measurements. 
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When using the Biopac system, the measured PWV includes the PEP. The PEP is 
known to vary during position changes. PEP variations caused by subject 
movement or stress were avoided during the current study. Kortekaas et. al 
showed a variability of the PEP in healthy volunteers in rest of 58.5 ± 13.0 ms 
[13]. Over the distances travelled by the PWs in the current study, these PEP 
durations could account for no more than 1 m/s of the PWVbiopac. Consequently, 
PEP variations are unlikely to explain any variations in this study. 
Limitations of the two tested techniques include the challenge of accurately 
positioning the sensors, and the discrepancy between the measured distance 
between the sensors and the actual path length travelled by the PWs. When 
measuring the PWV more locally, such as between the wrist and a position at the 
lower arm, the discrepancy between the distance between the sensors and the 
actual path length travelled by the PWs should diminish. 
Furthermore, the utilized piezoelectric sensors in the Complior and PPG sensors in 
the Biopac system were quite sensitive to motion and positioning disturbances. 
This sensitivity to disturbances poses a potential limitation on the usability of these 
techniques in clinical practice. Moreover, the Complior system is not always 
comfortable for the subject: use of the clip on the neck was sometimes 
experienced as uncomfortable, whereas the sensor required for the Biopac system 
a photoplethysmography sensor on the finger and three ECG-leads on the wrists 
and right ankle are more comfortable than the Complior sensor and are generally 
available in hospitals. Using this system could benefit patients and clinical practice. 
Although the ‘7Step PW Filter’ algorithm used to eliminate distorted PWs 
functioned well, the availability of a PPG sensor less sensitive to disturbances and 
not requiring measuring sensor distances, would greatly simplify measuring PWs in 
awake and moving patients. Obviously, this is less relevant when measuring PWs 
in patients under general anaesthesia.  
7.5 Conclusion 
In conclusion, this study demonstrated that PWV values were consistently and 
significantly lower when measured with the Biopac system than when measured 
with the Complior system. Yet, despite the difference in absolute PWV values, the 
two systems did agree fairly well. This suggests that as long as the difference in 
PWV magnitudes are taken into account, either system could be used to measure 
PWV changes in time. However, when basing diagnosis on absolute PWV values, 
one should be very much aware of how the PWV was measured and with what 
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system. In the future, clinical practice could greatly benefit if software for 
calculating PWV is embedded in the commonly used anaesthesia monitors, 
enabling PWV measurements using a standard ECG and a standard pulse oximeter. 
This might allow PWV measurements to become a widely available diagnostic tool, 
and an easy-to-use, non-invasive, safe and quick method for objectively assessing 
arterial stiffness as a reliable prognostic parameter for cardiovascular morbidity 
and mortality. 
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The Multi Photodiode Array (MPA) has previously been tested in clinical studies that
were  intended  to  provide  insight  in  PWV  values  in  various  populations.
Unfortunately, all these studies showed highly fluctuating and unrealistic results. To
explore  how  to  optimize  the  MPA  positioning,  four  aspects  were  explored:  light
pollution  reduction,  using  collimators,  shortening  the  light  travel  paths  and
optimizing the contact between the MPA and the finger. The optimal use condition
of  the MPA  appeared  to  be:  soft‐side  positioning  of  the MPA,  locating  the  active
photodiodes across the middle, fleshy side‐part of the distal phalanx and using light
contact  pressure  between  the MPA  and  the  finger.  A  new  sensor  holder  concept
was designed to standardize the placement of the MPA on the finger for easy and
intuitive application of the optimal use condition. 
Effect of Multi Photodiode Array positioning on pulse 
wave velocity measurement quality 
Solving issues encountered in clinical studies 
Chapter 8
Marit. H.N. van Velzen, Sjoerd P. Niehof, Egbert G. Mik, Arjo J. Loeve 
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8.1 Introduction 
The Multi Photodiode Array (MPA) sensor has previously been tested in one study 
on healthy volunteers and two clinical studies that were intended to provide insight 
in PWV (pulse wave velocity) values in various populations. Unfortunately, most of 
these data had to be excluded: 
1. The study on healthy volunteers (Erasmus MC ethical board approval MEC-
2012-139, see also Chapter 7 [1] and Appendix 8.A) was intended as a 
comparison between three PWV measurement systems: Biopac, Complior 
and the new MPA (see Chapter 7). In this study, all data obtained from 25 
healthy volunteers with the MPA, used to measure PWVs on the left middle 
finger and reading out 4 of its 16 available photodiodes (diodes 1, 6, 11 
and 16, spaced 4 mm apart) distributed evenly over the MPA, were 
eventually excluded entirely because too many PWV values showed very 
fast fluctuations between extreme positive and at that time unexplainable 
negative values. 
2. While the study above was running, the first clinical study on patients 
(Erasmus MC ethical board approval MEC-2014-344, see also Appendix 
8.B) was initiated. In this study PWVs of 23 patients undergoing surgery 
under general anesthesia was measured during initiation of the anesthesia. 
The PWV was measured using the MPA affixed to the index finger 
contralateral to the side of the infusion catheter. PWVs were measured 
using 4 photodiodes (diodes 1, 6, 11 and 16, spaced 4 mm apart) 
distributed evenly over the MPA. Again, too many PWV values showed very 
fast fluctuations between extreme positive and at that time unexplainable 
negative values. 
3. A second clinical study (Erasmus MC ethical board approval METC-2015-
159, see also Appendix 8.C) was conducted in a last attempt to obtain 
usable clinical data and after once more validating that all hardware and 
software of the MPA system worked properly. In this study one MPA 
sensor was placed on the left index finger and one on the left big toe. 
From each MPA sensor 2 photodiodes (diodes 1 & 16, spaced 12 mm 
apart) were used to measure PWV. From many patients no suitable 
measurements could be obtained (due to their diseases the pulse waves 
had too small amplitudes or were too heavily distorted to be observed) 
and when PWVs could be properly measured, these data again showed 
very fast fluctuations between extreme positive and at that time 
unexplainable negative values. 
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These results were unexpected, because both the successful functional validation 
of the MPA [2] (Chapter 6), accompanying pilot measurements on healthy 
volunteers, and intermediate tests done by the authors showed perfectly fine PWV 
measurements in several pilot volunteers and even for test-PWVs much higher 
than would occur in the fingers. However, as the distances between the diodes on 
the MPA are relatively small and the time differences between arrival of the pulse 
waves at the successive diodes very short, it was suggested that maybe the peaks 
of the pulse waves were insufficiently accurately detected due to undersampling. 
This could indeed have been a viable explanation, easily solvable by using a faster 
(but more expensive) DAQ-card for the sensor readings. However, the functional 
validation of the MPA [2] (Chapter 6), already proved that the MPA could easily 
handle speeds up to 45 times higher than the PWV in a finger. This was further 
confirmed by using Equation 8.1 to calculate the number of samples (Nsamples) 
between the arrival times of a pulse wave at diodes spaced 1.6, 3.2 and 4.8 mm 
(da-b) for PWVs of 0.5 to 2 m/s (PWV) at a sample frequency of 62.5 kHz (fs). Table 
8.1 shows that even in the worst case scenario with the sensors closest together 
(even 3.2 to 7.5 times closer than in the experiments) and a very high PWV of 2 
m/s in the finger, there would still be 50 samples between the arrival times of the 
pulse waves at the two diodes. 
Consequently, taking the functional validation and above calculations into account, 
technical flaws or undersampling were definitively ruled out as possible causes of 
the oddities observed in the three human subjects studies. 
 ( 8.1) 
When considering the anatomy of the finger, no reason could be found to assume 
that negative PWVs would be true values originating from pressurized blood 
flowing in a distal-proximal direction. Yet, a possible explanation for the data 
obtained from the three human subject studies emerged when looking at the 
placement of the MPA photodiodes and LED light sources on the finger (see 
Figure 8.1).  
a b s
samples
d fN
PWV
 
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It is apparent that light from the LEDs cannot reach the photodiodes in a straight 
line. The light has to travel around the bone through soft tissue and blood vessels, 
while being scattered and diffused along the way. Depending on the micro-
anatomy in the finger and the travel path of the light from the individual LEDs, this 
implies that in this situation when a photodiode’s signal shows a peak, it does not 
mean that at that time there was a maximum vessel expansion (e.g., due to a 
pressure pulse) at the line between that photodiode and its most directly opposing, 
closest LED. Therefore, due to this light-path effect, when a pressure pulse wave 
travels along the direction indicated in Figure 8.1, a signal peak may, perhaps 
contra-intuitively, occur earlier at a downstream photodiode than at an upstream 
diode. 
Because of the light-path effect explained above, it was hypothesized that in order 
to enable reliable use of the MPA, a way had to be found to ensure or at least 
maximize the probability that the majority of the light that a photodiode receives 
originates from the LED directly across it. To clarify, in Figure 8.1 this would mean 
that each photodiode’s signal is determined as much as possible by the light 
coming from the LED with the same number as the photodiode and by the 
anatomical structures directly between the photodiode and the LED. 
Figure 8.1: Schematic overview of the multi photodiode array (MPA) and illustration of the 
calculation of the pulse wave velocity. 
Table 8.1: Number of samples between arrival times of pulse waves at different diodes on an MPA 
sensor for different PWVs at a sampling frequency of 62.5 kHz. 
PWV 
[m/s] 
Diodes distance da-b  
6-8 
Diodes distance da-b  
6-10 
Diodes distance da-b  
6-12 
2 50 100 150 
1.5 67 133 200 
1.0 100 200 300 
0.5 200 400 600 
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The goal of this study was to explore how to optimize the detection of the LEDs’ 
light by the photodiodes so that a peak in a photodiode signal truly corresponds to 
a maximum throughput of light over the line between that diode and its most 
directly opposing LED. Based on the considerations above and experiences during 
the development and testing of the MPA , four aspects were explored: 
1. Removing light pollution coming from the measurement environment. 
2. Using collimators to limit the field-of-view of the photodiodes 
3. Shortening the light travel paths by placing the photodiodes and LEDs on 
the soft tissue palmar of the finger (Figure 8.2) 
4. Optimizing the contact pressure between the MPA and the finger to avoid 
early light scattering and blood vessel occlusions 
8.2 Methods 
Throughout all of the tests described below, photodiodes 6, 8, 10 and 12 of the 
MPA were used and read out at 62.5 kHz (see Chapter 6 for further specifications 
of the data acquisition system). All tests were aimed at obtaining only realistic PWV 
values, corresponding with proximal-distal propagation of blood pressure pulse 
waves and an optimal line of sight between the photodiodes and their 
corresponding LEDs. The character, safety characteristics and durations of the 
tests were all such that no medical ethical committee review was needed. 
To avoid over-idealization of results and to incorporate at least some anatomical 
variations, all tests were conducted on the left index fingers of authors MvV and 
AL. Subject 1 was a healthy female, 29 years old, 1.57 m body height, BMI 23.5, 
and Subject 2 was a healthy male, 35 years old, 1.74 m body height, BMI 23.1. 
Each PWV measurement consisted of placing the left index finger in a test setup 
(Figure 8.2) that held the MPA sensor to keep the position and contact pressure 
constant during each test.  
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After setting the test conditions (see the five descriptions below) and verifying that 
the MPA photodiodes showed undisturbed pulse waves (indicating that the finger 
wasn’t squeezed too hard or too little and that the subject was properly holding 
still), the MPA data was acquired for 15-30 seconds. For each test the same data-
filtering and PWV calculation methods were used as in Chapter 6, resulting in PWV 
values between each pair of read-out photodiodes (e.g., between 6 and 8, 6 and 
 
Figure 8.2: Setup used to systematically investigate and standardize the effect of MPA positioning along 
the finger axis and contact pressure with the finger on PWV measurement quality. The finger is placed 
with the nail towards the LEDs. The x-stage is used to control the placement of the MPA along the 
finger. The y-stage is used to control the contact pressure between the MPA and the finger. The finger 
position limiter is used to assure consistent positioning of the finger. 
Chapter 8 - Solving issues encountered in clinical studies 129 
10, 6 and 12, 8 and 10 etc., each indicated by PWVa-b (with a-b indicating the 
photodiodes pair for which the PWV value is given) and from which the median 
PWV of all photodiode combinations (PWVmed) was determined.  
8.2.1 Removing light pollution 
The first test served to find out whether light coming from the environment—such 
as light from lamps or computer screens—would affect the PWV measurements. 
The PWV measurements on both subjects were done on each subject once with 
the MPA and finger open to environmental light as usual and once with a black, 
light blocking cloth draped over the entire setup, MPA and finger. Between the 
measurements with and without cloth, the subject sat still with their finger kept in 
the setup without any alterations. The measurements were conducted in an 
approximately 2.5x4 m large, well-lit hospital room with several computer screens 
in the close proximity of the test setup and three TL lights. 
8.2.2 Using collimators 
One way of limiting the amount of light that a photodiode receives from other 
directions than from their directly opposing LEDs might be found in limiting the 
field photodiode’s field of view. To this purpose, a simple collimator was made, 
consisting of a black, opaque plate of acrylic glass, laser cut to the shape and 
dimensions shown in Figure 8.3. By placing the collimator over the MPA, with the 
openings over the active photodiodes and the other photodiodes blocked, their 
fields of view (the range of directions from which the photodiodes could receive 
light) were narrowed. PWV measurements were done on each subject once with 
 
Figure 8.3: Dimensions of the collimator (mask that ensures that only light falling-in nearly 
perpendicular to the diode reaches a diode) used to narrow the fields of view of the photodiodes. The 
collimator is shown on the right half of the image. The circular inset on the left is a magnification of the 
area indicated on the collimator.  
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and once without the collimator in place.  
8.2.3 Shortening light travel paths 
Because tests in sections 8.2.1 and 8.2.2 did not provide satisfying results, some 
explorative tests were done to see if better results were obtained when placing the 
photodiodes and LEDs both along the soft tissue on the volar side of the finger. 
The reasoning behind this was that this would shorten the travel path of the light, 
not only in absolute sense, but also as compared to the travel path of light coming 
from other directions than straight across a photodiode. Furthermore, because the 
light then only has to span soft tissue, less disturbing structures (i.e. bone, which 
is highly scattering) blocked or scattered the light, enabling a more direct line of 
sight than for the positioning in Figure 8.1. To stably and reliably put the MPA in 
the new soft-side position, an approximately 1 cm thick layer of textile was placed 
under the finger (Figure 8.4).  
Next, the effectiveness of the new soft-side position and its sensitivity to the 
sensor placement location along the axis of the finger were investigated. The left 
index finger of the test subject was placed initially with photodiode 16 at the 
proximal ridge of the distal phalanx, which put the active diodes (6, 8, 10 and 12) 
halfway the distal phalanx. The PWV acquisition was started, while after every 20 
seconds, the x-stage of the setup was adjusted to move the MPA for 5 mm more 
proximally over the finger. At each 5 mm the sensor was kept in place and PWVs 
were measured for 20 seconds before moving to the next more proximal location 
until the sensor had moved 20 mm, finally locating the active photodiodes at the 
site where the medial and distal phalanx meet. This test was done on entirely on 
 
Figure 8.4: Front view of the adaptation used to obtain the soft-side positioning of the MPA with respect 
to the finger. 
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Subject 1 and only the two locations providing the most promising results were 
repeated on Subject 2.  
8.2.4 Optimizing contact pressure 
During the tests in 8.2.1 to 8.2.3 it was noticed that the contact pressure between 
the MPA and the finger could strongly affect the measured signals. When pressing 
too hard with the MPA not in the soft-side position, the pulse waves disappeared 
due to occlusion of the blood vessels. Yet, also when applying light or moderate 
pressure, sometimes good and clearly distinguishable pulse waves were visible in 
the MPA signals, but when calculating the PWVs from these signals these could 
ever still result in randomly scattered, unrealistically high or even negative PWV 
values. Therefore, the best sensor location from the test in section 8.2.3 was 
chosen and for that position the effect of finger-sensor contact pressure was 
further explored. 
For both subjects the finger was placed as shown in Figure 8.4. The contact 
pressure between the MPA and the finger was varied by moving the y-stage of the 
setup in steps of 0.5 mm. Because both subjects had different sized fingers 
different pressure levels were used in different orders for both subjects: 
Subject 1: The y-stage was initially put such that there was almost impalpable 
contact between the MPA and the subject’s finger. At this pressure, PWVs were 
measured for 20 seconds. Next, the y-stage was tightened by 0.5 mm and another 
20 seconds PWVs measurement was done. This was repeated until and including 
the pressure at which PWs became undistinguishable. After that, the y-stage was 
moved back again in two steps of 0.5 mm and at each level another 20 seconds 
measurement was taken. 
Subject 2: A similar approach was taken as for Subject 1, but now the initial 
position of the y-stage was set to achieve a medium pressure level, comparable to 
that providing successful measurements in sections 8.2.1 to 8.2.4. From there, first 
the stage was loosened in three steps of 0.5 mm until there was almost impalpable 
contact and the PWs became undistinguishable. Then, the y-stage was tightened 
again in steps of 0.5 mm until the contact pressure became uncomfortable. At 
each contact pressure level a 20 seconds PWVs measurement was done. 
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8.3 Results 
8.3.1 Removing light pollution 
No effect of covering or not covering the measurement area was observed. All data 
showed comparable amplitudes and no observable improvements in the PWV 
values were found (see Figure 8.5). 
8.3.2 Using collimators 
The collimators did have an effect on the measured signals, but not in the way 
expected. The collimator reduced the amount of light reaching the sensor so 
strongly that the MPA signals became unusable. 
8.3.3 Shortening light travel paths 
Changing the MPA placement to the soft-side position enabled proper PWV 
measurements. Figure 8.6 shows the PWVs for the individual tested locations along 
the axis of the left index fingers for Subject 1 and 2. All locations (A to D) provided 
reasonably good results (few or no negative PWV values), but the locations where 
 
Figure 8.5: Amplitudes of photodiode signals and resulting PWVmed for tests with and without black 
opaque cloth covering the measurement area. The PWV values fluctuate around zero and are often 
negative. 
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the active photodiodes got very close to or on the  
distal-interphalangeal joint (C and D), the PWVs started to show more scattering. 
The best location, showing the little scattering and no negative PWVs appeared to 
be location B, where the active photodiodes (6, 8, 10 and 12 yellow area) spanned 
the soft side part of the fingertip. 
8.3.4 Optimizing contact pressure 
Figure 8.7 shows the PWVs obtained in Subjects 1 and 2 for the tested contact 
pressures created by tightening or loosening the y-stage. For both subjects it 
appeared that the best PWV measurements were obtained when applying light 
contact pressures (see Figure 8.7 for quantification). If pressures were too low, the 
data became very much scattered with many negative PWVs. Squeezing too hard 
may obstruct the blood flow, causing pulse waves to disappear or be malformed 
and making the calculated PWVs scatter and become unreliable. 
Figure 8.6: PWVmed measured during 20 s intervals at different positions along the axis of the left index 
finger. Gentle contact pressure between the MPA and the subjects’ fingers was used. The position of 
the photodiode array of the MPA is expressed as the distance in millimeters that photodiode 16 on the 
array was moved from the ridge at the base of the distal phalanx towards the hand. 
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Figure 8.7: PWVmed measured during 20 s intervals and at different contact pressures with the  
MPA at the soft-side position (Figure 8.4) at location B from Figure 3. The contact pressures are 
expressed both in subjective terms as well as in the distance [mm] that the y-stage (Figure 8.2) was 
moved to squeeze the finger, starting from the 0-position providing almost impalpable contact between 
the MPA and the finger. 
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8.4 Discussion 
This study aimed to establish how the MPA can be used or adapted in such a way 
that PWV measurements are less affected by light-path effects between the LED 
array and the photodiode array. The results showed that removing light pollution 
did not contribute to a solution in any way. Yet, the suitability of using collimators 
could not be excluded in this study. However, further exploring that solution would 
require stronger light sources and would make the design of the MPA more 
complex. As a simpler solution was found, the idea of using collimators was 
abandoned. 
The key to achieving credible PWV measurements with little scattering and no 
negative values appeared to be simply in the positioning of the MPA on the finger. 
Avoiding disturbing (highly scattering, reflecting or absorbing) structures in the line 
of sight between LEDs and photodiodes and by making the line of sight shorter 
and more direct enabled true measurement of the light transmission fluctuations 
between a photodiode and the LED directly opposed to it. The new soft-side 
positioning of the MPA involved placing the photodiodes and LEDs such that the 
light was transmitted only through the soft-tissues on the side of the finger.  
It appeared that, although the soft-side positioning shown in Figure 8.4 was much 
more robust than the original sensor positioning shown in Figure 8.1, the 
measurement quality still appeared to depend on the placement location of the 
active photodiodes along the fingertip and on the contact pressure between the 
sensor and the finger. When located too far to the tip of the finger, the most distal 
photodiodes loose contact with the finger, whereas locating the active photodiodes 
close to the site where the medial and distal phalanx meet, the joint structures 
seem to get in the line of sight, with both situations leading to scattered PWV 
measurements with negative values. The optimal use condition of the MPA 
provided consistently satisfying results and appeared to be: 
 soft-side positioning of the MPA: locating the active photodiodes across the 
middle, fleshy side part of the distal phalanx, 
 and using a light contact pressure. 
The major limitation of the presented work is that it is of highly explorative nature. 
However, the robustness and user-friendliness of the optimal use condition 
described above was further substantiated in a study on 30 healthy volunteers 
(Erasmus MC ethical board approval MEC-2017-453). For this study a new sensor 
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holder was designed (Figure 8.8) to standardize the placement of the finger on the 
MPA for the optimal use condition of the MPA (see Chapter 9 for further details). A 
standardized, light contact pressure was applied by placing an elastic tourniquet 
band at a preset pretension over the finger. During the study all participants could 
easily, rapidly, and consistently be placed in the setup. All measurements could be 
done without any adjustments to the setup, sensor placement or contact pressure.  
The PWV measurements all showed good pulse waves, little scattering and positive 
PWVs, except for one subject who had extremely cold hands and later told to 
suffer from pernio, which perfectly explained why no proper pulse waves could be 
observed. 
Figure 8.8: Test setup and sensor holder designed for the optimal use condition of the MPA, used to 
measure PWVs in 30 healthy volunteers. The main parts of the setup are: 1) LED array holder; 2) LED 
array; 3) Photodiode array; 4) Photodiode array holder; 5) y-stage, used to control distance between 
LEDs and photodiodes; 6) Finger position limiter; 7) x-stage, used to control photodiode array location 
along the finger. For further explanation, please see Chapter 9. 
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An optimal use condition for the MPA was established and proved to be very 
suitable for human subject research. However, before being suitable for everyday 
clinical use, the MPA should be redesigned into a pulse-oximeter-like device that 
clips on the finger and ensures proper and consistent placement and contact 
 
Figure 8.9: Artist impression of the MPA system used in a clinical-practice-ready medical device for 
integrated measurement of pulse rate, oxygen saturation and pulse wave velocity. Sensor location 
along the finger is standardized by using a position indicator combined with anti-slip edges and a self-
locking limiter that prevents the finger from moving into the sensor clip once set at the correct distance. 
Contact pressure between the sensor and the finger is controlled by a self-balancing spring system. 
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pressure independent of the caretaker or patient. An artist impression of how this 
future device could be designed is shown in Figure 8.9. In order for this design to 
function robustly and consistently, future research should provide more insight into 
the optimal contact pressure, location and orientation of the MPA on the finger. 
8.5 Conclusions 
The current study has brought the MPA from a pure research tool one step closer 
to a clinical-practice-ready diagnostic device. It was shown that soft-side 
positioning halfway the distal phalanx with some light pressure was the key to 
obtaining consistent and good quality measurements. Further developments will 
have to lift the MPA from a research tool to a user-friendly medical device for 
every-day clinical practice. 
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Chapter 7 [1] described the study that was conducted in healthy volunteers to 
measure the PWV with two different systems over different trajectories to 
investigate whether these provided comparable results. This study was initially 
intended as a comparison between three PWV measurement systems: Biopac, 
Complior and the MPA, but the MPA results were excluded because these provided 
no usable results at all. For reasons of completeness, these results are summarized 
below.  
Materials & Methods 
Twenty-five healthy volunteers, 20-30 years old, without any known history of 
atherosclerosis associated diseases (such as diabetes mellitus, hypertension, 
coronary artery disease, stroke, renal disorder) or injuries at the upper limbs were 
included in the study. This study was approved by the medical ethics committee of 
Erasmus University Medical Center Rotterdam, the Netherlands (approval number 
MEC-2012-139) and was conducted between 20 November 2014 and 17 December 
2014. For further details about the study design, see Chapter 7.  
The stripped MPA was used to measure PWVs on the left middle finger by reading 
out four of its sixteen available photodiodes (diodes 1, 6, 11 and 16, spaced 4 mm 
apart). The stripped MPA (see Appendix A) was placed as shown in Figure A.2 of 
Appendix A. 
The data were analyzed using Matlab R2010a (The MathWorks, Inc. Matick, MA, 
USA) to calculate the PWVs from the PPG-signals. The PPG-signals were filtered 
with a fourth-order low-pass Butterworth filter with a cut-off frequency of 9 Hz. 
The PWV for each position (sitting 1, lying, standing, sitting 2) was determined for 
each pair of photodiodes i and j by dividing the distance between these 
photodiodes by the time difference between the arrival of the PPG-signals’ peaks at 
the locations of these successive photodiodes. This was done for each combination 
of any two of the used photodiodes (photodiodes pairs 1-6, 6-11, 11-16, 1-11, 6-
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16, 1-16). All distorted (and thus unusable) PWs were filtered out using the ‘7Step 
PW-Filter’ [2]. The median PWV was calculated per heartbeat for each combination 
of any of two of the used photodiodes. The mean PWV was calculated for each 
position. 
Results & Discussion 
Figure 8A.1 shows three examples of typical PWV values measured in three of the 
volunteers. In each section of Figure 8A.1 the PWVs for each combination of any 
two of the used photodiodes are shown for position Sitting 1.  
Figure 8A.1A shows a dataset in which almost all of the PWVs of each combination 
of any two of the used photodiodes are positive and around 2 m/s. The PWV 
between photodiodes 1 and 6 is most of the time negative, extremely high, or 
extremely low. Figure 8A.1B shows a dataset with mostly negative PWV values. 
The PWV between photodiodes 11 and 16 is the only one for which the PWV 
sometimes was positive. However, the PWV between photodiodes 11 and 16 is not 
stable and shows a very large variation (between -5 and 20 m/s). Figure 8A.1C 
shows a dataset in which the PWV values are scattered all over the plot, with PWV 
values between -50 and 50 m/s.  
The results obtained in this study were unexpected, because both the successful 
functional validation of the MPA [3] (Chapter 6), accompanying pilot measurement 
on healthy volunteers, and intermediate tests done by the authors showed 
perfectly fine PWV measurements, even for test-PWVs much higher than would 
occur in the fingers. Although Figure 8A.1 shows only three examples, these data 
are representative for all healthy volunteers. The data obtained with the MPA were 
eventually excluded entirely because too many signals showed very fast PWV 
fluctuations between extreme positive and at that time unexplainable negative 
values. As the observed results remained unexplainable, it was recommended, and 
later decided, to first investigate how to optimize the PWV measurements using 
the MPA. 
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Figure 8A.1: Typical examples of PWVs measured with the MPA in three different volunteers (A, B and 
C). 
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During induction of general anesthesia the compliance of vessels changes (in 
general: increases) because of loss of sympathetic drive and/or vascular tonus. 
The change in compliance of the vessels is perceptible in the pulse wave velocity 
(PWV) of the pressure pulse waves (PWs). The magnitude of the change in PWV 
may indicate a potential problem with the arterial stiffness, e.g. due to structural 
vascular changes or the use of medication. Ultimately, the Multi Photodiode Array 
(MPA) could aid in identifying patients at risk of cardiovascular events during or 
after general anesthesia. The aim of this study was to verify whether the MPA can 
be used to detect changes in PWV due to altered blood vessel compliance during 
induction of general anesthesia. 
Materials & Methods 
Twenty-three patients, 20-75 years old, without injuries at the upper limbs were 
included in this study. Any patient who was scheduled to receive general 
anesthesia could be included in this study. No specific exclusion criteria were 
applied as long as the measurements were technically feasible (i.e. presence of an 
accessible finger). This study was approved by the medical ethics committee of 
Erasmus University Medical Center Rotterdam, the Netherlands (approval number 
MEC-2014-344) and was conducted between 31 July 2014 and 7 May 2015.  
Prior to transfer to the operating room, the patients were informed about the study 
and were asked questions concerning their general health. The stripped 
MPA-sensor (see Appendix A) was placed on the index finger, contralateral of 
where the infusion catheter was placed. During the measurement, the patient was 
lying in bed or on the operation table. A baseline PWV measurement was 
conducted on the preoperative holding for approximately 1 minute (M1). After 
that, the patient was transferred to the operation room and placed from the bed 
on the operation table. In the operation room, the PWV measurements started 
with a baseline measurement for approximately 1 minute before the anesthesia 
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had been induced (M2). During the entire procedure of induction of general 
anesthesia, continuing until 1 minute after the procedure the PWV was measured 
(M3). The anesthesiologist indicated whether general anesthesia had set in. 
PWVs were measured using four photodiodes (diodes 1, 6, 11 and 16, spaced 4 
mm apart). The data were analyzed using Matlab R2010a (The MathWorks, Inc. 
Matick, MA, USA) to calculate the PWV from the PPG-signals. The PPG-signals were 
filtered with a fourth-order low-pass Butterworth filter with a cut-off frequency of 9 
Hz. The PWVs for each measurement period (M1, M2, M3) were determined per 
heartbeat for each pair of photodiodes i and j by dividing the distance between 
these photodiodes by the time difference between the arrival of the PPG-signals’ 
peaks at the locations of these successive photodiodes. This was done for each 
combination of any two of the used photodiodes (photodiodes pairs 1-6, 6-11, 11-
16, 1-11, 6-16, 1-16). Any distorted (and thus unusable) PWs were filtered out 
using the ‘7Step PW-Filter’ [1]. The median PWV was calculated for each 
combination of any of two of the used photodiodes per heartbeat. The mean PWV 
was calculated of each measurement period. 
Results & Discussion 
Of all patients, only one showed consistent, positive and stable PWV-values during 
the three measurement periods (see Figure 8B.1 and Table 8B.1). This patient was 
a male, 29 years old, 1.86 m body height, BMI 23.7, smoking, American Society of 
Anesthesiologists score (ASA) II. The patient’s blood pressure was 151/90 before 
start of induction of general anesthesia and the MPA was measured on the left 
index finger. All the other patients’ PWV values showed the same patterns as in 
Appendix 8A (see Figure 8A.1) with fast fluctuations between extreme positive and 
at that time unexplainable negative values.  
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Figure 8B.1: PWV values of the single volunteer showing consistently positive and stable results during 
measurements at the holding, and before and after induction of general anesthesia. 
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Because only one patient could be included for the analyses, the study was 
considered failed and the results were not further analyzed. As the observed 
results remained unexplainable, it was recommended, and later decided, to first 
investigate how to optimize the PWV measurements using the MPA. 
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Table 8B.1: The PWV values measured during each measurement period in the single volunteer who 
showed consistently positive and stable results. 
PWV [mean ± sd] 
Measurement period 1 [m/s] 0.6 ± 0.1 
Measurement period 2 [m/s] 0.8 ± 0.3 
Measurement period 3 [m/s] 1.0 ± 0.2 
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The Ankle Brachial Index (ABI) is considered the gold standard indicator of 
peripheral artery disease (PAD) [1]. The gold standard for determining the ABI 
consists of taking the ratio between the systolic blood pressure at the ankle and 
the systolic blood pressure in the arm [2]. An ABI below 0.9 is a reliable indicator 
of compromised blood flow in the legs and is diagnostic for PAD [2, 3]. 
Furthermore, a decreased ABI is associated with an increased risk for 
cardiovascular events in general. 
In clinical practice, ABIs are routinely measured using a Doppler blood flow 
detector and a sphygmomanometer, once on the arm and once on the leg. The 
sphygmomanometer cuff is inflated proximal to the artery of the extremity until the 
arterial pulse ceases. The cuff is then slowly deflated until the artery’s pulse wave 
is re-detected by the Doppler probe. The pressure in the cuff at that moment 
indicates the systolic pressure of that artery. The same procedure is performed in 
both arms and legs. The ABI is calculated by dividing the systolic blood pressure at 
the ankle level by the systolic blood pressure at the arm. 
It was hypothesized that the Multi Photodiode Array (MPA) may potentially aid in 
more objectively identifying patients with PAD by measuring the PWV instead of 
the ABI. Furthermore, the MPA may allow easier and simpler measurements than 
the method described above. Therefore, the aim of this study was to verify 
whether the MPA can detect changes in peripheral PW due to the presence of 
cardiovascular disease as determined by the gold standard ABI. 
Materials & methods 
A prospective, observational study was conducted. Fifty-two patients, older than 18 
years, who were already scheduled for ABI measurement as part of their treatment 
for PAD at the department of Vascular Surgery in the Erasmus Medical Center, 
Rotterdam, the Netherlands, were included in this study after obtaining written 
informed consent. There were no specific exclusion criteria as long as the 
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measurement was technically feasible (i.e. presence of an accessible 
finger/arm/leg/toe). The study was approved by the Medical Ethics Committee of 
Erasmus University Medical Center Rotterdam (approval number MEC-2015-149) 
and was conducted between 5 June 2015 and 24 July 2015. 
The standard ABI-procedure at the department of Vascular Surgery consist of: 
1. Measuring the blood pressure (BP) on the left and right upper arms 
2. Measuring the ABI on the left and right sides, using the Dopplex 
ABIlity device (Huntleigh Healthcare, Wales, United Kingdom). 
3. Walking for maximum of 10 minutes on a treadmill. 
4. Measuring the BP on the left arm. 
5. Measuring the ABI on the left and right side, using the Dopplex ABIlity 
device (Huntleigh Healthcare, Wales, United Kingdom). 
After starting the standard ABI-procedure, the PWV was measured two times for 
up to 1 minute, each time before the ABI-measurement (between steps 1 and 2 
and between steps 4 and 5). Two Vamulec MPA sensors (see Appendix A) were 
used as shown in Figure A.3 of Appendix A: one on the left index finger and one 
on the left big toe.  
From each Vamulec MPA-sensor two photodiodes (diodes 1 & 16, spaced 12 mm 
apart) were read out to measure the PWV. The data were analyzed using Matlab 
R2010a (The MathWorks, Inc. Matick, MA, USA) to calculate the PWV from the 
PPG-signals. The PPG-signals were filtered with a fourth-order low-pass 
Butterworth filter with a cut-off frequency of 9 Hz. Any distorted (and thus 
unusable) PWs were filter out using the ‘7Step PW-Filter’ [3]. The mean PWV for 
each of the two measurement periods was determined by dividing the distance 
between photodiodes 1 and 16 by the time-difference between the arrival of the 
PPG-signals’ peaks at the locations of these successive photodiodes. 
Results & Discussion  
Of the 52 patients, 17 patients were excluded from the analysis because they 
could not undergo the entire standard ABI-procedure. This was often due to a 
patient’s inability to walk on the treadmill. Another reason sometimes occurring 
was that the patient had a shunt in the left arm, making the BP and ABI 
measurements on that arm impossible.  
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The remaining 35 patients (20 male, 15 female) underwent the entire ABI-
procedure. The Dopplex ABIlity device returned the ABI value and classification 
(Table 8C.1). 
In many patients no suitable PWV-measurements could be obtained at all. In the 
classification groups ‘serious’, ‘moderate’ and ‘mild’ not a single patient had a 
usable PWV-measurement. In the group ‘normal’ there were nine usable PWV-
measurements for the finger and eleven usable PWV-measurements for the toe. 
However, in only two patients a usable PWV-measurement could be obtained 
before and after walking the treadmill. In the group ‘incorrectly high’ there was 
one usable PWV-measurement for the finger and there were two usable 
PWV-measurements for the foot. For only one patient a usable PWV-measurement 
could be obtained before and after walking the treadmill.  
The PWV-measurements were largely unusable because the patients showed 
hardly any undistorted PWs, which was likely caused by the patients’ diseases. In 
the few patients who did show PWs that could be properly measured, the PWV-
values still showed fast fluctuations between extreme positive and at that time 
unexplainable negative values, like in Appendices 8A & 8B.  
Figure 8C.1 shows two typical examples of the data. One of the very few patients 
with usable results and one of the many patients with unusable results. Table 8C.2 
shows the results of the ABI-measurement for these two example patients. 
Table 8C.1: The ABI (ankle brachial index) classification and corresponding values. 
Number of patients Classification ABI [mean ± sd] 
2 Serious 0.5 ± 0.0 
8 Moderate 0.7 ± 0.1 
5 Mild 0.9 ± 0.1 
16 Normal 1.2 ± 0.1 
4 Incorrectly high 1.4 ± 0.1 
 
 150 
Patient A was one of the few showing usable PWV-measurements. Patient A was a 
male, 51 years old, 1.74 m body height, BMI 24.8, smoking, non-diabetes. All PWs 
(100%) proved to be of good quality according to the ‘7Step PW-filter’ (see 
Chapter 2) before and after walking. The PWV values in the toe showed larger 
variations than in the finger.  
 
Figure 8C.1: The PPG (photoplethysmography) and PWV (pulse wave velocity) measured with the MPA 
during the ABI-procedure for two example patients. 
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Patient B is an example of the unusable PWV-measurements, in which hardly any 
suitable values could be obtained at all. Patient B was a male, 80 years old, 1.77 m 
body height, BMI 28.7, smoking, non-diabetes. In this patient, mainly bad quality 
PWs were observed, with only 13% and 46% suitable PWs before walking and 7% 
and 93% suitable PWs after walking in the finger and toe, respectively. After 
walking there were only 4 PWs in the finger that passed the ‘7Step PW-filter’ of the 
55 PW in total. Consequently, there were too few PWV-values left for a reliable 
measurement. 
Because almost all subjects had to be excluded during the analysis, this study was 
considered failed and the results were not further analyzed. As the observed 
results remained unexplainable, it was recommended, and later decided, to first 
investigate how to optimize PWV measurements using the MPA.  
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Table 8C.2: The ABI (ankle brachial index) and PWV (pulse wave velocity) values obtained for the two 
example patients discussed in this appendix.  
  Patient A Patient B 
Before walking 
ABI  1.06 0.55 
PWV [mean ± SD] finger 0.6 ± 0.2 -0.4 ± 10.2 
toe 0.8 ± 5.1 -0.6 ± 11.7 
PWV index [foot / hand]  1.3 1.3 
After walking 
ABI  1.08 0.95 
PWV [mean ± SD] finger 0.6 ± 0.2 0.1 ± 0.8 
toe 1.2 ± 0.6 0.5 ± 11.2 
PWV index [foot / hand]  2.0 4.8 
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The speed of pressure pulses traveling through the blood, the pulse wave velocity
(PWV),  is  a  metric  that  provides  substantial  information  about  the  passive  and
active elasticity of the blood vessels. Therefore, PWV is a valuable parameter in the
diagnosis of  cardiovascular diseases.  The purpose of  this  study was  to  investigate
whether  a  novel,  simple,  easy‐  to  use,  photoplethysmography‐based  Multi
Photodiode  Array  (MPA)  provides  PWV  measurements  that  agree  with
measurements  done with more  complicated  and  harder‐to‐use  systems  currently
used  in  clinical  practice.  An  often‐used  vascular  perturbation  that  changes  the
conduit  artery  vasomotor  tone  during  reactive  hyperemia  was  imposed  on  thirty
healthy volunteers. The MPA was used alongside and its results compared to those
of  a  commonly  used  measurement  device,  the  Biopac‐system,  during  flow‐
mediated dilation (FMD). This way it was investigated if measurements with these
systems,  measuring  over  two  different  vessel  trajectories  agree.  The  baseline
absolute  PWV  values  were  significantly  lower  for  the  MPA  as  compared  to  the
Biopac‐system. Yet, the Bland‐Altman plots show good agreement between the two
measurement  systems.  Additionally,  the  Bland‐Altman  plot  showed  good
agreement  between  the  two  PWV  measurement  techniques  during  the  FMD.
Measuring PWV with  the MPA  in  clinical  practice  is  feasible  and provides  reliable
data in healthy volunteers. The MPA may substantially simplify PWV measurements
and may enable long‐term PWV monitoring as long as one is aware of the relation
between PWV and the vascular trajectory over which it is measured. 
Measuring pulse wave velocity with a novel, simple 
sensor on the finger tip: A feasibility study in healthy 
volunteers 
Chapter 9
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10.1 Introduction 
The goal of this Ph.D. study was to develop and validate a non-invasive, 
photoplethysmography (PPG)-based device for peripheral measurement of the 
Pulse Wave Velocity (PWV), on the finger. In this chapter, the results, limitations, 
and recommendations that followed from the obtained achievements are discussed 
while following the stated aims, which are repeated below:  
 to confirm the value of peripheral PWV measurements, 
 to design and technically validate a PPG-based device for measuring PWV 
in the finger, 
 to validate the developed device in clinical studies. 
Part I - Substantiation, of this thesis showed the value of peripheral PWV 
measurements and presented a platform-independent and measurement-
technique-independent algorithm for improvement of PWV measurements.  
Part II - Development & Validation, described the design, technical validation, 
testing, further improvement and final validation of the Multi Photodiode Array 
(MPA), the PWV measurement device developed during this Ph.D. study. 
10.2 Substantiation 
The literature study in Chapter 2 revealed that filtering techniques or methods that 
are used to eliminate unsuitable PWs are often not described and differ between 
studies. In fact, most studies do not report whether any or what kind of filtering 
algorithm was used to eliminated unsuitable PWs. Using unfiltered PPG-data may 
result in deviations in the calculated values with orders of magnitude close to 
commonly measured effect sizes in human subject studies. Yet, visually and 
manually selecting and removing unsuitable PWs is highly time consuming and 
therefore often undesirable or inconvenient in clinical practice. In order to obtain 
valid PW-based data, it is essential to only use PWs that contain the morphological 
landmarks on which the definition of Pulse Transit Time (PTT) is based.  
The '7-step PW-filter' algorithm was developed to apply 7 criteria to determine 
whether a PW matches the characteristics required to allow PTT/PWV-calculation. 
The ‘7Step PW-filter’ offers objectivity and substantial time savings compared to 
manual elimination and can be implemented in many coding languages due to its 
simple and straight-forward concept. 
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The transit time of a PW traveling from within the heart to easily accessible 
locations, such as the extremities of the neck, consists of 2 components: the PW 
propagation-time from the heart through the artery and to the PW measurement 
location, Vascular Transit Time (VTT), and the isometric contraction time of the 
heart (pre-ejection period, PEP). In Chapter 3 it was shown in a study on both 
volunteers and patients that, when using the Biopac-system, the contribution of 
PEP to the PTT measured at the fingertip at rest is approximately 20%. The 
remaining 80% of the PTT is determined by the VTT. As the intra-individual 
variability of PEP is only minor, a change in PTT in a person at rest is most 
probably the result of a change in VTT. Thus, PTT at rest is an easy, non-invasive 
and accurate approximation of VTT for monitoring arterial stiffness. In order to 
further eliminate the effect of the PEP, measuring PWV on the finger may be a 
feasible approach. 
After improving the PW measurement technique in Chapter 2 and confirming the 
limited effect of the PEP on PTT and PWV in Chapter 3, the remaining chapters of 
Part I were used to show two clinically relevant applications of such 
measurements. In Chapter 4 a patient study performed on 23 patients who were 
scheduled for elective unilateral upper limb surgery under axillary block 
demonstrated that PTT can provide a fast and objective alternative to the current 
methods for determining whether an axillary plexus block has set in properly. An 
axillary block is used to block the sensory and motion function of the arm which is 
essential for, e.g., hand or arm surgery in awake patients. This block also causes 
relaxation of the vascular musculature and dilatation of the blood vessels.. Early, 
reliable and objective assessment of a block can improve the efficacy of operating 
room time and minimize patients’ fear of possible conversion to general 
anesthesia. Even when different local anesthetics are used with different onset 
times, measuring the PTT proved to be a much quicker an objective indication of 
the state of the vascular system than the conventional sensory test. This may 
enable an early additional intervention when necessary. 
Another useful potential application of PTT measurements was found in the 
objective assessment of pain, which is commonly assessed subjectively by 
interpretations of patient behavior and/or reports from patients. Pain is a sensation 
that is highly subjective, but also has objective aspects. In Chapter 5 it was shown 
that a bilaterally significant decrease of PTT occurs in response to heat-induced 
pain stimuli in volunteers, who all underwent pain stimuli leading to similar pain 
scores. Furthermore, the pain response appeared to be centrally mediated. It was 
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concluded that PTT is a reliable indicator of pain-induced alterations of vasotonus 
and can be measured on a contralateral extremity in situations in which it is 
impossible or undesirable to measure directly on the affected extremity. In the 
future, PTT may be applied as an objective indicator of pain stimulus, either 
together with the standard self-report tests, or instead of it, when self-reporting is 
impossible.  
10.3 Development & Validation 
Although it was made clear in Part I that measuring the speed of PWs could be 
highly valuable and beneficial in clinical practice, the available techniques for 
obtaining these measurements were still far from ideal. Therefore, the Multi 
Photodiode Array (MPA) was developed. The MPA is a novel transmission 
photoplethysmography sensor with a single photodiode array. Chapter 6 describes 
its design and validation. The MPA was developed for PWV measurements on the 
finger, measures the pulse rate, pulse wave amplitude, and peripheral PTT, and 
could also measure SpO2. The MPA was shown to enable reliably and accurately 
measuring PWVs with a maximum deviation of 3.0%, within clinically relevant 
ranges and even well beyond 
A study on volunteers was set up to compare the MPA to two currently available 
and widely used, but harder to use systems for measuring PWVs: the Complior and 
the Biopac system. Chapter 7 described the results for the Complior and the Biopac 
system. However, the data obtained with the MPA showed unexplainably large 
variations, many negative PWV values and many unsuitable (and therefore 
removed) PWs. Therefore, the MPA results are only briefly shown and discussed in 
Appendix 8.A. Nonetheless, the comparison between the Complior and Biopac 
systems did provide valuable insights in the differences and similarities between 
measuring PWV from the carotid to the wrist (Complior) and measuring PWV from 
the heart to the fingertips (Biopac).  
Two extensive patient studies (see Appendices 8.B and 8.C) with the MPA were 
also conducted. The study in Appendix 8.B consisted of PWV measurements on 
surgical patients during induction of general anesthesia. The study described in 
Appendix 8.C focused on measuring PWVs in further unspecified outpatients with 
vascular diseases who had their ankle brachial index measured. When analyzing 
the data after the experiments were done, the MPA appeared to have delivered 
erroneous data, which was not useable, but unnoticeably during the experiments. 
This appeared not to have been caused by technical malfunction, but failed use  
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condition. Furthermore, most of the patients with vascular diseases had such 
heavily affected vascular functions that the vast majority of PWs were too distorted 
to pass the ‘7Step PW filter’. 
Despite failing to obtain proper PWV measurements with the MPA at that time, the 
studies described in Chapter 7 and Appendix 8.A-C did provide the onset to a 
thorough and systematic investigation of how the MPA should be used in practice. 
After all, Chapter 6 had already shown that the MPA properly functioned 
technically. The acquisition rate and accuracy of the MPA hardware and software 
proved to be more than sufficient to allow measuring the relatively low PWVs in 
the finger. Even PWVs twenty times higher could reliably be measured with four 
diodes simultaneously. 
The Biopac and Complior systems have several disadvantages, such as hard to 
accurately position sensors, discomfort for the patient, the need for extra 
equipment in the hospital, and the discrepancy between the measured distance 
between the sensors and the actual path length travelled by the PWs. Therefore, 
the need for further developing the MPA was ever clear. In Chapter 8 the optimal 
use condition of the MPA was systematically investigated and it appeared that 
consistently satisfying PWV measurements could be obtained, provided that the 
following conditions were met: 
 soft-side positioning of the MPA: locating the active photodiode array 
across the middle, fleshy side part of the distal phalanx, 
 and using light contact pressure. 
The robustness and user-friendliness of the optimal use condition was further 
substantiated in a study on 30 healthy volunteers, described in Chapter 9. In this 
study the MPA could easily, rapidly, and consistently be positioned with respect to 
the patient in such a way that proper PWs and PWVs were obtained. The PWV 
values were lower than the PWVBiopac values found in Chapter 7, which were also 
lower than the PWVComplior values, so it seems that the more peripherally the PWV 
is measured, the lower the PWV will be. Obviously, this makes sense looking at the 
Moens-Korteweg; equation, this difference may be explained by vessels being 
more narrower, thinner walled and more compliant closer to the periphery with the 
reduced vessel stiffness and wall thickness apparently outweighing the reduced 
vascular diameter.  
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10.4 Recommendations 
PWV measurements are widely used as an index of arterial stiffness [2] and for the 
evaluation of cardiovascular risk. A preferred clinical next step required further 
research, to investigate whether the PWVs measured with the MPA on the finger 
can be used as an index for evaluation of aortic stiffness as a factor of 
cardiovascular risk [3]. This will require that PWVs measured purely locally on the 
finger can be shown to correlate with the arterial conditions elsewhere in the 
vascular system. A subsequent step is to examine the reproducibility and variance 
of the PWV in cardiovascular risk patients when applying measurements over short 
trajectories at relevant locations, such as over a short section of the carotid artery 
or along the arm, instead of the currently used measurements over larger 
distances. Furthermore, PWV could be used in the future as a measurement of 
pain stimuli during general anesthesia. 
Although the patient studies were aimed to find differences in PWV under various 
pathophysiological circumstances, the produced results were disappointing. 
Nonetheless, these studies provided useful insights and eventually led to the 
development of the optimal use condition described in Chapter 8. Yet, these 
studies also underlined the importance of always properly validating a medical 
device before using it on patients. This validation should not only cover functional 
tests, but also thorough testing of the use conditions of the device in situations 
and on populations in which the expected outcome is as clear as possible. Another 
valuable insight obtained through the patient studies, which is also a 
recommendation for further expansion of the applicability of the MPA, was that 
measuring the PWV is unlikely to provide useful results in patients with vessels 
seriously affected by vascular disease. However, the MPA might still be used in 
combination with the 7Step PW-filter to determine the PW quality ratio ‘PWQR’ as: 
S UPWQR
S U
     (10.1) 
In which ‘S ’ is the number of suitable PWs and ‘U ’ is the number of unsuitable 
pulse waves. The PWQR will limit to 1 if S >>U or if U=0, and to -1 for the inverse 
situation. So, boldly stated, as long as proper application of the MPA is guaranteed, 
a PWQR of 1 would indicate healthy vessels and a PWQR of -1 would indicate 
unhealthy vessels. 
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In November 2015, 10 months after we first presented the functional testing of the 
MPA system at a conference, a conference paper was published by Nabeel et al. 
presenting PWV measurements on the carotid using reflective Hall sensors and 
photoplethysmography (PPG) sensors at 20 mm distance [1]. Although that system 
has clear similarities with the MPA system, it is not suitable for prolonged 
measurements without causing discomfort and requires adding extra devices to the 
vast number of equipment already present in the hospital. It would be 
advantageous if PWV measurements could be performed while integrated into 
currently available medical devices. One of the simplest potentially suitable devices 
broadly used in the clinic are the commonly available finger clip PPG-sensors used 
for SpO2 and pulse rate monitoring, which basically already are MPA sensors with 
only a single photodiode. Clinical practice would particularly benefit from such a 
simple PWV measuring device because its use and presence is already familiar to 
clinicians, while being comfortable for patients and easy-to-use. Because of its 
simplicity and the elimination of the need for any other measurement systems, 
such as ECG, for measuring PWV, using the MPA will reduce the need for trained 
staff and costly equipment, and will allow for comfortable continuous monitoring.  
 
Figure 10.1: Artist impression of the m-MPA clip used in a clinical-practice-ready medical device for 
integrated measurement of pulse rate, oxygen saturation and PWV. 
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Therefore, for future clinical use, the MPA should be further designed into a pulse-
oximeter-like device that clips on the finger and ensures proper and consistent 
placement and contact pressure independent of the caretaker or patient. An artist 
impression of how this future device, called the m-MPA (modular MPA) could be 
designed is shown in Figure 10.1. The device consists of a basic housing in which 
several identical sensing modules can be placed in a linear array. The modules 
contain the sensors and transmitters for measuring PWV, SpO2, pulse rate, 
temperature, or whatever physiologic signal could be measured by any sensor put 
in such a module. Contact pressure between the sensor and the finger is controlled 
by a self-balancing spring system, which also defines the positioning of the finger 
with respect to the sensor. 
10.5 Concluding remarks 
Although there is still much to investigate before the MPA is ready for broad clinical 
use for non-invasive, easy and comfortable measurement of peripheral PWVs, the 
achievements reached through the work described in this thesis suggest that the 
MPA could readily be made useful in clinical practice. It would be advantageous if 
PWV measurements could be performed while the MPA is integrated into currently 
available medical devices, such as standard pulse-oximeters. It has been 
demonstrated that the MPA functions as intended and that clinical practice is likely 
to benefit from the MPA in a broad range of applications, such as objectively 
confirming axillary blocks, pain and vascular diseases. 
In short, this Ph.D. study consisted of: developing and validating a novel data 
filtering algorithm; building several new measurement setups; designing, building 
and validating five different versions of MPA prototypes; 5 clinical studies on a total 
115 volunteers; and 4 clinical studies on a total of 135 patients. With respect to 
the goals stated in Chapter 1, the following achievements were reached: 
 the value of the peripheral PWV measurements were confirmed through 
volunteer and patient studies and the quality of PWV data acquisition was 
improved with the 7Step PW-filter.  
 the Multi Photodiode Array (MPA), a PPG-based device for measuring PWV 
in the finger was designed, built and technically validated for PWV ranges 
well exceeding clinically relevant ranges. 
 the MPA was validated for PWV measurements in human volunteers in a 
controlled clinical study. 
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Overall, the results of this thesis indicate that the novel, PPG-based, MPA allows 
accurate and reliable PWV measurements within all clinically relevant ranges. Some 
important advantages of the MPA as compared to other PWV measurement 
systems are that the MPA is easy-to-use, non-invasive, and provides objective 
data. Additionally, the MPA combined with the 7Step PW-filter may help assessing 
vascular condition through the newly suggested pulse wave quality ratio. In the 
future, the MPA may substantially simplify PWV measurements and enable 
long-term monitoring of vascular health, which may contribute to improving 
prevention, diagnosis and treatment of cardiovascular diseases. 
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 During  this  Ph.D.  study  six  different  versions  of  the  MPA  and  its  holder  (sensor
units) were designed and manufactured in order to accomplice optimal placement
of  the  MPA  on  the  finger  and  measurement  of  the  finger  pulse  wave.  In  this
appendix these six developed sensor units are explained:  
 MPA placed in an original SpO2 clip 
 Stripped MPA 
 Vamulec 
 Smart sensor holder   
 Soft‐side positioning holder 
 m‐MPA clip 
Designs of MPA sensors and holders 
Appendix A
 
180 
MPA placed in an original SpO2 clip 
Figure A.1 shows the MPA sensor (developed by M.H.N. van Velzen) placed in an 
original, commercially available SpO2 clip (Datascope SpO2 sensor) that normally 
contains only a single LED and photodiode for measuring heartbeats and oxygen 
saturation levels of the blood. This was done to investigate the possibility of 
placing all the components of the MPA system into an SpO2 clip. All the 16 signals 
from the photodiode array were read out through the PPG100C amplifier (Biopac 
System, Inc, USA) at a sampling frequency of 2 kHz. During the research described 
in this thesis it appeared that this sampling frequency was too low to measure all 
16 PPG-signals and their PWV-values accurately enough. However, this simple 
adaptation of the SpO2 clip did prove the feasibility of incorporating the MPA-
technology in a simple-to-use finger clip. 
  
 
Figure A.1: The MPA placed in an original SpO2 clip  
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Stripped MPA 
To investigate how the MPA should best be positioned on the finger, a stripped 
version of the MPA was built (developed by M.H.N. van Velzen). The stripped MPA 
consists of two independent sides, the LED array (with two infrared and two red 
LEDs) and the photodiode array (see Figure A.2). All of the 16 analogue signals 
from the photodiode array were converted to digital signals through a NI-USB 
62289 Multifunction Data Acquistion system and LabVIEW 2010 software (both: 
National Instruments, Austin, TX, USA). This data acquisition-system has a 250 
kHz sampling rate and 32 analog, 16-bit input channels and was used with all of 
the designs of MPA and holders, except for the ‘MPA placed in an original SpO2 clip’ 
(see previous section). 
  
 
Figure A.2: The stripped MPA, used to investigate how the MPA should best be positioned on the finger. 
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Valumec 
Figure A.3 shows the “Vamulec”. The Vamulec was developed by G. van Geest 
during his master graduation process of Integrated Product Design at the faculty of 
Industrial Design Engineering, Delft University of Technology, supervised by the 
author of this thesis. The Vamulec is a clip consisting of two elements: the body 
and the roller. The body is a cylinder, ending in two lips that contain the LEDs and 
the photodiode array of the MPA. The finger is placed between these two lips. The 
roller is rolled over the two lips, which presses the LEDs and photodiode array 
down onto the finger. The Vamulec was designed to keep the sensor stably 
positioned on a variety the finger sizes during use. However, because of the 
change to a different positioning method (see Chapter 8), further use and 
development of the Valumec was abandoned. 
  
 
Figure A.3: The Vamulec placed on a finger 
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Smart sensor holder 
The “smart sensor holder” (Figure A.4) was the outcome of the research project 
done by five students (J. Floor, K. Braham, G. Klarenbeek, D. Koot and J. Vergeer) 
of the minor Technical Multidisciplinary Design, University of Applied Science 
Utrecht, supervised by the author of this thesis. The smart sensor holder is a 
holder in which three stripped MPA-sensors can be placed on three different 
positions between the lower arm and the fingertip. The distance between the MPA-
sensors is measured using potentiometers, allowing accurate measurement of the 
PWV over the entire lower arm. Although being less easy-to-use and offering less 
flexibility, the smart sensor holder does enable PWV measurements over various 
trajectories in the lower arm. 
  
Figure A.4: The smart sensor holder with the fingertip, wrist and lower arm each lying on one of the 
three MPA-sensors. 
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Soft-side positioning holder  
The presented research in Chapter 8 showed what the optimal use conditions of 
the MPA are to provide consistently satisfying results. This optimal use condition 
consisted of: 
 soft-side positioning of the MPA: locating the active photodiodes across the 
middle, fleshy side part of the distal phalanx, 
 and using a light contact pressure. 
In Figure A.5 the new sensor holder is shown (developed by M.H.N. van Velzen 
and A.J. Loeve), which was designed to standardize the placement of the finger on 
the MPA for the optimal use condition of the MPA. This soft-side positioning holder 
was used on 30 healthy volunteers (see Chapter 9).  
  
 
Figure A.5: Soft-side positioning holder designed for the optimal use condition of the MPA, used to 
measure PWVs in healthy volunteers (see Chapter 9). 
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m-MPA clip 
An optimal use condition for the MPA was established and proved to be very 
suitable for human subject research, called the m-MPA clip (modular-MPA clip) 
(see Chapter 9). For future clinical use, the MPA should be redesigned into a pulse-
oximeter-like device that clips on the finger and ensures proper and consistent 
placement and contact pressure independent of the caretaker or patient. An artist 
impression of how this future device could be designed to look like (made by 
M.H.N. van Velzen and A.J. Loeve) is shown in Figure A.6. The device consists of a 
basic housing in which any desired number of identical sensing modules can be 
placed in a linear array. An extensible finger positioning clamp ensures proper 
contact pressure and positioning of the finger on the MPA. See Chapter 8 for 
further details. 
  
Figure A.6: Artist impression of the m-MPA clip, in which the MPA system is integrated for measurement 
of pulse rate, oxygen saturation and pulse wave velocity.  
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Worldwide, cardiovascular diseases (CVDs) are the number one cause of death. 
Smoking, unhealthy diet, physical inactivity and excessive use of alcohol are the 
most important behavioural risk factors of CVDs. As an effect, individuals may 
develop hypertension, diabetes, heart failure or atherosclerosis, most often related 
to a change in arterial stiffness. Considering the wide spread of CVDs in the world, 
there is a strong need for, besides adopting prevention, an easy and quick 
prognostic indicator of this disease to support early diagnosis.  
Arterial stiffness is most commonly used to express the viscoelastic properties of 
the arterial wall and is expressed as the relationship between change in pressure 
and change in volume. Arterial stiffness is a reliable prognostic indicator of 
cardiovascular morbidity. The gold standard for determining arterial stiffness is 
measuring the pulse wave velocity (PWV), which is the speed of the pressure pulse 
traveling through the moving blood. The goal of this Ph.D. study was to develop 
and validate a non-invasive, photoplethysmography (PPG)-based device for 
peripheral measurement of the PWV on the finger. To that purpose, the following 
aims were formulated: 
 to confirm the value of peripheral PWV measurements, 
 to design and technically validate a PPG-based device for measuring PWV 
in the finger, 
 to validate the developed device in clinical studies. 
The Ph.D. study existed of two complementary parts: Part I – Substantiation, 
illustrates the value of peripheral PWV measurements and provides a platform-
independent and measurement technique independent algorithm for improvement 
of PWV measurements. Part II - Development & Validation, describes the design, 
technical validation, testing, further improvement and final validation of the Multi 
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Photodiode Array (MPA), the PWV measurement device developed during this 
Ph.D. study. 
Literature study revealed that filtering techniques that are used to eliminate 
unsuitable pulse waves (PWs) are often not described in articles using PWs to 
determine physiological parameters for research or diagnostic purposes. Using 
unfiltered PPG-data may result in deviations in the calculated values from the 
actual values. In order to obtain valid measurements, it is essential to only use 
PWs that contain the morphological landmarks on which the definition of a PW is 
based. A '7Step PW-filter' algorithm was developed to apply 7 criteria to PW data 
to determine whether a PW matches the characteristics required to allow pulse 
transit time (PTT) or PWV-calculations. 
PTT, the propagation time of a PW going from the heart tot the peripheral arteries, 
consist of 2 components: the isovolumetric contraction time (pre-ejection period 
‘PEP’) and the PW propagation time through the vessel. The PEP is known to vary 
with cardiac preload and heart rate. When measuring PTT or PWV with a method 
that includes the PEP, the PEP contributes approximately 20% of the measured 
value. PTT/PWV at rest is an easy-to-use, non-invasive and accurate physiological 
parameter for monitoring arterial stiffness. In order not to suffer from the PEP, a 
system that allows measuring the PWV without including the PEP would be 
beneficial.  
PTT/PWV measurements are valuable in various clinical applications. For upper 
limb surgery, an axillary plexus block is used to desensitize and demobilize the arm 
and deactivate the vascular walls. The axillary plexus block affect the sympathetic 
nerves resulting in relaxation of the arterial wall muscle and vasodilatation, and 
change the state of the vascular system. By measuring the change of PTT during 
an axillary plexus block the condition of the vascular system can be determined 
much quicker and more objectively than by the conventional, subjective sensory 
test. 
Pain is commonly assessed subjectively by interpreting patient behaviour and/or by 
report from patients. Pain is a sensation that is highly subjective, but also has 
objective aspects. An experiment on 25 volunteers showed that the PTT decreases 
centrally in response to heat-induced pain stimuli. This suggests that the PTT is 
reliable parameter of pain-induced alterations of vasotonus and can be measured 
on a contralateral extremity in situations in which it is impossible or undesirable to 
measured directly on the affected extremity.  
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A novel sensor, called “Multi Photodiode Array” (‘MPA’), was designed for 
peripheral, non-invasive PWV measurements along a trajectory of 12 mm on the 
finger. The MPA basically is a transmission PPG sensor with a single row 
photodiode array instead of a single photodiode. The MPA can simultaneously 
measure the pulse rate, pulse wave amplitude, and peripheral PTT, and could also 
measure SpO2. The MPA was shown to deliver reliable and accurate PWV 
measurements with a deviation below 3% within clinically relevant ranges. 
Biopac and Complior are two existing systems that are generally used to 
non-invasively measure the PWV in the large arteries over a long trajectory. A 
study was conducted on healthy volunteers to investigate whether comparable 
results are provided by these systems, which both measure PWV over similar, but 
different trajectories. The results showed that the two systems correlated well, but 
the Biopac returned consistently lower PWV values than the Complior. This 
suggests that as long as the difference in PWV magnitude is taken into account, 
either system could be used to measure PWV changes over time. 
During the course of the research it was observed that the MPA positioning on the 
finger could strongly affect the quality of the PWV measurements. Therefore, an 
explorative study was conducted to find the optimal use condition of the MPA. Four 
aspects were explored: light pollution reduction, using collimators, shortening the 
light travel paths between the LEDs and photodiodes in the MPA, and optimizing 
the contact pressure of the MPA on the finger. The optimal use condition of the 
MPA appeared to be: soft-side positioning of the MPA, locating the active 
photodiodes across the middle, fleshy side part of the distal phalanx and using 
light contact pressure. The robustness and user-friendliness of the established 
optimal use condition was further substantiated in a final clinical validation study 
on 30 healthy volunteers of various ages and builds. That study showed that the 
MPA could be placed easily, rapidly, and consistently, irrespective of the volunteer.  
Overall, the results in this thesis suggest that the novel, PPG-based, MPA allows 
accurate and reliable PWV measurements within clinically relevant ranges. Some 
important advantages of the MPA as compared to other PWV measurement 
systems are that the MPA is easy-to-use, non-invasive, and provides objective 
data. In the future, the MPA may substantially simplify PWV measurements and 
enable long-term monitoring of vascular health, which may contribute to improving 
prevention, diagnosis and treatment of CVDs. 
Marit van Velzen, 2019 
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Wereldwijd zijn hart- en vaatziekten (HVZ) doodsoorzaak nummer één. Roken, 
ongezond eten, niet sporten en overmatig alcoholgebruik zijn belangrijke factoren 
voor HVZ. Als gevolg daarvan kan men hypertensie, diabetes, hartkwalen of 
aderverkalking ontwikkelen. Gezien de grote omvang van HVZ wereldwijd, is het 
van groot belang dat er onderzoek gedaan wordt naar een makkelijke en snelle 
methode voor het opsporen van deze aandoeningen om een tijdige diagnose te 
kunnen stellen.  
Arteriële stijfheid is de meest gebruikte maat voor de viscoelastische 
eigenschappen van de vaatwanden wordt bepaald uit de relatie tussen de 
verandering van de bloedvatdiameter als gevolg van een drukverandering in het 
vat. Daardoor is de arteriële stijfheid een reële indicator voor cardiovasculair 
morbiditeit. De gouden standaard voor het bepalen van arteriële stijfheid is het 
meten van de “pulse wave velocity” (PWV), oftewel de snelheid waarmee een 
bloeddrukpuls door het bloed in de vaten reist. Het doel van dit promotieonderzoek 
was het ontwikkelen en valideren van een niet-invasief, fotoplethysmografie (PPG)-
gebaseerd apparaat voor het perifeer meten van de PWV in de vinger. Daarvoor 
zijn de volgende doelen gesteld: 
 het onderbouwen van het nut van perifere PWV-metingen, 
 het ontwerpen en technische valideren van een PPG-gebaseerd apparaat 
voor het meten van de PWV in de vinger,  
 het ontwikkelde apparaat in klinische studies valideren. 
Het promotieonderzoek bestaat uit twee delen: Deel I - Onderbouwing laat zien 
wat de waarde is van perifere PWV-metingen en biedt een platform- en 
meettechniek-onafhankelijk algoritme voor verbetering van PWV-metingen. Deel II 
- Ontwikkeling & Validatie beschrijft het ontwerp, technische validatie, testen, 
DE SNELHEID VAN GOLVEN 
Het meten van de snelheid van bloeddrukgolven 
 die door perifere bloedvaten bewegen 
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verdere verbetering en uiteindelijke validatie van de Multi Photodiode Array (MPA), 
het PWV-meetinstrument dat tijdens dit promotieonderzoek is ontwikkeld. 
Uit literatuurstudie is gebleken dat filtertechnieken die worden gebruikt om voor 
analyse ongeschikte bloeddrukgolven (PW's) te elimineren vaak niet worden 
beschreven in artikelen die PW’s gebruiken om fysiologische parameters te bepalen 
voor onderzoek of diagnostische doeleinden. Het gebruik van ongefilterde PPG-
data kan leiden tot afwijkingen in de berekende waarden ten opzichte van de 
werkelijke waarden. Om geldige PWV-waarden te verkrijgen, is het van essentieel 
belang om alleen PW's te gebruiken die de morfologische oriëntatiepunten 
bevatten waarop PWV is gedefinieerd. Een '7Step PW-filter'-algoritme is ontwikkeld 
om te bepalen of een PW overeenkomt met de zeven karakteristieken die vereist 
zijn om pulse transit time (PTT) en PWV-berekening mogelijk te maken. 
Pulse transit time is de voortplantingstijd van een PW die van het hart naar de 
perifere vaten gaat en omvat mede de isovolumetrische samentrekkingsduur (pre-
ejectieperiode, PEP). Het is bekend dat de PEP varieert met de hartvoorspanning 
en hartslag. Wanneer de PTT of PWV gemeten wordt met een methode waarbij de 
PEP wordt meegenomen, is de bijdrage van de PEP ongeveer 20% van de 
gemeten waarde. PTT in rust is een eenvoudige, niet-invasieve en nauwkeurige 
fysiologische parameter voor het monitoren van de arteriële stijfheid. Om invloed 
van de PEP uit te sluiten, zou een systeem dat het mogelijk maakt de PWV te 
meten zonder de PEP mee te nemen gunstig zijn.  
PTT/PWV metingen zijn waardevol in verschillende klinische toepassingen. Voor 
een operatie aan de bovenste ledematen kan een axillair plexusblok gebruikt 
worden om de arm ongevoelig te maken en de vaatwanden te deactiveren. De 
blokkade beïnvloedt de sympathische zenuwen resulterend in ontspanning van de 
slagaderlijke wandspier en vasodilatatie, en verandert de toestand van het 
vasculaire systeem. Door de verandering van PTT te meten tijdens een blokkade 
kan veel sneller en objectiever de toestand van het vasculaire systeem gemeten 
worden dan met conventionele, subjectieve, sensorische tests. 
Pijn wordt vaak subjectief beoordeeld door interpretaties van het gedrag en/of 
meldingen van patiënten. Pijn is een sensatie die zeer subjectief is, maar ook 
objectieve aspecten heeft. Een test op 25 vrijwilligers liet zien dat de PTT centraal 
daalt als gevolg van een door warmte geïnduceerde pijnpuls. Dit suggereert dat de 
PTT een betrouwbare parameter is voor door pijn geïnduceerde veranderingen van 
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vasotonus en kan worden gemeten aan de contralaterale zijde in situaties waarin 
het onmogelijk of onwenselijk is om direct op de aangedane extremiteit te meten. 
Een nieuwe sensor, genaamd “Multi Photodiode Array’’, is ontworpen voor perifere, 
niet-invasieve PWV metingen over een traject van 12 mm op de vinger. De MPA is 
een transmissie-PPG-sensor met een fotodiode-array voor PWV-metingen. De MPA 
kan tegelijkertijd ook de pulsfrequentie, pulsgolf-amplitude, perifere PTT en SpO2 
meten. Het is aangetoond dat de MPA betrouwbare en accurate PWV metingen 
levert met een afwijking van minder dan 3% binnen klinische relevante bereiken 
Biopac en Complior zijn twee bestaande systemen die worden gebruikt om niet- 
invasief de PWV in de grote slagaders over een lang traject te meten. Er is een 
studie uitgevoerd bij gezonde vrijwilligers om te onderzoeken of vergelijkbare 
resultaten worden geleverd door deze systemen, die beide de PWV meten over 
vergelijkbare, maar verschillende trajecten. De resultaten toonden aan dat de twee 
systemen goed gecorreleerd zijn, maar dat de Biopac consistent lagere PWV 
waarden ten opzichte van de Complior leverde. Dit suggereert dat, zolang het 
verschil in PWV-waarde wordt meegenomen, beide systemen gebruikt kunnen 
worden om PWV-veranderingen over de tijd te meten. 
Tijdens het onderzoek werd vastgesteld dat de positionering van de MPA op de 
vinger de kwaliteit van de PWV metingen sterk kon beïnvloeden. Daarom is een 
verkennend onderzoek uitgevoerd om de optimale gebruiksconditie van de MPA te 
vinden. Vier aspecten werken onderzocht: vermindering van lichtverstoring, 
gebruik van collimators, kortere lichtroutes tussen de LED’s en fotodiodes en de 
optimalisatie van de contactdruk van de MPA op de vinger. De optimale 
gebruiksconditie van de MPA bleek te zijn: zachte-zijdepositionering van de MPA, 
lokaliseren van de actieve fotodiodes over het middelste, vlezige deel van de 
zijkant van de vinger en gebruikmakend van lichte contactdruk. De robuustheid en 
gebruiksvriendelijkheid van de optimale gebruiksconditie is verder onderbouwd in 
een klinische validatiestudie op 30 gezonde vrijwilligers van verschillende 
leeftijden. Uit de studie bleek dat de MPA gemakkelijk, snel en consistent kon 
worden geplaatst, ongeacht de vrijwilliger. 
Over het algemeen suggereren de resultaten in dit proefschrift dat de nieuwe, op 
PPG gebaseerde, MPA accurate en betrouwbare PWV metingen mogelijk maakt 
binnen een klinisch relevante bereik. Enkele belangrijke voordelen van de MPA in 
vergelijking met andere PWV-meetsystemen zijn dat de MPA gemakkelijk in 
gebruik is, niet-invasief is en objectieve informatie levert. In de toekomst kan de 
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MPA-sensor PWV metingen aanzienlijk vereenvoudigen en langdurige monitoring 
van vasculaire gezondheid mogelijk maken, wat kan bijdragen aan het verbeteren 
van de preventie, diagnose en behandeling van hart- en vaatziekten. 
Marit van Velzen, 2019 
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